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ABSTRACT 
 
There has been renewed interest into affective symptoms and psychological 
approaches to schizophrenia and other psychosis, yet no in-depth investigation as to 
the course, consequences or indeed psychological causes of depression in a phase 
specific manner in the important first episode. Our understanding of risk and 
aetiological processes in psychotic illness will only advance once we accurately 
identify the “end phenotype” of psychotic illness. 
This series of studies investigates the course of depression in first episode 
psychosis, its significance in terms of suicidal thinking, and relation to both diagnosis 
and other symptom domains. Depression in the acute and post psychotic phases is 
explored, through the importance of the awareness and appraisal of positive 
symptoms, and diagnosis itself.  
Significant findings include a pervasive nature of depression throughout the course 
of first episode psychosis, the predictive nature of prodromal depression and the 
high prevalence of suicidal acts. Appeasement and engagement with voices, 
subordination to persecutors and the (ineffective) use of safety behaviours drive a 
position of entrapment, demoralization and a lack of control. In addition negative 
illness appraisals are stable and may vary between cultural groups. 
Implications are explored, in terms of clinical practice, aetiological pathways, 
potential treatments and intervention strategies.   
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CHAPTER 1 
1.1 Schizophrenia  
Schizophrenia is currently described as a severe mental illness that affects 1 person 
in every 100, with an incidence rate of between 0.2-0.4 per 1000 annually (1). 
Schizophrenia presents for the first time between age 15 – 30 years for the majority 
of patients and often follows a relapsing and remitting course thereafter. Significant 
functional decline can occur (2).  Over 80% of patients achieve remission after first 
presentation, however nearly 50% have a subsequent episode within 2 years(1). 
Inception cohort studies in recent years show that 60 % of patients have an episodic 
course; 19% had achieved a full symptomatic remission and only 21% had a 
minimum weekly social contact. 27% regained employment (3). Life expectancy in 
schizophrenia is reduced, with 5 to 10% of patients committing suicide(4). 
Schizophrenia remains one of the most expensive illnesses in terms of global 
economic burden, in the UK alone costs are estimated at £864 million per year in 
care and lost earnings (5). Yet or knowledge at present is coloured by a theoretical 
enquiry that has looked at schizophrenia as so defined: a chronic illness with 
relapsing and remitting course. Recently increasing evidence has challenged this 
assumption, and targeted early interventions shown to be effective in altering the 
course of illness(6). 
 At present Schizophrenia is defined by specific symptoms of abnormal experience 
(in other terms “positive symptoms”) combined with blunted or inappropriate affect 
and lack of motivation (“negative symptoms”). The Positive/Negative symptom 
classification is widely used in clinical practice(7). The International Classification of 
Disease (ICD-10) defines schizophrenia thus: “The schizophrenic disorders are 
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characterized in general by fundamental and characteristic distortions of thinking and 
perception, and affects that are inappropriate or blunted. Clear consciousness and 
intellectual capacity are usually maintained although certain cognitive deficits may 
evolve in the course of time. The most important psychopathological phenomena 
include thought echo; thought insertion or withdrawal; thought broadcasting; 
delusional perception and delusions of control; influence or passivity; hallucinatory 
voices commenting or discussing the patient in the third person; thought disorders 
and negative symptoms. The course of schizophrenic disorders can be either 
continuous, or episodic with progressive or stable deficit, or there can be one or 
more episodes with complete or incomplete remission. The diagnosis of 
schizophrenia should not be made in the presence of extensive depressive or manic 
symptoms unless it is clear that schizophrenic symptoms antedate the affective 
disturbance”(4). Diagnostic and Statistical Manual (DSM –IV) diagnostic criteria for 
schizophrenia likewise are based on the premise that it is a discrete illness entity, in 
particular distinct from affective psychoses (for example Bipolar Affective Disorder) 
with an emphasis on the pathognomonic nature of certain symptoms including 
disturbances in thought, perception, affect, behaviour, and communication. Mood 
disorders are again offered as exclusion criteria (8). 
Schizophrenia has been said to occur equally in men and women, although recent 
evidence reports more frequent occurrence in males (9). It is identified in across all 
cultures but has been shown to occur much more frequently in minority ethnic 
groups(4). In the UK this is particularly marked in those of Caribbean decent, 
however the risk to minority groups extends well beyond individual ethnic groups and 
has been demonstrated in many different countries and cultures(10). The prognosis 
of schizophrenia is said to be affected by many factors, including the number and 
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severity of relapses, insight and treatment adherence, co-morbid drug or alcohol 
misuse, pre-morbid level of functioning, level family support, expressed emotion, 
insidious v/s acute onset amongst many others(4)  
There is no one cause for schizophrenia. Family history is found in some patients, 
and genetic aetiological pathway is attracting much research(11). Other aetiological 
theories currently attracting attention include such risk factors of cannabis misuse, 
living in an urban environment and early childhood trauma amongst others 
previously examined such as seasonality of birth (reflecting a maternal viral 
aetiology) birth trauma and hypoxic brain injury(1). 
1.11 Historical Concepts of Schizophrenia  
To begin with a succinct definition of schizophrenia, in laying out what will be a 
cornerstone of this thesis, would at first glance appear a sensible and straightforward 
piece of work. However, the concept, definition and meaning of schizophrenia could 
fill a volume in its own right. Current diagnostic terms, as outlined above, stem in part 
from a legacy of successful and unsuccessful historical classifications and must be 
understood in such a context. Textbooks of psychiatry themselves are disparaging 
“the current view of schizophrenia is not the result of one definition and one object of 
inquiry successively studied by various psychiatric teams, but is a patchwork made 
out of clinical features plucked from different definitions. More research is needed to 
find out what led to this sorry state of affairs”(4).  With the publication of ICD-10 and 
DSM-IV, a consensus view of schizophrenia at least unified what was prior to this a 
myriad of differing views, yet this has not brought about the definitive answer.  
Attempts to define and categorize mental illness began in the 19th century, prior to 
which insanity or “madness” would refer to everything physicians were unable to 
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separate(12). Indeed it was the advance of our understanding of physical illnesses 
such as infections and delirium, for example with the revelations that treponema 
paillidum was the cause of syphilis, that first enabled the concept of mental illness to 
be considered separately from that of the physical. Yet we know that mental illness 
in its broadest term has been evident throughout the millennium, with psychotic 
symptoms clearly present. Hippocrates wrote about madness, melancholia and 
puerperal psychoses amongst many others.(13)  
The modern history of psychotic illness begins with Morel, who in 1850 coined the 
term démence précoce to refer to states of cognitive deficit that begin in 
adolescence.  This was quickly followed by Kahlbaum and Hecklers definitions of 
catatonia and hebephreina (12). At the end of the century, Kraepelin proposed that 
both disorders of demence precoce and catatonia come together with ‘dementia 
paranoides’ (which he had recently termed) and were manifestations of the same 
underlying disease process(14). Kraepelin called this disease dementia praecox, 
later termed schizophrenia by Emile Bleuler. Kraepelin’s subsequent influence in part 
may stem from the rigour and extent of his data, kept on follow up cards for 
hundreds of patients. It is also important to recognise that Kraepelin’s concept of 
dementia praecox was proposed at a time when the term dementia likewise was 
undergoing transformation, from one meaning general incompetency, to acquired 
deficits and finally one resembling a modern concept whereby disturbance of 
memory was the main paradigm(12). European psychiatry followed Kraepelin’s lead, 
further ratified by Schneider’s work in the 1930’s and an emphasis on a 
psychopathological (symptom based) approach to define the disorder(12). Following 
on from this Karl Jaspers proposed a hierarchical approach to symptoms and 
diagnosis, culminating in present day definitions. These  clearly outline that some 
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symptoms, are ‘trumped’ by the presence of those of “first rank”, in terms of 
diagnosis and treatment(12).  
1.12 Historical Concepts of Affect in Schizophrenia 
Kraepelin, when defining dementia praecox also coined the term Manic Depressive 
Psychosis, and grouped melancholia and mania together for the first time. Again the 
legacy of this is strong; “Kraepelin's broad clinical experience resulted in compelling 
descriptions of the symptoms of mood disorders that have arguably never been 
surpassed. The Kraepelinian nosology continues to provide a touchstone for modern 
classification systems of the mood disorders” written in this century(15). The result of 
the dichotomous classification of manic-depressive psychosis and dementia praecox 
has, however, resulted in an under recognition of affective disturbance in 
schizophrenia and created the view that affective disturbance in schizophrenia is of 
lesser importance. Moreover, affective symptoms in schizophrenia present a 
continued challenge to the fundamental classification system that some find difficult 
to tolerate(16). 
Alternative definitions to those proposed by Kraepelin were however put forward by 
many. Bleuler(17) first coined the term “schizophrenia” subsequently adopted by the 
psychopathological approach. Yet at the time his proposed meaning of 
schizophrenia was very different. Influenced by psychoanalytical approach of the 
early 20th century, Jung indeed was one of his own pupils, the main focus of the 
disturbance in schizophrenia as proposed by Bleuler was a “splitting”; a loss of the 
unity of personality. For Bleuler the main symptoms of this disease were the 
loosening of associations, disturbances of affectivity, ambivalence, and autism (“the 
four A’s”). Bleuler also recognised that the condition was not a single disease (he 
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referred to a “whole group” of schizophrenias [3], was not invariably incurable, and 
did not always progress to full dementia. Whilst European psychiatry was influenced 
by Kraepelin, American psychiatry followed Bleuler and the psychoanalysts. In the 
end, Kraepelin and Schneider were “discovered” in the United States in the 1960’s, 
when psychoanalysis and indeed psychological treatments for schizophrenia fell out 
of favour. DSM-IV and ICD-10 now define very clear diagnostic criteria for 
schizophrenia, the implication being that as a result of agreement we have indeed 
discovered a distinct disease entity. The division of schizophrenia from affective 
psychosis in practice meant that affective symptoms have been ignored, or viewed 
as of secondary importance if recognised at all. 
 
1.13 Current Concepts of Schizophrenia 
Uncertainty surrounding the Kraepelinian dichotomy has however long been present, 
if suppressed.  For example, writing about the diagnosis of schizophrenia more than 
two decades ago Professor Brockington, one of Britain's most sophisticated 
nosological experts wrote ; "It is important to loosen the grip which the concept of 
schizophrenia' has on the minds of psychiatrists. Schizophrenia is an idea whose 
very essence is equivocal, a nosological category without natural boundaries, a 
barren hypothesis. Such a blurred concept is not a valid object of scientific 
enquiry'(18) Similarly, Brockington and Kendall concluded "there was no compelling 
evidence that the universe of psychotic patients falls naturally into two groups"(19). 
Crow has recently reminded us (20) that Kraepelin himself had doubts:“No 
experienced psychiatrist will deny that there is an alarmingly large number of cases 
in which it seems impossible, in spite of the most careful observation, to make a firm 
diagnosis…. It is becoming increasingly clear that we cannot distinguish satisfactorily 
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between these two illnesses and this brings home the suspicion that our formulation 
of the problem may be incorrect”.  
 
Among recent challenges to the dichotomous classification, the continuum approach 
and the dimensional view are presently gathering evidence. Both have in common 
however, an increasing emphasis on affective symptoms.  
 
 
a) Continuum Psychosis 
A continuum of psychosis, whilst first proposed by Griesinger as a “unitary” concept 
has in recent years seen a re-emergence(21). This stems in part from the recognition 
of schizoaffective disorder; Angst(22) first showed us in 1979 that patients 
presenting with schizoaffective disorders were significant in number. Initially 
Griesinger, building on work by Zeller, argued that madness was the consequence of 
a single disease of the brain, all permutations of which were representations of 
different stages of the same unifying primary process(14).  Whilst it is no longer the 
view that a single disease entity will be found for psychotic illness, it has now been 
proposed that there is a continuum of psychotic illness which may run between 
manic depressive psychosis and schizophrenia, with more affective symptoms 
weighted at one end, and negative, neurocognitive and poorer outcome at the other.  
This is a model recently put forward again by Craddock and Owen, in light of results 
from large scale genetic studies (see figure 1.1). These have repeatedly challenged 
a Kraepelinian dichotomy with many candidate genes identified in bipolar disorder 
also being found in schizophrenia and vice versa. However, Craddock and Owen 
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propose that there may still three overlapping broad domains of “prototype 
schizophrenia”, schizoaffective disorder and “prototype bipolar disorder” (20, 23).  
They argue that that the majority of patients will lie on the continuum rather than be 
“outliers” at either end. They have also recently purported that autism and “mental 
retardation” represent an extreme end of the spectrum(23) Yet a simplistic 
continuum does not allow for differing aetiological pathways, and an overlap of 
symptoms at disparate points along the continuum: for example affective symptoms 
within autistic spectrum. “Mental retardation” has multiple and independent 
aetiological causes, and Craddock findings are based singularly in their finding on 
susceptibility genes(24). Of course an alternative explanation may well lie in the false 
hope that molecular science will help elucidate what observational science has 
struggled with for many years. Crow has similarly argued recently for a continuum 
approach to psychosis, proposing that Craddock and Owen reach the right 
conclusions for the wrong reasons: the cause for an absence in replication of genetic 
studies may not be based in DNA sequence, rather it is “epigenetic” in form(20). In 
other words factors occurring at levels above or beyond the genetic susceptibility 
convey risk for schizophrenia when interacting with environmental influences. 
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Figure 1.1 Continuum Psychosis: From Cradock and Owen 2010(23) 
 
 
b) Dimensional View of Psychotic Symptoms 
An alternative view on a unitary concept for psychosis is the dimensional approach, 
whereby overlapping dimensions, or clusters of symptoms, will have distinct 
presentations, also reflecting underlying neurobiological process. An example of this 
may first be seen in the modern age with Liddle’s seminal work on a three dimension 
approach: reality distortion, psychomotor poverty and disorganization which showed 
clear evidence  to linked patterns of cerebral blood flow (25).  
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More recently factor analytic studies of psychotic symptoms have attempted to re-
examine and test the positive/negative symptom split in schizophrenia. They have 
uncovered four or five dimensional models (16, 26, 27), with dimensions including 
anxiety, negative symptoms, depression, excitement and positive symptoms. See 
figure 1.2.  
All recently proposed dimensional models contain a distinct depressive dimension. 
McGorry et al.(28) found a four factor dimensional solution, including depression, 
and advocate the study of psychosis rather than schizophrenia to halt the degree of 
premature closure on the psychopathology of schizophrenia. Van Os, in advocating 
a dimensional approach, again identified a well-defined four-factor solution with a 
depressive dimension clear in a sample with chronic psychosis(16) In addition, 
dimensional correlations within general population samples are clear (29), as is 
familial aggregation of dimensions, with the disorganization dimension showing the 
strongest family links (30). This, in addition to other lines of investigations such as 
stress reactivity in psychosis, has led some authors to propose an affective, and 
alternative cognitive, pathway to psychosis (31, 32).  
Much of our knowledge regarding outcome, prognostic indicators and risk come from 
samples where the categorical classifications have been used. However, there is 
evidence that a dimensional classification may prove more useful. Van Os 
demonstrated in1996 that a combination of bizarre behaviour and inappropriate 
affect showed poorer outcome, whereas a dimension distinguished by manic 
symptomatology predicted a more benign illness course (33).  Similarly, this paper 
also found that dimensional representations of psychopathological features were 
found to be considerably more useful than categorical representations along ICD-10 
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or DSM-IV as predictors of illness course and treatment decisions. More recently in 
combination with work form Kapur (34) a proposal of  the concept of “salience 
dysregulation” along dimensional classification, as an alternative to the term 
schizophrenia, has been proposed (35) 
Figure 1.2 Dimensional approach to Salience Dysregulation from Van Os 2009(35) 
 
c) Dimensional Psychosis vs Categorical Schizophrenia 
There are benefits and draw backs to using either a categorical, continuum or 
dimensional approach to grouping mental illness. Categorical approaches provide 
many benefits, and given the historical perspective outlined above, were a key 
advance. Unifying diagnosis and allowing reliability in research were clear 
advantages in the mid twentieth century. Indeed, research measures using 
standardised interviews based on DSM and ICD categories have shown good inter-
rater reliability across the world. In addition, communication between clinicians, 
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communication to patients and research into therapeutic options are all benefits from 
a categorical diagnostic approach. Robins and Guze (36) suggested five criteria to 
establish the validity of psychiatric diagnoses and illustrated their applicability to 
schizophrenia, namely, clinical description, laboratory studies, delimitation from other 
disorders, follow-up studies, and family studies. However, the difficulty with this 
categorical approach is well rehearsed above, with increasing evidence that whilst 
reliability is established, validity is less certain. Benefits of a continuum approach, 
rehearsed above, include a clearer understanding of one aetiological pathway, for 
example genetic, yet allow little room for complex interplay of psychopathology and 
vulnerability. Dimensional approaches on the other hand capture this variation in 
individual presentation, and allow for multiple aetiological pathways, yet as yet lack 
the succinct short hand and conveying of information offered in a categorical 
approach.  
Current and historical research in schizophrenia therefore has investigated an illness 
defined by various parameters, at differing stages of course and disease trajectory. 
Questionable generalizability has followed to predict poor or progressive outcome in 
the majority of sufferers. The “end phenotype”; psychosis, end stage schizophrenia, 
first rank or positive symptoms, psychotic illness with functional outcome or 
symptomatic remission needs to be more clearly defined to allow consistent 
investigation. Prospective studies of the full range of symptoms and outcome in 
prospective first episode samples is the start of this process. 
 
1.14 First Episode Psychosis 
The sustained, and indeed growing, criticism of the concept of a “Krapelinian” 
dichotomy has been fuelled in part by the interest in First Episode Psychosis and 
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associated research. First episode psychosis can be defined as the first presentation 
of a psychotic illness, including categorical diagnosis of schizophrenia, acute and 
transient psychotic disorders, depression with psychotic symptoms, schizoaffective 
disorders and a manic episode with psychotic symptoms (37). 
 
As discussed above, much of our understanding of the course and prognosis of 
schizophrenia comes from a categorical diagnostic perspective, however a difficult 
tautology exists: by definition schizophrenia offers a progressive course for most 
individuals, hence if schizophrenia is studied as this defined category it is 
unsurprising that this negative course will be found. The study of first episode 
samples prospectively has the advantage of not predetermining outcome for 
diagnostic purposes. In addition, diagnostic stability after first episode psychosis 
(FEP) is known to be modest to poor; Whitty et al 2005 (38) examined 147 patients 
with FEP at first presentation and four years later and found that one quarter had 
changed diagnostic category, with the largest shift form schizophreniform disorder to 
schizophrenia. 
Another attraction to research in FEP samples is that confounders such as 
medication, number and severity of relapse or episodes of illness different symptom 
(or dimensional) presentations are less prominent.  Research in FEP samples has 
grown enormously in the past ten years, particularly since the publication of the 
Edinburgh High risk Studies (39, 40) and much has been learnt. The course of 
psychosis from prodromal through to first episode and the importance of untreated 
psychosis to subsequent intervention has been made clear (37). See figure1.3 from 
Larsen 2001(37). Duration of untreated psychosis (DUP) is a more recent concept 
clearly linked to outcome in schizophrenia. DUP is defined as the period of time 
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between the onset of frank psychotic symptoms and adequate treatment. Recovery 
is affected by DUP both in terms of treatment effectiveness for positive symptoms, 
subsequent relapse and functional recovery(41).  
 
Effectiveness of interventions at this stage has been investigated, and much work 
also focused on service delivery and structure (41-44).  It has been possible to 
identify groups at high risk and ultra high risk (UHR) for psychosis through looking at 
prospective FEP studies (45, 46). The extent of psychotic-like experiences in the 
general population (47), what constitutes transitions to psychosis and symptoms, the 
risk of transition from UHR to “caseness” (48) and many other advances have been 
possible through the FEP research.  
 
 
 
Figure 1.3 Adapted from Larsen 2001 (37) 
premorbid phase very early symptoms psychotic symptoms
The typical course of psychosis
Psychosis
Recovery Relapse?
“DUP”
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1.2 Depression 
Depression is a common disorder that affects up to 20% of the population in their 
lifetime, and is characterized by core symptoms of low mood, fatigability, and 
anhedonia. Associated symptoms include reduced concentration and attention, 
reduced self-esteem and self-confidence ideas of guilt and unworthiness, bleak and 
pessimistic views of the future and ideas or acts of self-harm or suicide. Disturbed 
sleep and diminished appetite, known as “biological symptoms” also occur. Women 
exceed men in prevalence rates by up to twofold (4). Individuals with depression 
have a high chance of psychosocial dysfunction, an elevated morbidity and mortality, 
however, only around one quarter of individuals with depression seek medical 
help(49). Known risk factors for depression include family history; familial 
aggregation studies suggest a genetic process. Non genetic familial factors also play 
a role(50), and subsequent exposure to several potential susceptibility risk factors 
including early parental separation,  deprivation, and early childhood trauma (51, 52). 
Depression, like schizophrenia, is a concept or medical diagnoses that can be 
critiqued. Trauma and environmental stressors, discussed in more detail below may, 
be considered as common precipitants or causes of depression yet the biological 
model of depression remains in common use. 
1.21 Depression in Schizophrenia: Literature review 
Leaving aside a dimensional approach to psychosis, where all recent dimensional 
models contain a depressive grouping, even within categorical classification of 
schizophrenia, depression is more evident than first expected. Depression is 
extremely common in schizophrenia, as research over the last twenty years has 
confirmed (53, 54). A Pubmed search using the search terms “Depression and 
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Schizophrenia” as major descriptors reveal over 342 papers since 2000 alone. See 
appendix 1 for further details. Reviewing the detailed results of this review shows 
that the majority report briefly on depression as either a consequence of 
antipsychotic medication or a confounder for negative symptoms and few studies 
have depression as the primary or main focus of enquiry.  Siris and Bench (55) 
reported on 40 published studies documenting depressive symptomatology in 
schizophrenia. Depression is now accepted as common in schizophrenia, but often 
thought of as“co morbidity”. There is wide variance of rates of depression in 
schizophrenia reported, and this depends largely on whether a full syndrome or 
single symptoms are being reported, whether point or lifetime prevalence explored 
and what illness stage studied(55). This has often confounded and confused the 
research.  
 a) Prevalence of Depression in Acute Psychosis: 
This area has attracted relatively little research, yet there is evidence that depression 
may be more evident in the acute phase of illness.  Figures for the prevalence of 
depression in acute samples report rates from 45% to 68% (55-57). Tapp 
demonstrated in established cases of schizophrenia, depression accompanied the 
acute episode in 29% of patients, and this depression largely resolved with treatment 
of positive symptoms (58).  
b) Prevalence of Post Psychotic Depression 
Post psychotic depression is the most widely recognised depressive syndrome in 
psychosis; Kendell and Brockington (59), McGlashan and Carpenter (60) have all 
investigated this. ICD-10 (61) defines post-psychotic depression (F20.4) and 
requires that “some schizophrenic symptoms, either positive or negative, must still 
be present, but that they no longer dominate the clinical picture. If the patient no 
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longer has any schizophrenic symptoms, a depressive episode should be diagnosed 
(F32) If schizophrenic symptoms are still florid and prominent, the diagnosis should 
remain that of the appropriate schizophrenic subtype (F20.0-F20.3)”. These criteria 
confirm many of the assumptions outlined in the introduction above, that the 
predominance of schizophrenia symptoms often precludes the diagnosis of a 
concurrent depressive syndrome. 
Studies in chronic schizophrenia show lower rates of depression following the acute 
phase; 5-40% (56, 62) with a modal rate for the occurrence of depression across all 
samples of 25% (55). In the past, studies have rarely distinguished between the 
immediate post-psychotic and chronic phases of illness, and often included a mixed 
sample of participants(55, 63). Zisook (64) placed emphasis on older patients, 
finding a 20% point prevalence of severe depression (defined as a Hamilton 
Depression score of >17), and concluded that depressive symptoms are also 
common in older patients with schizophrenia.  
1.22 Depression in First Episode Psychosis 
There is some evidence that depression may be more evident in first episode 
psychosis, and this group may give important insight as to the origins of depression 
in schizophrenia, and indeed this dimension of psychosis. Koreen et al(65) examined 
70 patients with first episode schizophrenia and found depressive symptoms as high 
as 75%; Addington (66) found that depression was also significantly higher in first 
episode patients when compared with established cases and that depression scores 
were higher in the acute phase than at follow up. We do not however have 
information on the prevalence of depression thorough out the course of FEP and 
how this might predict future episodes. 
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 The initial prodrome of psychosis is also a potentially important period for 
elucidating the depressive dimension (67). It is now recognised that individuals can 
be accurately recognised within the prodromal phase, and that it may be possible for 
interventions here can alleviate, delay or even prevent transition to a full psychotic 
episode (45, 68, 69). Despite early ambiguity, there are now recognised core 
symptoms commonly presenting in prodromal and high-risk groups (70). What is 
striking however is the strong presence of depressive symptoms in prodromal 
clusters, in both retrospective and prospective study designs (45, 71, 72). Yung (73, 
74) found rates of depressive symptoms of 76%, and identified high levels of 
emotional disturbance as being more predictive of transition to psychosis than sub-
threshold positive symptoms. McGorry (67) found that 45% of high risk groups met 
criteria for DSM depressive disorder. Heiden and Hafner (75) in the ABC first 
episode sample report that 83% of their sample showed a depressed mood in the 2 
weeks before first admission, on average depressive symptoms appearing 52 weeks 
before first admission. Results from the Edinburgh High Risk study (40) found that 
high amounts of anxiety and depression were found in the high-risk sample long 
before those individuals developed frank psychotic symptoms features. These 
affective symptoms were also significantly worse in those who subsequently 
experienced first episode schizophrenia. 
1.23 Why is Depression in Schizophrenia and FEP Important?  
a) Suicide: 
Suicide is a common cause of preventable mortality across the world. Estimates 
currently place one million deaths per year caused by suicide globally(76). However 
there is real evidence that this may be a considerable underestimation, perhaps by 
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as much as 15%. Reporting of suicide varies considerably between countries, and 
religious and cultural variations affect the acceptability, and hence openness 
surrounding the reporting of suicide (77). In the UK suicide rates currently remain a 
cause for concern, with rates between 15-25 per 100,000 per year(78). Whilst rates 
appear to have fallen in recent years in older population groups, there was a distinct 
rise in young men in the 1990’s and early 21st century. Between 1950 to 1998 in 
England and Wales, rates of suicide in men under 45 years of age doubled, while 
rates in women and older men declined. During the 1990s, rates in young men aged 
15-24 years reached an all time high and were also at their highest since the 1920s 
in men 25-34 years of age (78). Some evidence suggests this has now peaked, with 
the wide spread use of catalytic converters in cars reducing the number of completed 
suicides by exhaust fumes as a possible explanation(78). However the current 
economic crisis again is prompting an expectation of a further rise, and suicide still 
accounts for the 5th most common cause of death in young men(79).  
Completed suicide rates vary between ethnic groups in the UK, with lowest rates 
seen in Afro-Caribbean, for women higher in Asian women and highest in white 
men(80). Risk factors for completed suicide are complex and varied. Division 
between proximal and distal factors can be helpful (76); Distal factors may include 
factors such as a family history (reflecting a possible genetic link), early traumatic life 
events, restricted foetal growth and personality characteristics. Proximal risk factors 
include psychiatric illness, physical illness, psychosocial crisis and availability of 
means. People at higher risk of suicide, such as those who are socially and 
economically disadvantaged, are also at high risk of mental illness (81). 
Mortensen and colleagues showed that the importance of socioeconomic 
variables as risk factors for suicide was reduced after adjustment was made for a 
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history of mental illness, implying the weight of risk is mediated or driven by mental 
illness (81). Hopelessness as an independent proximal risk factor has strong 
evidence for conveying risk of completed suicide (82, 83). However, one of the most 
consistent findings is that the strongest predictor for completed suicide is a previous 
non fatal attempt (84).  
b) Deliberate Self Harm: 
Following presenting to hospital with nonfatal overdose or deliberate self harm 
(DSH), between 1% and 6% will go on to complete suicide in the following year(85). 
There is some debate over whether attempted suicide (i.e. acts committed with the 
overt intention of ending life) can be distinguished from deliberate self harm; 
however the risk incurred appears to be clear regardless of intent, and remains for a 
number of years. Owens found the risk incurred from DSH continued some 9 years 
after the index episode, and incurred a 100% increase in the likelihood of completed 
suicide (85). DSH is increasing in young people. In a school survey of 15-16 year 
olds, 6.9% participants reported an act of deliberate self harm in the previous year.   
Only 12.6% of episodes had resulted in presentation to hospital. Deliberate self harm 
was more common in females than it was in males(84).  
 
1.24 Suicide and Deliberate Self Harm  
Depression in schizophrenia is important, not least because it is significantly 
associated with suicide (86, 87). Completed suicide remains tragically frequent in 
psychotic illness (88-90) with an estimated 4.9%-10% of patients with schizophrenia 
committing suicide during their lifetimes(91). There is mixed evidence as tot he rate 
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of suicide, which in some studies is increasing or at least not significantly reducing 
(92, 93), other more recent papers point to a fall in suicide in early intervention 
settings(94). Suicidal behaviour in patients with psychotic disorders was said to 
“represent a seriously under-treated life-threatening condition” by the International 
suicide prevention (interSePT) trial (95). 
The early phase of illness is a particularly high-risk period: Mortensen & Juel 
(96)followed up 9,156 first admitted schizophrenia patients and found that suicide 
accounts for 50% of deaths in men and 35% in women. They identified that suicide 
risk was particularly high in the first year of follow up. Alternatively, the OPUS study 
(97), which focused on suicidal behaviour in first episode psychosis in the 
Netherlands, found female gender, hopelessness, hallucinations and suicide 
attempts at baseline to be predictive of future suicide attempts. Verdoux et al. (87) in 
a more recent study found that 11% of patients with psychosis displayed suicidal 
behaviour in the 2 years after the onset of a first psychotic illness. A history of DSH 
and a deteriorating clinical course predicted those at increased risk.  Previously, 
Westermeyer et al. (98) identified that those diagnosed with schizophrenia and other 
psychotic patients were especially vulnerable to suicide in the first 6 years after first 
hospitalisation and that white, male patients with high measured intelligence quotient 
(IQ), and  a more gradual onset of disorder were more at risk. 
Thus the risk of suicide in psychotic illness remains highest in the early phases of 
psychosis, including the periods before and after the first episode (99). Suicidal 
behaviour in patients with psychotic disorders “represents a seriously under-treated 
life-threatening condition” (95), yet an elimination of  suicide in schizophrenia 
remains an elusive goal of mental health services.  Early intervention services and 
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psychological therapy in schizophrenia are showing some positive results in reducing 
suicide(100): targeted therapy for depression in schizophrenia has not however often 
been explored. There is however some literature pointing that this will be a 
potentially important area to target; cognitive therapy has been shown to be effective 
in the reduction of suicidality in schizophrenia (101) 
Depression and hopelessness are known precursors of deliberate self harm and 
suicide in psychosis (97). Suicide in schizophrenia appears different from other 
groups; factors increasing risk in general populations such as gender or lack of a 
partner are not found in patients completing suicide with schizophrenia. Alternatively, 
as the OPUS trial showed, hopelessness, depression, persistent suicidal thinking 
and previous attempts were much more prominent (102). 
1.25 Depression in Schizophrenia and other outcomes: 
Depression not only conveys a risk for poor outcome in terms of suicide. Functional 
recovery is also impaired by the presence of significant post psychotic depression; 
Sands (103) showed that in addition to an increase risk of suicidal thinking, 
depression in chronic schizophrenia indicated poorer overall outcome, work 
impairment, lower activity and dissatisfaction. In addition, recent evidence has shown 
that neurocognitive deficits are high in those with psychotic depression at first 
episode. Patients with depressive psychosis as well as those with schizophrenia at 
first presentation demonstrated widespread impairments, yet deficits in patients with 
bipolar disorder or mania were less pervasive (104). There is also evidence also that 
affective symptoms can indicate a better prognosis: If indeed a continuum approach 
is used, symptoms from the bipolar or affective end of the continuum will resemble 
bipolar disorder more than schizophrenia and have a better outcome. Oosthien 
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showed that depressive symptoms at baseline predicted fewer negative symptoms 
and better functional recovery in a short twenty four week follow up study (105).  
Globally, schizophrenia has a huge burden to society costing billions of pounds 
annually; $62 billion in the United States, in the UK £862 million (5) in terms of 
treatment costs and lost productivity. In the current financial climate and NHS 
spending, any new therapies need to have a clear evidence base and be shown to 
be cost effective. In summary, although there is huge potential for new interventions 
to impact on the scale of recovery and cost effectiveness of treatments for psychotic 
illness, further understanding of the psychoses is prerequisite, and evidence needed 
to demonstrate where effective interventions may be targeted.  
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Chapter 2 
2.1 Psychological Models of Depression 
Over the last 40 years, many differing psychological models of depression have 
arisen; some however have had more impact than others. A complete review of all 
cognitive investigations and treatment models for depression is outside the scope of 
this thesis; however a brief overview of the main models is necessary before 
understanding of this potential origin of depression in schizophrenia and FEP. 
Psychological theories of depression can be grouped in to three primary themes 
focusing on: Cognitive processes and Depressogenic thinking; Early experiences 
and Adversity; and Social factors and Interpersonal relationships. 
Cognitive models and subsequent therapy for depression was first described by 
Aaron T. Beck in the 1960’s (106), subsequently undergoing a number of revisions 
and refinements. The main emphasis is on recognizing that behavioural and 
emotional responses are largely determined by schemata one has about oneself. 
Cognitive distortions shaped by previous experience may lead to negative emotional 
reactions and inaccurate or distorted thinking. Early like experiences, whist shaping 
and forming beliefs and schemas about the world are not the focus of therapy. 
Depression is characterized as a “thinking disorder”(107). Selective abstraction of 
data, negative self evaluations and overgeneralization are at work precipitating and 
perpetuating depression.  
Alternatively, with more emphasize early experiences and adversity as 
depressogenic, the Learned Helplessness model began with animal studies. It is the 
experience of an uncontrollable negative event administered with no opportunity of 
escape that will influence behaviour in subsequent negative events. Seligman (108) 
used dogs who were exposed to an unavoidable and inescapable shock, finding the 
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majorly of dogs subsequently did not escape from a shock when the opportunity then 
arose.  Seligman was able to describe and understand how previous experience can 
shape thought processes and subsequent risk of depression (108). In the learned 
helpless model of depression therefore, previous exposure to inescapable shock or 
punishment will lead an individual to be less likely to escape or change future events 
even when avenues are open. This has been used to explain particularly the 
biological symptoms of depression e.g. anergia, and hopelessness as cognitive 
process. In a revision of Seligman’s model, Abramson(109) in 1977 focused more on 
the role of helplessness: “When a person finds he is helpless, he asks why he is 
helpless. A causal attribution he makes then determines the generality and chronicity 
of his helplessness deficits as well as his self esteem”. The attribution bias in 
depression is framed around an individual’s tendency to give cause of negative 
outcomes to internal, global and stable factors, and positive outcomes to external 
unstable factors. For example, one may assess failing an exam as an enduring 
personal inadequacy, and passing an exam as down to “luck” or other external 
factors.  
In the third broad group of psychological models of depression, human affect and 
behaviour can also been understood within a wider social context. The social 
environment can bring with it certain risk factors for depression, as can individual 
interpersonal relationships within societal rules and meanings.  One of the most 
influential approaches has involved the role of life events in the genesis of 
depression. In 1978 Brown and Harris (52, 110) published the result of their in-depth 
study in to the nature of life events that provoke a depressive response. Their view, 
now widely adopted was that depression is an “understandable response to 
adversity”. They identified two types of event: that of ongoing difficulties, such as 
26 
 
poor housing, long term unemployment and social class, and provoking agents 
described as specific events that occur in a critical time frame, such as the death of a 
parent prior to adolescence. Brown and Harris, with many subsequent revisions(111, 
112) propose that depression does not just result from vulnerability factors alone, 
and vulnerability factors can also provide the context within which other events can 
occur. For example, a loss event can occur within the context of negative self 
evaluations, driving cognitive processes such as helplessness and hopelessness, 
resulting in depression, but also increasing the chance of experiencing further 
adversity and ongoing difficulty. Hopelessness is mentioned in many theories of 
depression and a key theme in the studies presented in this thesis. 
 
Evolutionary psychological models of depression are perhaps less well known, but 
are also very relevant. Evolutionary psychology forms its basis in Darwinian natural 
selection and the instinct needed to survive and reproduce. As human kind evolved, 
novel methods were needed to establish position in any group: position coming with 
it access to food, a mate and survival. In a species of scarce or precious numbers, 
dominance needs to be decided by ways that avoid direct physical conflict. A 
dominant subordinate relationship is thus established with in any human pair or in 
any group by a variety of forms of verbal and nonverbal communications: averting 
eye contact, nervous laughter, allowing others to speak, etc. Within the context of 
emotions, these common feelings are also proposed to have developed through a 
process of natural selection. A role is played in determining adaptation to certain 
situations where there is demand of an individual for that emotion will occur (113). 
Thus, as Nesse argues, a negative affect, or depression, is as adaptive in certain 
situations as a positive one(114). Like physical pain, negative affect can be an alert 
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that something is wrong. Additionally, shame as an emotion has attracted some 
attention in terms of a specific role in evolutionary psychology. Gilbert (113)  argued 
that shame, linked to depression and anxiety, is related to the establishment of 
dominant-subordinate relationship in terms of social attractiveness. High social 
status brings with it security and greater opportunities for selecting a mate, and by 
contrast ensuring competitors have a low status, by way of shame, increases the 
opportunities for the individual of high status. Any individual experiences shame 
when confronted by behaviours aimed, all is it subconsciously, at putting him or her 
down. Shame or indeed depression, is a negative emotional response, is a way of 
altering the lower status individual to this status and motivating him or her to regain a 
position of power. In this context depression is viewed as a signal marking down 
ranking or subordination, leading from feelings of humiliation and entrapment (114).  
 
2.2 The Origin of Depression in Schizophrenia and FEP 
Many different models of the link between depression and schizophrenia have been 
proposed. As summarised in Table 2.1, depression has been explained as an 
intrinsic part of the syndrome itself, as a side effect of antipsychotic medication, as 
an expression of negative symptoms or as a psychological reaction to psychosis as 
a major life event(63).  
 In more detail, it has been proposed by Heiden (115) that the depressive syndrome 
is a pre-formed reaction pattern associated with clear neurotransmitter dysfunction 
progressing as the underlying brain dysfunction progresses; a Jacksonian 
hierarchical model whereby in a pathway to brain dysfunction severe enough to 
produce psychotic symptoms, the lesser neural networks will inevitably be 
disordered. 
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Alternatively, negative symptoms of schizophrenia can overlap with those of 
depression, particularly diminished energy and motivation. Blunted affect can give an 
objective impression of depression, and care must be taken when assessing for 
affective disturbance that this overlap is teased out. Cognitive features such as guilt 
can be helpful in distinction(116, 117) 
Effects of neuroleptic medication have long been proposed as causes for depression 
in schizophrenia, with some merit. Dopamine is increasingly known in regard to 
“reward” systems within the brain, and blockade could theoretically produce a 
dysphoric response and anhedonia.  In addition to direct effects on dopamine, side 
effects of medication can mimic depression in other ways. Akinesia and akathasia 
commonly occur. Older studies looked at the relationship between haloperidol 
plasma levels and depressive symptoms in chronic schizophrenia with positive 
results(117). The hope was that the advent of atypical antipsychotic medication 
would produce a reduction in post psychotic depression, unfortunately this has not 
been fulfilled(117). 
In contrast, the psychological response model has modelled depression as a 
cognitive process in psychosis, reflecting themes discussed in chapter 2.1. This will 
be discussed in more detail below. 
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Table 2.1 Models of depression in Schizophrenia  
Modified from Upthegrove 2009(63) 
 
1             Proposed origins of depression in schizophrenia 
Model Comment 
Intrinsic to the illness itself A Jacksonian hierarchy: all ‘lesser’ 
neurobiological abnormalities will 
be common when mental illness 
severe enough to produce 
psychotic symptoms exists 
Medication effects For example: bradykinesia, loss of 
spontaneity, sedation, akathisia 
An expression of negative symptoms The overlap of biological 
symptoms of depression with 
negative symptoms (e.g. motor 
retardation) and symptoms of 
apathy  
Psychological response model Emphasis on the personal 
significance of psychosis and 
positive symptoms. Appraisals of 
loss and threat key.  
Dimensional Approach In contrast to categories, psychosis 
consists of dimensions and 
depression is one of 5 dimensions 
present to a greater or lesser 
extent in any individual 
 
 
2.3 Psychological Models of Depression in Psychosis: 
2.31 The Role of Insight 
Depression in psychotic illness has long been linked to insight, or awareness of 
illness (118), however insight in itself is not a concept without difficulty. For the past 
three centuries ideas of insight have been variously written about throughout the 
psychological domains. Psychologists, early psychotherapists and psychiatrists have 
all struggled to define what this term means to them. Perhaps the very real 
difficulties in definition and in quantifying what we mean by insight have hampered 
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research and progress of thought. It has also long been recognised that the lack of 
awareness in the psychoses is similar to that whereby structural damage has 
occurred in the brain resulting in denial of affliction. It was Babinsky  in 1914 (119) 
who first introduced the term anosognosia to describe the denial of disability of 
patients following right hemisphere lesions. The developing thoughts on insight in 
psychosis did not occur in isolation or in parallel to these developments. Berrios and 
Markova (120) argue that it was essential that the developments in the psychological 
and psychoanalytical spheres on consciousness and insight came in order to provide 
those interested in psychosis with the language and background for their own work. 
The phenomenologist’s incorporated their ideas of insight in to the core of 
psychopathology; Jaspers at first appears dismissive: “In psychosis there is no 
lasting or complete insight”(121) and it is clear that, although insight eventually gains 
its own space in the mental state examination, there are not the volumes of 
discussion that can be found for delusions or abnormal perceptions. Prior to the work 
of the great phenenomenologists, the idea of any awareness in psychosis would 
have been a contradiction in terms. Insight was not a variable but a parameter in the 
definition of insanity (122). Only the development of partial madness and of 
monomania allowed for the existence of an insanity that was aware of itself(123). On 
closer inspection Jaspers (121) has more to say. He observes that in the early 
stages of illness patients are perplexed, and that this was an understandable 
reaction. As the illness progresses the patient might try to make sense of his 
symptoms, by elaborating on his delusions. Jaspers makes the distinction between 
schizophrenia and the other psychoses, by using insight, stating that here the patient 
would not have insight. Kraepelin, in 1919 (12) described patients with dementia 
praecox as being typically unaware of the gravity of their disorder.  
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Aubrey Lewis appears more interested in insight than others, and given the seminal 
nature of his original article in 1934, which still resonates today, it is worth looking at 
this in more detail. Lewis begins, after reviewing the meanings of the term to the 
prominent groups of the time to derive its meaning from origins: “Seeing with the 
eyes of the mind, having inner vision and discernment”. He goes on to comment that 
insight is concerned with looking inwards rather that outwards(124).  Awareness of 
change might primarily be determined by neuropsychological function, as a 
component of the illness itself and its biological components. The judgement of this 
change and its communication would appear to be more susceptible to social 
factors: education, culture, vocabulary available, and belief structures. It is with his 
whole disordered mind that the patient contemplates his state or his individual 
symptoms(125). 
Modern definitions and investigation of Insight have however brought some degree 
of agreement. Broadly, insight is recognised by research and increasingly in clinical 
practice, to be grouped in to three clusters. Firstly the ability to recognise one has an 
illness, and that this is a mental illness (“awareness of illness”). Secondly, for the 
patient to be involved in treatment compliance or adherence and thirdly, the ability to 
re-label specific psychopathology as abnormal; for example to recognise a voice is a 
product of one’s own mind (119). 
 
2.32 Illness Appraisals 
Appraisal itself can be defined as the classification of someone or something with 
respect to their worth. Poor self appraisal is a key feature in the generation of or 
propensity to depression, clearly reflecting themes of self esteem, position, social 
power and helplessness. Increased insight in psychosis comes with a value 
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judgement for the meaning of an individual’s recent or ongoing experience. As 
defined above, ideas based on social ranking can be modelled into theories for the 
development of depression: Gilbert argues that social rank and power make certain 
situations more likely to be depressogenic, particularly if accompanied by feelings of 
loss, humiliation or defeat (126, 127). First episode psychosis can be viewed as a 
major life event, but also an event which during which the experiences of humiliation, 
shame and defeat are common (56). One archetypal factor that is highly congruent 
with the course of depression is self-esteem (112). Reflecting an evolutionary 
perspective,  Dunkley, et al., (128) have further explored the characteristics of 
psychological models in severe mental illness, arguing that depression-prone 
individuals suffer from insecurities regarding attachment and social acceptance. In 
addition, the developmental nature of self-representations is argued to be a 
significant factor in the recovery of individuals with severe mental illness. Davidson 
and Strauss (129) suggest that reconstruction of the self can only occur following 
acceptance of the disorder, allowing individuals to focus on their sense of self and 
‘move forward’ in life. Yet after FEP individuals may fall short of their preferred or 
aspired-to self, resulting in a sense of entrapment and loss.   
Alternatively Estroff (130) outlines several key appraisals used by patients 
recovering from mental illness, and proposes that these are distinct from recovery 
from other physical illness. Mental illness challenges self identity, and is influenced 
by societal and scientific stereotypy of the illness. For example, a patient is the 
disorder (“I am a schizophrenic”) rather than someone with the disorder (“I have 
hypertension”). They propose this leads to an engulfment in the illness, or a defeat to 
it, where by the self is “taken hostage” by the diagnosis. 
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Patients’ appraisal of the diagnosis of psychosis and experience, and its impact on 
social roles and status in terms of loss, shame and entrapment have been shown to 
have predictive value in the development of post-psychotic depression (131). In their 
detailed study of the of post psychotic depression, Iqbal (131) identified 70% of their 
chronic sample as depressed at onset (in an acute phase), and that 54% developed 
a post psychotic depression. There were four distinct course types identified: 
Depressed at onset, improvement, and return of depression, No depression at onset; 
depressed at one or more follow-up points, Depressed at onset; no depression 
throughout the follow-up period and no depression at onset or throughout the follow 
up period. Their results demonstrate that those who go on to develop depression 
appraised greater loss, humiliation and entrapment arising from their psychosis, and 
were more likely to attribute the cause of the psychosis to the self. During post 
psychotic depression a lowering of self-esteem and hardening of these negative 
appraisals has been demonstrated (131-133). No such studies have occurred in 
FEP, where affective symptoms are more common, the risk of suicide greater and 
the potential to effect illness prognosis and trajectory greatest. 
 
2.33 Insight and Illness Appraisals; Role in Suicide 
 
 
The link between awareness of illness, depression and indeed suicidal behaviour 
has long been acknowledged, and explored in the past(134). Whilst greater 
awareness and treatment compliance has been typically associated with better long-
term outcome, increased awareness is positively associated with suicide risk (134). 
Awareness in this context has traditionally been viewed in terms awareness of illness 
itself, the capacity to re-label psychotic experiences as abnormal and treatment 
compliance (135). The links here to hopelessness and suicidal thinking have been 
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explored with researchers suggesting that greater insight into the fact that they have 
mental illness precipitates these beliefs (86). This has real relevance to clinical 
practice: Rathod and Kingdon (136)showed CBT is effective in increasing insight, but 
also demonstrated that those with an improvement in insight will become more 
depressed. This association is long reaching; recognition of mental illness within  six 
months after an acute episode of psychosis has been shown to be predictive 
depression and attempted suicide within four years(137).  
 
2.34 Appraisal of the Positive Symptoms of Psychosis 
Clear links have been established between auditory hallucinations and depression, 
and postulated to be mediated thought appraisal; in chronic schizophrenia 
Birchwood and Chadwick(138) reported that two thirds of patients with chronic 
auditory hallucinations reported at least moderate levels of depression, and 
suggested that the depression was linked to beliefs about voices. These beliefs were 
described as centering on the power and intent rather than the specific content or 
frequency. In essence a dominant subordinate relationship develops between and 
individual and their voices. This has been replicated in other studies in chronic 
schizophrenia (133) and a clear demonstration of depression in chronic voice 
hearers has been made. Acting on commands, reflecting seminal work by Milligram 
in the 1960’s, has also been demonstrated to be a result of this dominant-
subordinate positioning in voice hearers(139); patients are more likely to act on 
commands when they perceive their voice as being in a position of higher status or 
as power powerful position. In developing this theory, Chadwick suggests that 
patients with auditory hallucinations with malevolent content and powerful voices are 
trapped in a threatening reality. This results in feelings of helplessness and 
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depression, therefore recalling psychological models of depression rehearsed above, 
common themes are a dominant subordinate relationship, shame, negative 
emotions, helplessness in the face of an inescapable situation and an ongoing 
adversity (139). 
Freeman (140), in relation to the cognitive reaction to persecutory delusions, found 
higher depression and distress associated with higher power and omnipotence of 
persecutors, again reflecting ideas from evolutionary psychology.  Here distress was 
mitigated by patients’ ability to avoid the threat by adopting ‘safety behaviors’. Safety 
behaviours can be described as the taking up of actions carried out with the intention 
of reducing perceived threat. These can be seen as protective actions taken up to 
avoid or deal with a threat, for example avoidance of social situations or public 
transport or actions carried out in order to protect oneself against direct threat, for 
example carrying a knife. Freeman and Garety propose safety behaviours provide a 
new way of understanding how patients act on delusions(140). One study(141) has 
examined the prevalence and correlates of safety behaviors in relation to 
persecutory delusions. One hundred patients with persecutory delusions were 
assessed for safety behaviours, acting on delusions, anxiety, depression, and 
psychotic symptoms and the vast majority: ninety-six had used safety behaviours 
and their use was associated with higher levels of distress, violence and suicide 
attempts. They concluded that safety behaviors are a common form of acting on 
persecutory delusions and that these behaviors have the consequence that they are 
likely to prevent the processing of dis-confirmatory evidence and will therefore 
contribute to delusion persistence, as well as an emotional reaction to the ongoing 
adversity. 
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2.4 Psychological Treatments in Schizophrenia and FEP 
Cognitive Behavioural Therapy (CBT) is now regarded as a major treatment option in 
schizophrenia (142), and is a core therapy for this disorder as recommended by 
NICE (143). As discussed later in this chapter however depression in schizophrenia 
has many potential origins, and in addition avenues open and suitable for 
psychological therapies abound: insight, appraisals of illness, hopelessness, and 
persecutory beliefs. To date most studies evaluating the effectiveness of CBT in 
schizophrenia have looked at the remediation of positive symptoms in general (144), 
specific subgroups of symptoms (eg command hallucinations) or overall 
improvement, with good results (138, 142). Only a small minority have evaluated 
depression as an outcome, and most of these have not had this affective symptom 
as a main outcome measure. CBT has been accused of being treated as a quasi 
neuroleptic,(145) with the effective components of treatments under recognised and 
under researched.  
 
2.5 Summary: 
The definition of severe mental illness has shifted again in recent years from an 
acceptance of distinct disease categories, with predetermined outcomes, to a 
consideration of other possibilities. This has led way to a renewed interest of 
psychological approaches and understanding of schizophrenia and other psychosis, 
fuelled by interest in First Episode Psychosis (FEP). Depression appears to be 
common in schizophrenia and FEP, however there has been no in-depth 
investigation as to the course, consequences or indeed psychological causes of 
depression at this crucial time. This area of research is both novel and important: 
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FEP is a time of high risk, and depression and hopelessness clear precursors of 
suicidal thinking. Furthermore, our understanding of aetiological processes in 
psychotic illness will only advance once we successfully address a full understanding 
of the disorders and accurately identify the “end phenotype”.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
38 
 
3.0 Aims and Hypotheses 
In these studies, the overarching aim will be to explore in detail, for the first time, the 
evolution and aetiology of depression in first episode psychosis (FEP). In particular 
the significance of depression will be explored in terms of suicidality, and the 
psychological response model explored as an aetiological factor. Furthermore, the 
personal impact of patients’ appraisal of the threat posed by voices, persecutors and 
diagnosis in first episode psychosis will be examined. 
 First, a determination of the prevalence and course of depression in first episode 
psychosis will be charted, as will the role of depression in predicting acts and 
thoughts of self harm. As rehearsed in Chapter 1, this is an area of novel yet 
clinically relevant research.   
Once the prevalence and course is established, the role of illness appraisals and 
threat from persecutors within the generation of depression in the acute phase will 
be investigated. The psychological response model has been investigated in 
established samples, and in post psychotic depression in previous literature, but has 
not been investigated in the acute first episode. Intuitively these appraisals will be 
more relevant in this phase of illness, particularly as the experience of psychosis, of 
hearing voices or experiencing persecution will be novel, “new”, to patients at this 
stage. 
Factors involved in the prediction and severity of post psychotic depression will then 
be evaluated. Although post psychotic depression is the most widely recognised 
depressive syndrome in schizophrenia there has been relatively little research in a 
clearly defined post psychotic phase. As discussed in Chapter 1, many samples are 
from generic “chronic” groups with longstanding and well established diagnosis.  One 
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previous study has looked at the psychological response model in a defined post 
psychotic group, but again this was in an established sample. Influences of post 
psychotic depression in a first episode sample has seldom been explored. 
A recurring theme in the aims to this point is the subjective appraisal of psychosis in 
terms of its personal significance, particularly with regard to loss, shame and feeling 
of entrapment. One limitation from any results and their predictive capacity will 
centre around the direction of causality; participants may either perceive greater loss 
because they are depressed or become depressed because they have experienced 
loss. A clinical intervention trail would be the clearest way to further investigate the 
direction of causality; however some information can be obtained by examining the 
stability of negative illness appraisals during recovery. This will form the aim in the 
fourth study. 
Finally, it is well known that the incidence, outcome and experience of psychosis 
vary in different ethnic and socio-demographic groups. Urbanicity and ethnicity are 
now thought to play a more causal role than previously understood. In addition 
ethnicity plays a clear role as a prognostic indicator, particularly in terms of use of 
the Mental Health Act, hospital admission and forensic involvement. Whilst these 
areas remain contentious in some respects, and many will cite institutional racism in 
psychiatry in trying to understand these differences, there is a need to investigate the 
role of culture and ethnicity further. This has not been done to date in respect of 
perceptions of loss and shame. The extreme poor outcome, completed suicide, 
appears to be higher in those with more awareness of illness and previously higher 
functioning. Deprivation is also a key factor for affective disorders, and a more 
causal link well established here. The final aim will therefore be to determine whether 
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negative perceptions of illness differ in term of socio-demographic variables including 
ethnicity, previous occupation and levels of deprivation.    
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Chapter 4  
Methodology 
4.1 Study design: 
A longitudinal follow up cohort study using validated questionnaires and semi 
structured interviews.   
4.2 Setting:  
The project studies were set in the Birmingham Early Intervention Service (EIS). This 
service was set up from 1995 onwards to offer intense case management and 
treatment to all patients presenting with a first episode of a psychotic illness. The 
Birmingham EIS covered the population of the Heart of Birmingham from 1995-2004, 
however after the 2000 National Service Framework for Mental Health (146), EIS 
teams developed from 2004-2006 to cover the entire city.  
Patients are referred to EI services from GP’s, Community Mental Health Teams and 
Home Treatment Teams. Patients are seen in their own homes or clinic setting, also 
remaining under the care of the EI team if requiring hospital admission. Patients, 
from their first contact with mental health services are followed up using an assertive 
outreach approach.  
The City of Birmingham, UK, has a population of 1.2M, and is a city of diverse socio-
economic and ethnic communities; in the 2001 census 67% were White British, 
20.7% Asian or Asian British and 6.7% Black or Black British (147). 
In the first sampling time frame (see 4.4) patients were recruited from the West Heart 
of Birmingham (HOB) EIS team, at the time the only established EIS team in 
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Birmingham. The West HOB area consists of Handsworth, and Ladywood, total 
population 200,000. This area contains within it some of the highest wards on 
deprivation indices (148). Ethnic communities represented include a large 
percentage of Black or Black British (the majority African –Caribbean) and Asian or 
Asian British (the majority Pakistani Muslim), together with smaller numbers of South 
Asian and Black African communities. 82% of the population are from Black and 
Minority Ethnic (BME) groups (147). 
In the second sampling time frame (see 4.4) patients were recruited from the South 
EIS team. South Birmingham, population 400,000, consists of a wider range of 
ethnicity, including predominantly White (67%) and smaller proportions of Black 
(6.7%) and Asian (20.7%) communities and wards of less deprivation(148). 
 
4.3 Sampling 
All sequential referrals to the Early Intervention Service (EIS) in the West HOB and 
South teams, as described in the time frame, were screened for participation in the 
study. Sampling moved purposefully from the West HOB to the South Team in the 
second sample period in order to ensure an adequate number of participants from all 
socio-demographic and ethnic groups, in line with the study hypotheses.  
 Referring agencies (Community teams, Home Treatment teams and admission 
facilities) were contacted on a weekly basis to ensure patients were recruited soon 
after first contact with services and during the acute episode. Informed written 
consent was obtained following verbal and written information in line with ethical 
approval (see 4.8). 
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4.4 Principle Contributions 
The author is responsible for study designs, aims, hypotheses, ethical committee 
approval, data entry and the majority of baseline (80%) and follow up assessments 
(65%). Remaining data were collected by an experienced psychiatrist; Dr Richard 
McCullom and clinical psychologists Dr Katerin Brunet and Dr Kerry Ross, all trained 
in the research instruments to satisfactory reliability.  All data entry, statistical 
analysis, presentation and interpretation of results, and write up is the sole 
responsibility of the author (RU). 
 
4.5 Time-frame 
2004-2005: Baseline Sampling West HOB EIS 
2005-2006 Follow up Sampling West HOB EIS 
2006-2007: Baseline Sampling South EIS  
2007-2008 Follow up sampling South EIS 
2007-2008: Data entry and analysis 
2008-2009 Paper Publication (63, 149) 
2009-2010 Thesis Write up 
 
4.6 Inclusion Criteria 
Participants were included in line with broad EIS intake criteria:  
• age 16-35 
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• Within 4 weeks of onset of treatment 
• Acute phase of illness  
• First episode of psychosis: conforming to ICD-10 F20-29, F30.2, F31.2, 
F31.5 and F32.3.  
A broad diagnostic range was chosen in order to assess the predictive value of 
diagnostic status and in order to avoid premature exclusion of participants during a 
period of diagnostic uncertainty. 
 
4.7 Exclusion Criteria 
Excluded were those with 
• Previous treated episode of psychosis  
• Organic process as the primary diagnosis.  
• Unable to communicate verbally in English. 
 
4.8 Research Measures 
4.81 Baseline Measures 
1.Schedule for Clinical Assessment in Neuropsychiatry 2.1(SCAN)(150): 
This semi-structured interview, supplemented here with informant responses and 
case note information, is a reliable and widely used research instrument. SCAN was 
used to assess lifetime diagnosis. Interviewers using the SCAN received formal 
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training to acceptable reliability. SCAN diagnoses were generated using the 
CATEGO algorithms, with any discrepancy between clinical and computer generated 
diagnoses discussed by at least two researchers and a consensus reached. In 
addition, a random selection of 25 participants interviews were rated a second time 
with best estimate lifetime diagnosis made by researchers experienced in making 
research diagnosis and blind to the CATEGO diagnosis given. 
 
2. Positive and Negative Symptom Scale (PANSS)(151): 
Whilst the SCAN interview accurately charts the presence or absence of illness, and 
has within it ratings of mild, moderate or severe, the severity of current symptoms 
was captured using the PANSS, which rates symptom severity on a broader scale. 
PANSS ratings of positive, negative symptoms and general psychopathology were 
made on the basis of the semi-structured interview: the Structured Clinical Interview 
for PANSS (SCI-PANSS) developed to optimise the instrument's objectivity (151).  
PANSS is a valid, reliable and internationally recognized measure of current state 
psychosis symptoms (152). PANSS was developed for measuring symptom 
reduction of schizophrenia patients, but has also been widely used in the study of 
psychosis. The scale has seven positive-symptom items, seven negative-symptom 
items and, sixteen general psychopathology symptom items. Each item is scored on 
the same 1-7 point severity scale whereby 1 is absent and 7 extreme. See Appendix 
1. PANSS was based on two previously established psychiatric rating systems, the 
Brief psychiatric rating Scale (BPRS)(153) and the Psychopathology Rating Scale 
(154), and developed at a time when the positive and negative symptom dimensional 
split was first purported (151). 
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PANSS has strong evidence for criterion-related validity, sensitivity and utility for 
both diagnostic and dimensional assessment (151). In the studies presented here 
PANSS was used only to rate current symptom severity, using positive, negative and 
general psychopathology scales.  
 
  3. Suicide Attempt -Self Injury Interview (SAS-II)(155).  
This structured interview records dates, frequency and methods of self harm. The 
SASII also assesses variables related to lethality and impulsivity of the act, likelihood 
of rescue, suicide intent or ambivalence and other motivations, consequences, and 
habitual self-injury. The SASII has very good inter-rater reliability and acceptable 
validity(155). For the studies presented here, all episodes of deliberate self harm 
(DSH), regardless of self reported suicidal intent were recorded over the lifetime of 
participants, and prospectively during the 12 months following the first episode of 
psychosis. Episodes of DSH were identified as occurring within the lifetime of the 
individual, during the DUP phase and within 12 month follow up periods.  
 
4. Duration of Untreated Psychosis (DUP): 
 DUP was calculated as the interval between the onset of psychosis and the onset of 
criterion treatment. ‘Onset of psychosis’ followed the definition used by Larsen et al 
(156, 157) and required either one symptom from the positive scale of the PANSS at 
a level of 4 or above in the context of a manifestation of psychotic symptoms; or a 
cluster of these symptoms including either delusions, conceptual disorganisation or 
hallucinatory behaviour and reaching a total rating of 7 or more (excluding ‘absent’ 
ratings). Symptoms had to be present for a minimum of 2 weeks unless remission 
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was due to treatment. ‘Onset of criteria treatment’ required antipsychotic treatment 
either at dosage levels recommended by the British National Formulary (BNF) (158) 
(for example 2 mg risperidone) with participants taking medication regularly for 1 
month after commencement; or leading to a significant reduction in symptoms. 
 
5. Depression Measures: 
a) Prodromal Depression 
The full SCAN (150) interview enables the interviewer to accurately date symptoms 
and chart previous episodes of mental illness. SCAN was used to rate the present 
state and primary ICD-10 lifetime diagnosis, as detailed above. The full interview 
was also used here to rate prodromal depression. Specifically, using anchor dates 
identified in sections 17,18,19 and 20 of SCAN and the DUP measures above, the 
presence of a depressive episode during the prodromal period was specifically rated 
for in the 6 month period leading up to the onset of psychosis using Section 6, 7 and 
8 of SCAN.  SCAN allows the rating of mild, moderate or severe for each depressive 
episode, however given the retrospective nature of the assessment as used in this 
study, depression in the prodrome was rated as absent, or present only when 
moderate or severe in nature.  
 
b) Acute Depression  
Calgary Depression Scale for Schizophrenia(116) 
The Calgary Depression Scale for Schizophrenia (CDSS) is an observer rated, goal 
directed semi- structured interview designed for the assessment of depression in 
schizophrenia (159).The CDSS ensures separation from negative or extra pyramidal 
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symptoms. Symptoms are scored for the preceding 2 weeks and are used to rate a 
depressive episode. A score of 7 or more has a  82% specificity and 85% sensitivity 
to predict a moderate or severe depressive episode (160). The CDSS is composed 
of eight structured questions and one interviewer observation, and includes direct 
questions on suicidal ideation and intent.  It is the most widely used measure for the 
assessment of depression in schizophrenia and first episode samples (63) and has 
been translated into over 30 languages. The CDSS has demonstrably less overlap 
with negative or extrapyramidal symptoms compared with other more generic 
depression rating scales, for example the Hamilton Rating scale (161) and good 
internal and inter-rater reliability. 
 
5. Insight and Illness Appraisals 
a)  Insight Scale(IS) (162) 
Different insight scales have been developed for use in schizophrenia, for example 
the Scale for the Assessment of Unawareness of Mental Disorders (SUMD) (163), 
the Schedule for the Assessment of Insight (SAI-E) (123) and the Insight and 
Treatment Attitude Questionnaire (ITAQ) (164). The Insight Scale (IS) has the 
advantage of being relatively short, consisting of just 8 questions, whilst still looking 
at the various dimensions of insight and retaining validity and reliability. This is 
relevant to this project where there are a significant number of schedules and 
questionnaires to complete. A review of insight rating scales, including the IS, ITAQ 
and SUMD together with PANSS G12  found most had a high degree of inter 
correlation(165).  The IS has good psychometric properties and is widely used in 
psychosis research (165). Insight on the IS is grouped into three: Awareness of 
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Illness, Awareness of Symptoms and Need for Treatment, each scoring 0-4 where 4 
indicates full insight. A total score is available for overall insight on a 0-12 scale 
whereby 12 is full insight. Scores over 9 represent “good” insight.  
 
b)  Personal Beliefs about Illness Questionnaire (PBIQ-R) (133) 
The PBIQ-R is grounded in social ranking theory, and was designed to evaluate how 
individuals appraise the personal threat of their illness, when viewed as a life event. 
The PBIQ-R yields five subscales, assessing appraisals in terms of: ‘loss’, referring 
to the loss of social goals, roles and status; ‘entrapment’, evaluating the degree to 
which individuals feel unable to escape from their situation; ‘shame’, assessing the 
degree of shame experienced; ‘control’, referring to the degree to which individuals 
feel in control of their illness; and ‘group fit’, referring to the extent to which 
individuals feel that they no longer ‘fit in’ or are socially excluded because of their 
illness. The PBIQ-R demonstrates high consistency, Cronbach’s alphas for the five 
subscales ranging from 0.72 to 0.81. Satisfactory discriminate validity is reported 
between the five subscales, and convergent validity demonstrated by correlation with 
measures of social comparison(166). Other similar scales have been developed, for 
example the Illness Perception Questionnaire (167) however this scale gives less 
emphasis on the appraisals of loss and shame, which are intuitively important in the 
generation of depression and suicidal thinking, focussing more on course of illness 
and perceptions of cause. 
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6. Psychological Response to Symptoms: Appraisal of Voices and Persecutors 
 
a)Beliefs about Voices Questionnaire – Revised  (BAVQ-R)(168): 
The BAVQ-R is a psychometrically validated self-report measure of patient’s beliefs 
and behaviour about auditory hallucinations. It assesses the perceived malevolence, 
benevolence and omnipotence of voices and patients’ resistance and engagement 
with their voices. The BAVQ-R is widely used in cognitive research and possesses 
excellent psychometric properties. There are 35 items measuring people's beliefs 
about auditory hallucinations, and their emotional and behavioural reactions to them. 
The three sub-scales relate to: malevolence (six items: e.g. ‘My voice is punishing 
me for something I have done’ or “My voice is evil”); benevolence (six items: e.g. ‘My 
voice wants to protect me’ or “My voice is helping me to develop special powers and 
abilities”); omnipotence (six items e.g. “My voice is very powerful”) in addition to two 
sub scales reflecting an individuals’ reaction and behaviour in relation to their voice: 
resistance (7 items e.g. in relation to my voice I “tell it to leave me alone”) and 
engagement (8 items e.g. “I willingly do what my voice tells me to do”. All responses 
are rated on a 4-point scale: disagree (0); unsure (1); agree slightly (2); agree 
strongly (3). The measure thus assesses degree of endorsement of items. 
Individuals hearing more than one auditory hallucination complete the questionnaire 
for their ‘dominant voice’.   
 
b) Voice Topography (169) 
The Voice Topography Scale is a five point self-rating scale providing further detailed 
information on auditory hallucinations including frequency, loudness, clarity, distress 
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and ability to ignore. The scale contains five items rated on a 1-5 likert scale. For 
example “Over the last few days my voices have been; very frequent (1).....absent(5) 
or very clear(1)...very quiet (5). It has sound psychometric properties and has been 
widely used in research into voices. This scale was used in addition to the PANSS 
and BAVQ-R to provide richer detail as to the severity of voices in terms of 
frequency, loudness and intrusiveness.  
 
c)  Voice Power Differential Scale(170) 
The perceived power of voices was rated using the Voice Power Differential Scale 
(VPD) (170). This employs a differential scale of 7 bipolar constructs linked to the 
concept of power and omnipotence.  The voice hearer is asked the question, “in 
relation to my voice I feel…..much more powerful than my voice “(Score 1); “we have 
the same power as each other” (Score 3); “my voice is much more powerful than me” 
(Score 5), with intermediate descriptors for scores 2 and 4. The internal reliability of 
the VPD is reasonable (Cronbach’s Alpha 0.85) and one week retest reliability 0.8 
(170).   
 
d)  Details of Threat Questionnaire & Safety Behaviours Questionnaire (140): 
Details of persecutory beliefs including strength of conviction, time-scale of threat 
and pervasiveness of threat were obtained with the Details of Threat (DOT) 
developed by Freeman et al (140). The DOT is a semi-structured interview that also 
gains information as to the identity, type of threat and power of persecutors. Distress, 
perceived “awfulness” and ability to cope should the threat occur are self-rated on 0-
10 linear scales and strength of belief on a self report 0-100% scale. The DOT has 
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been previously  used to assess delusional distress and power of persecutors in 
relation to the development and maintenance of persecutory beliefs (171) 
Safety behaviours used in the last month were assessed the semi-structured Safety 
Behaviours Questionnaire (SBQ)(140). Safety behaviours are enquired about with an 
open question at first, followed by direct questioning of seven specific types of safety 
behaviour, e.g. Avoidance, In-Situation safety behaviours, Escape, Compliance with 
persecutors demands, Help seeking, Aggressive acts and those carried out by the 
participant in the hope of reducing threat but judged by the interviewer to have no 
logical relation to the achievement of this aim (Delusional). For each positive 
response, frequency of engagement with safety behaviours is rated on a four-point 
scale. The SBQ interview ends with four questions that assess respondents’ views of 
the success of the safety behaviours, the control that they have over the situation, 
the presence of any ‘rescue factors’ (factors beyond their control that may rescue 
them from harm), and whether the rescue factors may be successful. The SBQ has 
been shown to have good inter-related reliability and acceptable test-retest reliability 
(141). 
 
6. Demographic Details  
A proforma was used to gather baseline demographic data of age, gender, 
occupational status, experience of detention under the Mental Health Act (MHA) 
1983 and ethnicity. Ethnicity was recorded as identified by the participant in line with 
categories used for the 2001 census. A record was made of simple frequency and 
type of substance misuse. Postcode address was matched with deprivation indices 
in line with the 2001 census. 
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4.82 Follow Up Measures: 
CDSS:  repeated at 6 and 12 months 
PANSS: repeated at 12 months 
PBIQ-R: repeated at 12 months 
SAS-II assessment of self harm behaviour completed throughout the follow up period 
when further acts of self harm occurred: care co-ordinators were contacted and 
clinical notes screened monthly. 
4.9 Interventions during follow up phase: 
The studies presented are not designed to test any specific intervention. However it 
should be noted that during the 12 month follow up phase all participants will have 
been offered intensive case management, pharmacological and psychological 
interventions as clinically needed. 
 
4.10 RECRUITMENT AND FEASIBILITY:  
Acceptability: 
 A pilot interview including all baseline schedules was timed at 2 hours maximum. 
Given patients were seen in the acute phase of illness, interviews took place over 
more than one session as needed, both sessions occurring within the same seven 
day period. Initial SCAN and PANNS informed which further schedules were 
indicated, i.e. whether auditory hallucinations or persecutory beliefs are present, thus 
cutting down interview time for some participants.  Follow up interviews took a 
maximum of one hour. 
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Feasibility:  
Baseline data was collected during clinical interviews and assessment for the Early 
Intervention team by main investigator (RU).  Patients were identified and recruited 
from all those referred to the West HOB and South Birmingham Early Intervention 
service as detailed 4.3. As a lead clinician in both teams the author was involved in 
the initial assessment of all new referrals and thus time spent recruiting participants 
was minimized for both participants and researcher. 
Recruitment and Drop-out Rate: 
Audit and population demographics lead us to expect up to 100 new referrals per 
team per year in the West HOB and South EIS teams. Previous audits have 
identified 90% of new episodes will be referred and managed by Early Intervention 
Teams, thus the sample will be representative of the population of FEP’s in this 
area. On the basis of previous EIS prospective studies (172), we expect  15%  drop 
out rate during follow up.  See section 4.5 for detail of timetabling. 
  
4.11 Statistical Analysis:  
A database was created using SPSS. Please see individual studies for details of 
statistical methods used. However, statistical advice and ongoing support was 
sought from Dr. M. Siad Haque, statistician and Research Fellow in the University of 
Birmingham. Initial power calculations, taken on one main outcome measure (PBIQ -
R) used in previously published studies (131) reveal that a sample size of 36 in each 
group of depressed and non-depressed participants will have a 90% power to detect 
a difference in means of 0.7. These studies aimed to recruit significantly more at 
base line and at follow up. 
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4.12 Ethical Issues  
Full National Research Ethic Committee (NRES) approval was obtained for the study 
in both locations (HOB and South Birmingham). No major amendments were asked 
for by the committee. However one clear ethical issue discussed was whether 
participants in an acute phase of illness would have capacity to consent. Clearly not 
all patients presenting with FEP are incapacitated, however this cannot be entirely 
excluded. The NRES committee was satisfied that both written and verbal 
information was given to participants and carers. In addition new legislation, the 
Mental Capacity Act (MCA) (173), came into force during this study in  October 2007, 
however  “research which started prior to 1 October 2007 is not required to comply 
with sections 30-34 of the code of practice until 1 October 2008, provided it has 
ethical approval.”(173) Recruitment for this study was completed prior to this date. 
Even now guidance and regulations available in light of the MCA centre around 
clinical intervention trials and are not readily applicable to the present study, where 
there is no clinical intervention and incapacity if present will be temporary 
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Chapter 5 
The Evolution of Depression and Suicidality in First Episode Psychosis 
5.1 Introduction: 
 As shown in Chapter 1, depression is documented as commonly occurring in the 
prodrome (40, 174), acute (56, 58) and post psychotic phases (117, 131) and is now 
proposed by some to occupy a distinct dimension of psychotic phenomenology(27). 
These data on the depressive dimension of psychosis has brought real challenge to 
the Kraepelinian dichotomy(175) (176) between schizophrenia and affective 
psychoses which has shaped our classification systems for the last hundred years. 
Increased recognition and understanding of depression in psychotic illness is 
prerequisite if we are to make an impact on suicide. As discussed in Chapter 1, the 
risk of suicide in psychotic illness remains high at approximately 7 % (89); this is 
highest in the early phases of psychosis, including the periods before and after the 
first episode (99). Suicidal behaviour in patients with psychotic disorders “represents 
a seriously under-treated life-threatening condition” (95), yet a reduction in suicide in 
schizophrenia remains an elusive goal of mental health services. Depression and 
hopelessness are known precursors of deliberate self harm and suicide in psychosis 
(97). However, we do not have a clear understanding of the ebb and flow of 
depression and suicidal thinking in the early phase of psychosis, whether these are 
predictable and how they relate to the early course of psychotic symptoms. Studies 
that have looked at the course of depression have demonstrated evidence for a 
distinct depressive dimension; depression can break through in the post psychotic 
phase independent of positive symptoms(56), also depression will reduce in line with 
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positive symptoms (131, 177). We do not however have evidence as to the evolution 
of depression in the first episode, and how this links to suicidal thinking. 
5.2 Aim: 
 In this study the aim is to examine prospectively the course of depression and 
suicidal thinking prior to, during and in the twelve months following, the first episode 
of psychosis. 
5.3 Method: 
5.31Sampling 
Please see chapter 4 for detailed description of methodology. However, in summary 
sequential referrals to the Early Intervention Service (EIS) in Birmingham with first 
episode of psychosis were screened for participation in the study between time 
frames 2004-2005 and 2006-2007.  The EIS is responsible for all cases of first 
episode psychosis presenting under the age of 35 years within the city of 
Birmingham, UK (pop 1.2M), a city of diverse socio-economic and ethnic 
communities. Inclusion criteria included: age 16-35; within 4 weeks of onset of 
treatment in the acute phase of illness, and a first episode of psychosis conforming 
to ICD-10 F20-29, F30.2, F31.2, F31.5 and F32.3. A broad diagnostic range was 
chosen in order to assess the predictive value of diagnostic status and in order to 
avoid premature exclusion of participants during a period of diagnostic uncertainty. 
Excluded were those with any previous treated episode of psychosis or those with 
any organic process as the primary diagnosis. Home treatment teams and admission 
facilities were contacted on a weekly basis to ensure patients were recruited soon 
after first contact with services. Informed written consent was obtained following 
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verbal and written information in line with ethical approval. Data were collected by 
experienced psychiatrists and clinical psychologists trained in the research 
instruments to satisfactory reliability.  
 
5.32 Measures 
Please see Chapter 4 for detailed description of study measures 
Baseline Measures: 
1. Schedule for Clinical Assessment in Neuropsychiatry 2.1(SCAN)(150): 
2. Positive and Negative Symptom Scale (PANSS)(151): 
3. Suicide Attempt -Self Injury Interview (SAS-II)(155).  
4. Duration of Untreated Psychosis: see 4.3 
5. Depression Measures: 
   a) Prodromal Depression: SCAN 
   b) Baseline: CDSS(116) 
  
Follow Up Measures: 
CDSS:  6 and 12 months. 
PANSS: 12 months  
SAS-II: completed monthly throughout the follow up period, as indicated by further 
self harm incidents  
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For this study, depression assessed at 6- and 12 month points will be referred to as 
“depression in the follow up phase” rather than “post psychotic depression” to avoid 
conflict with the strict ICD-10 Research Diagnostic Criteria for the use of this term. 
 
5.4 Statistical Analysis: 
The main aim, to chart the course of depression and suicidality through the first 
episode of psychosis requires no specific statistical analysis. However, for the 
univariate analysis of predictors of depression, a power calculation was conducted 
based on previous published studies (178) using both CDSS and PANSS. This 
established a sample size of 86 would have a 90% power to detect a significant 
difference (p<0.05) in PANSS scores between depressed and non depressed 
patients. Quantitative non-categorical data were tested for normal distribution using 
the Blom method of p-p plots, and parametric tests of significance were used as 
appropriate on measures demonstrating normal distribution. A simultaneous 
logistical model was also performed to determine the most significant predictors of 
acts of deliberate self harm. 
5.5 Results  
Sample Description: 
For the present study the full sample was used; total of 136 individuals were 
screened, of these, 10 were not in their first episode, 8 were not in the acute phase 
of illness and 8 did not have a psychotic illness. 18 eligible individuals refused to 
participate in the study, leaving 92 who consented to participate. Those declining to 
participate did not significantly differ in age, gender or ethnic group from the 
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participant group. Follow up data was available for 82 (89%) participants. Of those 
not completing follow up, 4 had disengaged from services and 6 declined to take part 
in follow up measures; this group likewise did not differ in terms of age, gender or 
ethnicity from those participating in follow up. (X2=0.26-0.27, p=ns).  Table 5.1 
provides demographic and clinical details of the study population.  
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Table 5.1 
Demographic and Clinical Details of Full Sample 
Mean Age 22.50 (s.d. 4.89) 
 Male 75% (n=69)  
Gender  Female 25% (n=23) 
White British 35 % (n=31) 
Asian (all) 29% (n=28) 
 
Ethnicity 
Black- Caribbean 36% (n=33) 
  
 
None/ Infrequent use 
 
76% (n=68) 
Cannabis daily 23% (n=21) 
 
Substance Misuse 
Other (Crack cocaine/ 
Heroin)  
1% (n=3) 
 
DUP (Days) 
 
Mean: 207 (s.d.389) 
 
Median: 59 
Positive  18.84  (s.d. 5.07)  
PANSS: Mean 
scores  
Negative  14.54   (s.d. 5.56) 
Schizophrenia 70% (n=65) 
Delusional Disorder 4.3% (n=4) 
Acute and Transient 
Psychotic Disorder 
8.7 %(n=8) 
Other non-organic 
psychotic disorder 
 3.3% (n=3) 
Schizoaffective Disorder  2.2% (n=2) 
Mania Severe with 
Psychotic Symptoms 
 7.6% (n=7) 
 
 
SCAN Diagnosis 
ICD-10 
Depressive Disorder 
Severe with Psychotic 
symptoms 
 3.3% (n=3) 
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5.51 SCAN Diagnoses   
The 25 interviews randomly selected to be rated a second time demonstrated high 
consistency with the CATEGO computer generated diagnosis (Kappa 0.84). In total 
87% met diagnostic criteria for a non-affective psychosis (consisting of 
schizophrenia, delusional disorder, acute and transient psychotic disorder and other 
non organic psychotic disorder), and 13% for an affective psychosis (consisting of 
schizoaffective disorder, mania with psychotic symptoms and depressive disorder 
with psychotic symptoms). When compared to the non-affective group, patients with 
an affective diagnosis did not differ in terms of mean age, gender, ethnicity or 
severity of PANSS positive or negative symptoms. The affective psychosis groups 
had a significantly lower mean depression score at baseline, with a median score of 
0, reflecting the inclusion in this group of participants with elevated mood at 
presentation (ICD-10; F30.2). (See Table 5.2) 
The remaining results will report for the full sample, in order to fulfil our aim of 
charting the course of depression and suicidality across the full spectrum of first 
episode psychosis. 
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Table 5.2  
Clinical and socio-demographic status of affective and non-affective diagnostic 
groups 
 Affective (n=12) 
Mean (s.d.) 
Non-Affective (n=80) 
Mean (s.d.) 
Sig.1 
Age  22.42 (5.61) 
 
22.51 (4.82) 0.96
PANSS Positive  19.67 (6.62) 18.71 (4.84) 0.54
PANSS Negative 11.83 (4.06) 14.95 (5.67) 0.07
 
CDSS  
3.67(5.70) 
(median 0) 
          8.06 (5.66)  
(median 8.5)  
0.01
DUP 216 (472) 
 
205 (378) 0.93
1. Independent samples (2 tailed) t-test 
 
 
5.52 Depression in the Prodrome, Acute and Follow up Periods 
Depression was defined as a moderate or severe depressive episode, as rated on 
the SCAN instrument in the prodromal phase, and/or a CDSS score of 7 or more in 
the baseline, 6- or 12 month assessment points. 
Prodromal Depression:  In the 6 months leading up to the first psychotic episode, 51 
(56%) of participants experienced a clinically significant depressive episode.  
Acute Phase Depression: In the acute phase of illness, 54 (59%) had moderate or 
severe depressive episode. 
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Depression in Follow Up : 32 (39%) of those completing follow up experienced  
significant depression at one or both follow up points during the 12 months following 
the first episode of psychosis. 
In total, throughout the course of the first episode, 66 (80%) participants experienced 
clinically significant depression, in one or more phases. The combined presence of 
depression and suicidal thoughts was present in 52 (63%) participants in one or 
more phases. 
 
5.53 Depression Pathways 
Eight patterns of the course of depression throughout the first episode were 
observed: see table 5.3.  Seventy nine percent (n=73) of the sample experienced the 
four most common patterns: 
1. Depressed at each stage (22%) 
2. Depressed in the prodrome and acute phases; no Depression in follow up 
(17%)  
3. No prodromal depression; depressed in acute phase (with or without 
depression in follow up) (20%) 
4. No depression throughout (20%) 
Diagnostic status was not associated with any pattern of depression (Pearson 
X2=6.87, ns). 
 Severity of depression was not significantly correlated with the severity of positive or 
negative symptoms in the acute (r=-0.16, ns; r= -0.03, ns) or follow up phases (r=-
0.04, ns; r=0.19, ns). 
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Table 5.3 
 Pathway of Depression through the First Episode of Psychosis 
 
 
Pattern of Depression: 
 
% (n) 
Depression throughout 22% (17) 
Depression in Prodrome and Acute phase, no Depression in Follow 
up 
17% (14) 
Depression in Prodrome only 13% (11) 
Depression in Prodrome, no Acute Depression, Depression in 
Follow up 
4% (3) 
No Depression throughout 20% (16) 
No Prodromal Depression, Depression in Acute phase, no 
Depression in Follow up 
12% (10) 
No Prodromal Depression: Depression in Acute and Follow up  8% (7) 
Depression in Follow up only 5% (4) 
 
 
5.54 The Predictive Significance of Prodromal Depression 
The pathways data suggest that the presence of prodromal depression influences 
the likelihood of recurrence at subsequent phases. The presence vs. absence of 
prodromal depression was significantly linked with a moderate or severe depressive 
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episode (CDSS score of greater than 7) in the acute (X2 =6.67, p= <0.01) and follow 
up (X2 3.22, p=<0.05) phases. In addition, mean CDSS scores were significantly 
higher in those who had depression in the prodrome; mean CDSS score in the acute 
phase with prodromal depression was 9.42 (s.d.5.5); without prodromal depression 
4.98 (s.d. 5.42); p=0.001. Highest mean CDSS score in either follow up point in 
those with prodromal depression was 4.71 (s.d.4.9); without prodromal depression 
2.55 (s.d.3.8); p=0.02.  
 
5.55 The Predictive Significance of Acute Depression 
The presence vs. absence of acute depression was likewise significantly linked with 
moderate or severe depression at the 6 or 12 month follow up points (X2   4.08, 
p=<0.03). Similarly, CDSS scores were higher in those who experienced depression 
in the acute phase: highest mean CDSS score in follow up phase following 
depression in acute phase 4.70 (s.d.4.84), without depression in acute phase 1.68 
(s.d.3.077); p=0.02.  
 
5. 56 Suicidal thinking and deliberate self harm 
52 (56.5%) of participants reported clear thoughts of self harm at their baseline 
interview and 30 participants (33%) reported a lifetime history of DSH (see Table 1). 
Where individuals reported more than one attempt, the method of the most serious 
attempt is reported. In 21 of the 30 (70%) with DSH this occurred during the phase of 
untreated psychosis. 6 (20%) had a history of DSH prior to the onset of psychosis 
and 3 participants (10%) had a history of DSH in both the DUP phase and prior to 
the emergence of psychosis. At baseline methods used include overdose (n13; 
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43%), attempted hanging (n5; 17%), cutting/stabbing (n5; 17%), walking in front of 
traffic (n 3;10%) and jumping from a height (n4;13%). 
 
At 12 month follow up, the number of participants reporting thoughts of DSH had 
reduced by approximately one half to 25 (27%). 6 (6.5%) had committed further acts 
of DSH during the 12 months follow up, 5 having taken an overdose and one 
deliberately walking into traffic. The presence of depression during follow up was 
significantly associated with the presence of acts of self harm (X2 =10.3, p=0.03), 
although the small number of acts of DSH at follow up should be noted.  
 
5.57 Regression Model 
In order to investigate the significance of each predictive factor, a logistic regression 
was performed to assess the impact on participants report of self harm at baseline. 
The model contained the variables: age, gender, ethnicity, presence or absence of 
substance misuse, diagnostic group, PANSS positive and negative scores, and the 
presence of depression during the prodrome. The full model containing all predictors 
was significant; X2 = 20.90, p<0.001. The model as a whole explained between 20% 
(Cox and Snell R square) and 30% (Nagelkerke R square) of cases. However, only 
one variable made a unique statistically significant contribution to the model: the 
presence of depression in the prodrome: OR 5.27 (95% C.I. 1.68-16.59), p= 0.004. 
See Table 5.4 
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Table 5.4. 
Summary of Simultaneous Logistical Regression Model to predict Self Harm  
 B  SE B Exp (B) 
Depression in 
Prodrome 
1.66  0.58 5.27* 
Age -0.09  0.05 0.91 
Gender 0.52  0.63 1.69 
Ethnic Group -0.43 0.29 0.65 
Diagnosis -0.24  0.15 0.78 
Positive Symptoms  0.007  0.05 1.00 
Negative symptoms  0.06  0.04 1.06 
Substance misuse 0.899 0.57 2.45 
 
* p<0.005 
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5.6 Discussion 
5.61 Depression in First Episode Psychosis 
This study has revealed that depression is pervasive during the early course of 
psychosis with eighty percent experiencing at least moderate levels of intensity 
during the months studied. Individuals who do not experience at least one clinically 
significant period of depression during the course of FEP are the exception. Sixty-
three percent experienced depression and suicidal intent or worse. Although 
depression pathways vary between individuals, we report here for the first time the 
waxing and waning of depression throughout the first episode. Prodromal depression 
and depression in the acute phase significantly predicted depression in the follow up 
period. Previous research by Koreen et al (179) also showed high rates of 
depression in acute psychosis,  with depression recovering in line with the resolution 
of psychotic symptoms in their sample. Similarly another study of post psychotic 
depression (133) found that seventy percent of the FEP sub-group experienced 
depression during the acute phase and fifty percent post psychotic depression (using 
the same measures as the present study). The weight of evidence for the importance 
of the so called “lesser” symptom accompanying psychosis is now clear (180). The 
new finding presented here is that prodromal depression, not the severity of positive 
or negative symptoms, is predictive of depression in the early course, underling the 
validity of the independence of a depressive dimension in the structure of psychosis. 
What was unique about the present study was the availability of data on depression 
longitudinally (and from the first treatment, prospectively). This revealed two 
important findings. First, depression in the follow up phase (“post psychotic 
depression”) rarely occurred de novo; that is, in the absence of depression in the 
prodrome or acute phases. Second, the presence of depression during the prodrome 
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was a significant predictor of depression later in the course. It has previously been 
shown that depression ‘follows the same course’ as positive symptoms following 
recovery from the acute episode (133)  and that post psychotic depression emerges 
later in the course following a period of quiescence of depression. The point here is 
that post psychotic depression breaks through during follow up in many individuals, 
independent of other psychosis symptoms, but it tends to do so in the same 
individuals who experienced depression during the prodromal and acute phases. 
The interpretation of this data, in addition to the study presented here, is that there is 
an ongoing vulnerability to depression that is manifest during the prodrome and can 
re-emerge at future points, for example as a response to stressors, including the 
diagnosis of a psychosis itself (131).  In the study presented here, it is important to 
note that 20% of participants first experienced depression in the acute phase, 
without prodromal depression. Thus the emergence of depression is linked to the 
emergence of acute psychotic symptoms in some individuals. Likewise depression in 
the acute phase has previously been shown to reduce in line with recovery from 
acute psychosis (177), yet at the same time there is robust evidence for a distinct 
depressive dimension in psychosis(16). The relationship between depression and 
positive symptoms is thus not linear or straightforward(132).   
There is good evidence that adolescent depression itself will predict future mental 
illness (181) and other studies investigating prodromal depression (182, 183) 
highlight that in addition that ‘basic’ cognitive symptoms such as indecisiveness, 
repetitive thought and disturbances in “experiencing self”, are better than core 
depressive symptoms per se at distinguishing those vulnerable to psychosis. The 
suggestion is that potential for treatments should target this prodromal stage(183). 
Tackling adolescent depression may have the potential to reduce suicide and future 
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severe mental illness including psychosis. A question arises as to whether 
depression in FEP is the result of a common vulnerability, e.g., expression of 
underlying brain dysfunction  or gene expression(184); the result of shared 
environmental risk factors for depression and psychosis (99, 185); or a occurs as a 
result of a psychological reaction to psychosis as a major life event (131). It is likely 
that more than one pathway to depression is at work in individual phases (56).  
These questions will form the basis of future chapters, however we know that 
patients with schizophrenia have been demonstrated to show more intense and 
variable negative emotional response to daily life hassles (186) and some family 
environments are sufficient to trigger  a psychotic relapse (53, 187). Stress reactivity 
is high in those without cerebral tissue alteration (188) or cognitive dysfunction (189); 
and affective dysfunction is high in those at high risk of psychosis (48). In other 
words intense reaction to daily life stressors predate the onset of psychosis. Such 
findings have led authors to argue that there is an affective pathway to psychosis 
(186). Our results support the concept of this pathway, and suggest this may be a 
primary mechanism involved in the majority of FEP, whether mediated at a 
neurobiological or cognitive level. 
There is strong evidence that depression precedes the onset of first episode 
psychosis for most individuals (40, 190) and our finding that 56% report a significant 
depressive episode during the prodrome is entirely consistent with this. The 
presence of depression in the early course of psychosis was related neither to 
severity of psychosis symptoms nor diagnostic category, including the broad 
affective vs. non- affective distinction; indeed depression was less prevalent in the 
‘affective’ diagnostic category. We can conclude from this that the presence vs 
absence of depression in the early phase of psychosis is not pathognomonic for a 
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subtype of schizophrenia (for example a schizoaffective disorder)  but may be best 
understood as a dimension of psychotic experience in its own right (27, 191).  
 
5.62 Suicidal Thinking 
The high rate of suicidal thinking and DSH observed in this study underlines 
consistent findings from previous research that the early phase of psychosis is a high 
risk period (95). Our findings concur with others showing a link between the 
frequency of DSH in first episode psychosis and depression (99), a relationship also 
seen later in the course of the illness (192). However, unlike findings from the 
AeSOP study (185) we did not find any gender differences. In our data the most 
frequent act was overdose, followed by attempted hanging, reflecting the serious 
nature of such attempts. DSH was reported in over a third of our sample, significantly 
this occurred within the period of untreated psychosis for seventy percent of cases, a 
finding in line with that of the TIPS (193) and InterSePT studies (95). Haw et al., 
(192) identified previous deliberate self harm as one of the key risk factors for 
completed suicide in schizophrenia, and a history of DSH is remains the best 
predictor of future self harm and completed suicide in psychosis. In addition, 
psychotic experiences themselves will increase the risk of self harm (194). Recent 
studies have also heighted the relationship between early onset and increased risk 
(195, 196), although in our data age was not significant in the prediction of actual 
acts of self harm. Early studies have shown that this high rate of DSH at presentation 
can be drastically reduced with early psychosis programs, with figures again 
reflecting those found in this study; McGorry et al., (197) report 15.1% attempted 
suicide prior to program entry with only 2.9% made an attempt in 12 months of 
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intensive treatment in a designated service. Atypical antipsychotic medication has 
not been shown to reduce the risk of suicidality in psychotic illness (95, 117). 
Treatment implications will be further discussed in Chapter 10, however the study 
presented in this chapter does emphasise how strategies in FEP need to focus on 
reducing untreated psychosis, and active monitoring and treatment of depression as 
a proximal risk factor for suicide, particularly in those with a history of deliberate self 
harm.  
 
5.7 Methodological Issues  
This study does have potential significant limitations.  A retrospective assessment of 
prodromal depression may be subject to recall bias, however is unavoidable without 
using large numbers of “at risk” subjects, which would lead to small numbers of 
patients in the follow up after transition to FEP. Secondly, the frequency of follow up 
measures will be a cause for concern. It is likely that episodes of depression in the 
follow up phase were missed that would have been captured by more frequent follow 
up. Thirdly, some might criticize the inclusion of all FEP participants, rather than 
including only those with schizophrenia spectrum disorders. Low numbers in the 
affective psychosis group should be noted.   However, it is clear that diagnostic 
certainty is slim in FEP, with the largest change in diagnostic group being from FEP 
to schizophrenia(38). Results in this chapter reflect the full FEP range and are thus 
generalizable to this group. The challenge of depression in psychotic disorders, and 
implications this might have for future classifications, was also a clear focus of the 
study. In addition, potential confounding factors, such as substance misuse, cannot 
be negated. Substance misuse was reported in 68% of the sample, and there is 
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potential for this to influence both the reporting of depressive symptomatology and 
suicidal thinking(198) 
 
5.8 Implications 
Efforts to reduce suicide risk in psychosis are paramount and our findings are clearly 
relevant to clinical practice. Depression in the prodromal phase is related to acute 
and follow up depression, and risk of self harm. The emergence depression after 
recovery from psychosis, unheralded by prodromal or acute depression, is rare. 
Thus prodromal symptoms and in particular depression, should be enquired about 
with rigour in all patients presenting with first episode psychosis. Our data on the 
frequency and timing of attempt at self harm should also be highlighted to clinicians. 
This is clearly relevant to early psychosis services, and adds to the weight of 
evidence on the importance of reducing DUP. In addition to improved functional 
outcomes, a reduction of DUP and effective treatment of early phase depression is 
the key starting point to reducing suicide risk. 
 Future research is most needed in this area if we are to make real change in 
outcomes and suicidality in psychosis.  From results presented here areas clearly 
warranting further investigation include trials of interventions to reduce acts of self 
harm and prodromal depression. The most significant predictor in the logistical 
regression in this sample was the presence of prodromal depression over age, 
gender and substance misuse, all highlighted as significant in established 
schizophrenia samples (192). Use of antidepressant medication is now evidenced as 
important in the prevention of suicide (199) and could show potential for further 
investigation in the treatment early in the course of psychosis. Over and above 
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physical therapy, the need to investigate the effectiveness of other phase specific 
treatments of so called “lesser” symptoms accompanying and leading up to 
psychosis is clear. This study shows that depression remains an important target for 
future work. 
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Chapter 6 
Appraisals of Illness and the development of Depression in Acute First 
Episode Psychosis 
 
6.1 Introduction 
The need to understand pathways to depression in psychotic illness is clearly 
detailed in Chapter one. Results presented in Chapter 5, concurring with previous 
research, show that depression in the acute phase is significant, often occurring at 
higher rates here than at other stages; reports range between 29-75% (58). Although 
depression and suicidal thinking are extremely common in acute FEP (149), the 
relationship between depression and other acute symptoms is poorly understood. 
We have shown that prodromal depression will convey an increased risk of 
depression at future points, however depression breaks through at all stages in 
some individuals, at times unheralded by previous depression. The early years of 
psychosis remain high risk, despite the increasing recognition of the importance of 
this phase, in terms of both suicidal behaviour (97) and setting the trajectory for 
future functional outcome (200, 201). A fuller understanding of the depressive 
dimension (16) in psychosis has potential to translate in to more accurately targeted 
therapies and better outcomes for patients. Knowledge of the development of 
depression in the acute phase of psychosis is an important piece of this 
understanding. 
 Insight, or more accurately the lack of insight, in psychosis has long been 
recognised as important. Indeed poor insight was recognised as the most common 
symptom in schizophrenia; the International Study of Schizophrenia in 1972(10)  
rated difficulty in insight as occurring in 92% of participants. However there is also 
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good evidence that some patients with psychosis are thinking about the personal 
significance of their experience, diagnosis and its implications for their future, even 
when acutely unwell (172, 202). Lack of insight, as rehearsed in Chapter 2, can be 
understood in some individuals in part as an active defence against the personal 
significance of accepting illness (134). Insight has rarely been studied in the acute 
phase of first episode psychosis. One study that has examined insight in FEP 
showed that insight, and in particular the awareness of illness, is present at this early 
stage, and also conveys a marked increase in risk for future suicidality (203). 
MacDonald (204) recently proposed a link between awareness of illness, stigma and 
outcome, concluding that a combination of high awareness and minimal stigma 
conveyed the best prognosis. Insight itself carries with it a value judgement, an 
appraisal, for the meaning of an individual’s recent or ongoing experience of mental 
illness (134). This value judgement has been proposed as surmounting to a 
traumatic life event (126). In more detail, ideas based on social ranking theory, 
together with well rehearsed concepts of vulnerability(110) and power from 
evolutionary psychology (126) have argued that certain life situations are more likely 
to be depressogenic, particularly if they encapsulate feelings of loss, humiliation or 
defeat. The personal significance of experiencing FEP can be viewed in these terms 
as a severely threatening life event (52). It has been shown with considerable 
evidence in studies such as those by Brown and Harris in 1977(110) and 
subsequently their 1995 paper(112), that life events  appraised as conveying ‘loss’, 
‘entrapment’ and ‘humiliation’ increase the likely hood of depression. They found the 
experience of humiliation and entrapment was important in provoking depression in 
both the patient and non-patient groups, and proved to be associated with a far 
greater risk than the experience danger without humiliation or entrapment (112).  
78 
 
 We know that negative self appraisals in general are a key feature in the generation 
of a propensity to develop depression throughout the lifespan, stemming from 
formative experiences leading to loss of self esteem and a positive attitude to self 
(205).  Blatt (206) argued that depression is associated with greater self-criticism, 
negative self image, and dependency. These factors are all now core to our 
understanding of unipolar depression itself, yet have not been elaborated in detail in 
psychotic illness, particularly in the first episode.  
 Appraisals have also been postulated to be active in the development of  psychosis 
itself, particularly the psychotic-like experiences (“PLEs’) or anomalous experiences 
which can convey personal threat (141). Garety et al., (207) argue that in the 
development of psychotic experience, quasi- psychotic experiences do not develop 
into full psychosis if the subject is able to reject their externality, utilizing the ability to 
employ correcting decisions; for example “ I thought I heard the voice of God but 
more likely my mind may be playing tricks”. This rejection of self serving attribution 
requires a degree of higher cognitive function and also postulated to be influenced 
by pre-existing negative schemas (208).  
Psychotic experiences themselves, for example a voice perceived as hostile or 
critical in nature, or threat of social or physical harm from persecutors may also be 
viewed as a form of very personal criticism. As rehearsed in Chapter 2, evolutionary 
psychology describes dominant- subordinate socially ranked relationships with 
concomitant behaviours that are necessary for our survival. For example, in animal 
models, competition for food or sexual partners will lead to a dominant party exerting 
control over a submissive rival via threats and control.  Challenges by subordinates 
are rewarded with posturing or actual attacks. Gilbert (126) suggests that these 
types of relationships (hostile attack- submissive defence) can also play out in 
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individuals internally, with one’s own “inner voice”. A high expressed emotion 
relationship can exist internally with attack signals, subordinate defences and 
negative self labels. These have been implicated in the development of 
depression(127). More recently however, there relationships have been explored in 
relation to auditory hallucinations and persecutory beliefs (131).  People who hear 
voices frequently have a role relationship with their voices (170). Malevolent voices 
are similar in this respect to the inner voice of depressed subjects described above. 
This dominant- subordinate relationship has previously been implicated in the 
development of depression in patients with chronic voices (126), yet not at illness 
onset. 
Freeman (140) has demonstrated the importance of the response to persecutors in 
delusional beliefs. Engagement with safety behaviours and emotional distress are 
implicated in the development and persistence of persecutory delusions, by 
preventing disconfirmation of the beliefs themselves. Cognitive factors such as 
hopelessness, helplessness and power, again reflecting a dominant subordinate 
relationship, have been recognised as significant factors in delusional beliefs(141) 
Similarly to voices these have only been explored to date in the post psychotic 
experience or in terms of driving  distress in those with persecutors in chronic illness 
(140, 209). How these factors predict depression in the acute episode has not been 
explored to date. 
In summary, depression has rarely been examined in detail in the acute phase of 
psychosis, although studies that have been done point to a higher rate here than at 
other phases (63). Prodromal depression predicts depression in the acute stage for 
some individuals, yet depression can also arise unheralded at this stage(149).  Lack 
of insight has often been proposed as a self-serving protective mechanism and 
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results in established samples show clearly the role of personal significance and 
threat of a psychotic diagnosis in the generation of depression (119, 131). Threat 
from persecutors and malevolent voices, and the cognitive response to this threat, 
have been implicated in the development of psychosis (140) and post psychotic 
depression(131).  Therefore in this study the presence of awareness of illness and 
the individual’s appraisal of his psychotic illness will be explored in the acute first 
episode phase. The significance of this awareness and appraisal in terms of the 
prediction of depression will be examined. In addition, the role of threat from voices, 
persecutors and their mitigation through safety behaviours in the prediction of 
depression in the acute phase of FEP will be scrutinized.  
 
6.2 Hypothesis 
In the acute phase of FEP 
• In the presence of significant awareness of illness, negative illness 
appraisals, in terms of Loss, Shame and Entrapment, will also be present.  
• Negative appraisals of psychosis will be linked to depression, after 
controlling for prodromal depression and severity of psychosis. 
• Personal threat from voices and persecutory delusions, combined with the 
use of safety behaviours, will be predictive of depression, independent of 
severity of psychosis. 
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6.3 Method: 
6.31 Sampling 
See Chapter 4 for a detailed report of methodology. In summary, sequential referrals 
to the Early Intervention Service (EIS) in Birmingham with first episode of psychosis 
were screened for participation within 4 weeks of onset of treatment in the acute 
phase of illness, and a first episode of psychosis conforming to ICD-10 F20-29, 
F30.2, F31.2, F31.5 and F32.3.  Excluded were those with any previous treated 
episode of psychosis or those with any organic process as the primary diagnosis. 
Home treatment teams and admission facilities were contacted on a weekly basis to 
ensure patients were recruited soon after first contact with services. Informed written 
consent was obtained following verbal and written information in line with ethical 
approval.  
6.32 Measures 
Please see Chapter 4, pages 43-52, for detailed description of the following 
measures. 
1. Schedule for Clinical Assessment in Neuropsychiatry 2.1(SCAN)(150): 
2. Positive and Negative Symptom Scale (PANSS)(151): 
3. Duration of Untreated Psychosis: 
4. Depression Measures: 
 a) Prodromal Depression: SCAN (150)  
 b) Depression in Acute Phase Calgary Depression Scale for Schizophrenia:(116) 
5. Insight and Illness Appraisals: 
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a) Insight Scale (162) 
b) Personal Beliefs about Illness Questionnaire (PBIQ-R) (133) 
 6. Appraisal of Threat from Voices and Persecutors: 
a) Beliefs about Voices Questionnaire – Revised (168): 
c)  Voice Topography Scale (169)  
d) Voice Power Differential Scale(170) 
e) Details of Threat Questionnaire (140) 
f) Safety Behaviours Questionnaire (140): 
 
6.4 Statistical Analysis 
Participants were grouped into those with and those without depression in the acute 
phase, as defined by a CDSS score of >7. A power calculation based on previous 
published studies (178) using both CDSS and PANSS established that a sample size 
of 86 would have a 90% power to detect a significant difference (p<0.05) in PANSS 
scores between depressed and non depressed patients. Quantitative non-categorical 
data were tested for normal distribution using the Blom method of p-p plots. 
Parametric tests of significance were used as appropriate between participants with 
and without depression using a one way between groups ANOVA. Due to multiple 
testing, significance was corrected with a bonferroni calculation to p< 0.03.  In 
addition, correlations between severity of depression and insight and PBIQ-R 
variables were calculated with Pearsons Correlation coefficient.  
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 In order to determine the most significant predictors for depression in the acute 
phase, variables were entered into a stepwise linear regression model. Prodromal 
depression force entered at step one to determine the significance of other variable 
over and above this factor. A stepwise, rather than a simultaneous logistical 
regression, model was used due to the large number of variables entered; in a 
stepwise model, non significant variables are removed at each step (210). 
 
6.5 Results  
Sample Population 
As described in Chapter 5, pages 51-52, a total of 136 individuals were screened. Of 
these, 10 were not in their first episode, eight were not in the acute phase of illness 
and eight did not have a psychotic illness. Eighteeneligible individuals refused to 
participate, leaving 92 who entered the study.  Those declining to participate did not 
significantly differ in age, gender or ethnic group from the participant group.  
Demographic and clinical details of the study sample are given in Table 5.1.  
 Full data on voice appraisals was available in 70 (76%) of patients: 19 (21%) 
reporting no auditory hallucinations and 3 (3%) not completing measures on voices. 
Full data on persecutory beliefs was available in 76 (82%), with 18 (19%) 
participants not reporting persecutors. All 92 participants completed the remaining 
measures. All continuous variables demonstrated normal distribution (p-p plots).  
 
In the six months leading up to the first psychotic episode, 51 (56%)  participants 
experienced a clinically significant depressive episode (prodromal depression). in the 
acute phase of illness, 54 (59%) had moderate or severe depressive episode and 
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65% reported hopelessness. Of all participants reporting acute depression, in 20 
(35%) this occurred “de novo”, without prodromal depression, and in 34 (65%) this 
was reported as continuous with prodromal depression.  
In the acute phase, when comparing depressed versus non depressed groups as 
defined by a CDSS score of 7 or more, no significant differences were found in age, 
gender, or ethnicity. Participants reporting any current substance misuse were more 
likely to be depressed (pearson chi-square = 3.93, p=0.047).   
 
6.51 Hypotheses 1; In the presence of significant awareness of illness, negative 
appraisals will also be present. 
Insight and negative illness appraisals were present in the acute phase at significant 
levels. Mean total IS score for the full sample was >9, indicating moderate insight 
across the sample (162).The  Awareness of Illness IS subscale was significantly 
correlated (pearsons r) with negative appraisals; Loss r=0.47, p<0.01, Shame r= 
0.38, p<0.01; Entrapment r=0.62, p<0.01, Control 0.54, p<0.001 and Group Fit 
r=0.53, p<0.001.   
 
6.52 Hypothesis 2: Negative appraisals of psychosis will be linked to depression, 
after controlling for prodromal depression, and severity of psychosis. 
 
Total IS score did not differ between depressed and non depressed subjects; 
however, the key subscale, Awareness of Illness, was significantly higher in the 
depressed participants (F4.64, p=0.03). See table 6.1.  
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Negative illness appraisals were greater in the depressed compared to non 
depressed groups. As measured by the PBIQ-R, depressed participants reported 
significantly higher appraisals on all measures: Loss (F23.9, p<0.001), Shame 
(F10.22, p<0.005), Entrapment (F26.62, p<0.001) and Control (F 20.35, p<0.001) 
and Group fit (F 21.89, p<0.001). See Table 6.1, figure 6.1 
The severity of depression in the acute phase, measured by the CDSS, was not 
correlated with PANSS positive (r= -0.17, n =92, p= ns), PANSS negative (r= -0.03, 
n=92, p=ns) scores or DUP (r=016, n=92, ns). See Regression 6.55 for further 
analysis. 
There were no significant differences in any appraisals of illness or symptoms, when 
comparing participants in whom depression arrived “de novo” compared to those 
whose depression was continuous with that in the prodrome. 
 
6.54 Hypothesis 3:  Personal threat from voices and persecutory delusions, 
combined with the use of safety behaviours, will be predictive of depression, 
independent of severity of psychosis. 
One way ANOVA between depressed and non depressed group showed significant 
differences in appraisals of voices and persecutors in the predicted direction. Voice 
hearers in the depressed group had higher BAVQ Malevolent and Lower BAVQ 
Benevolence scores (p<0.01). In addition, depressed subjects had significantly 
higher scores on BAVQ engagement (p <0.01).  Differences on power of voices did 
not reach statistical significance (p=0.07).  
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As predicted, depressed participants reported more powerful persecutors on the DoT 
measure (p=0.04) and were more distressed by the threat from persecutors 
(p<0.001). In addition, they reported a higher strength of delusional conviction 
(strength of belief, p=0.03) and a diminished ability to cope with the current threat 
(p=0.03).  SBQ results revealed that use of safety behaviours was significantly more 
frequent in the depressed group (p=0.003).See Table 6.2, Figure 6.2 and 6.3  
 
6.55 Regression Model 
Both hypotheses 2 and 3 make predictions of depression independent of prodromal 
depression and symptom severity. In order to explore this, variables of Prodromal 
Depression, PANSS positive score, DUP, voice malevolence, power of persecutors, 
delusional distress, safety behaviours and PBIQ loss, shame and entrapment were 
entered in to a stepwise linear regression model to predict the severity of depression 
in the acute phase. Prodromal depression was forced entered at step one, in order to 
explore the significance of other variables over and above its influence.  Preliminary 
analysis were conducted to ensure no violation if normality or multicollinearly (r 0.12-
0.63).  
Depression in the prodrome singularly explained 18% of the variance in CDSS 
depression in the acute phase (R Square = 0.18). A final model of BAVQ voice 
malevolence, DoT delusional distress, engagement in safety behaviours and PBIQ-R 
entrapment explained 64% (R square = 0.64) of the variance in CDSS depression 
score. The addition of these measures to the model explained an additional 46%, 
beyond that predicted by prodromal depression alone F (5, 41) =14.911, p<0.001.  
PANSS positive score and DUP were not significant in the model. 
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Table 6.1 Insight and Illness Appraisals: IS and PBIQ-R 
                           Mean (s.d)  
          
Variable 
 
Full sample Depressed Not Depressed 
ANOVA F 
 (sig p=) 
Total Score 9.66 (4.37) 10.01 (4.30) 9.15 (3.97)  0.95 (ns) 
Awareness of 
Symptoms 
2.72 (1.39) 2.68 (1.42) 2.87 (1.37) 0.12 (ns) 
Awareness of 
Illness 
3.76 (1.90 3.87 (1.92) 3.59 (1.88) 4.64 (0.03) 
Insight 
(n=92) 
Need for 
Treatment 
2.48 (1.36) 2.74(1.26) 2.43(1.43) 0.50 (ns) 
Loss 17.30 (4.39) 18.96 (4.00) 14.95 (3.84) 23.19 
(<0.001) 
Shame 14.39(4.32) 15.37 (2.83) 13.24 (3.56) 10.22  
(0.002) 
Entrapment 14.64 (3.40) 16.00 (2.96) 12.71 (3.07) 26.62 
(<0.001) 
Group Fit 11.53(2.90) 12.57 (2.45) 10.05 (2.88) 20.35 
(<0.001) 
Illness 
Appraisal 
(n=92) 
Control 12.25 (3.88) 13.54 (3.13) 10.42 (3.15)  21.88 
(<0.001) 
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Table 6.2 Threat from Persecutors: BAVQ and DOT 
                     
Mean (s.d.) 
 
Appraisal 
       
Depressed 
 
Not 
Depressed 
 
 
ANOVA F  
(sig p) 
         
Malevolence 9.08 (5.29) 5.17 (4.07) 11.30 (0.001) 
Benevolence 3.89 (3.85) 7.40 (4.97) 11.64 (0.001) 
Omnipotence 8.30 (4.05) 6.93 (3.87) 2.02 (ns) 
Resistance 14.53 (6.74) 10.87 (6.97) 4.89 (ns) 
Engagement 8.33 (5.56) 4.83 (4.20)  8.64 (0.004) 
Voice 
(n=70) 
Voice Power 23.58 (5.18) 21.10 (6.00)  3.19(ns) 
Power of 
Persecutors 
6.88 (2.45) 5.39 (3.29)  4.34 (0.04) 
Distress of 
Belief 
7.95 (1.97) 4.54 (3.97)  28.16 (0.001) 
Strength of 
Belief 
80.98 (23.21) 64.35 (39.55) 4.51 (0.03) 
Ability to Cope 4.10 (2.58) 5.70 (3.21) 4.79 (0.03) 
Persecutors 
(n=76) 
Safety 
behaviours 
21.73 (12.16) 11.77 (13.33) 9.56 (0.003) 
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Figure 6.1  PBIQ-R Appraisal of 
Psychosis
*sig p=<0.01 
 
Figure 6.2 BAVQ  Appraisal of Voice 
* sig p<0.01 
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Figure 6.3 Appraisal of Persecutors: DOT and SBQ 
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*all sig at p <0.03   **shown here on 0-10 scale; percentage reported in text. 
 
6.6 Discussion 
The presence of depression in the acute phase was significant, with fifty nine percent 
of participants reporting symptoms of a moderate of severe depressive episode. This 
compares to previous research indentifying rates of between  twenty nine and 
seventy five percent (63), with the higher rates (66) likewise seen in a first episode 
sample. Depression was not related to severity of positive or negative symptoms and 
occurred equally in male and female participants and across all ethnic groups 
represented. Depression was significantly more common in those currently abusing 
substances, this area itself warranting further investigation: for example, prodromal 
depression may be a driver for early substance misuse (and hence poorer outcome). 
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Further studies examining the direction of association here would be warranted, in 
keeping with the high prevalence and significant effects of substance misuse in the 
prodromal stage(211, 212). Indeed Turkington et al (43) recently showed that 
individuals with substance misuse had more severe depression and poorer outcome 
in the first episode. 
 
6.61 Hypotheses 1 and 2: 
The hypotheses proposed in the present study; that in the acute phase of FEP 
awareness of illness and negative appraisals of psychosis are present, and 
contribute to depression, has been upheld. Awareness of illness and negative 
appraisals were present at significant levels in the acute FEP and significantly 
correlated. The experience of FEP in terms of loss, shame and entrapment were also 
significantly higher in those with depression. Previous research has demonstrated a 
relationship between high levels of awareness and other negative appraisals: Cooke 
et al.,(213)  found high levels of insight related to low self-esteem, but not 
depression, in a sample of individuals with established psychosis. They conclude this 
relationship was driven by the awareness of illness dimension. Karatzias (214) 
recently explored negative appraisals in a sample with chronic illness and likewise 
found a strong association between personal beliefs about illness and affective 
comorbid conditions. Crumlish(203) demonstrated the significance of greater 
acknowledgment of illness in the prediction of depression and suicide attempts within 
4 years in their first episode sample, also reflecting findings presented in Chapter 5.  
Whilst prodromal depression is a significant factor for the generation of depression at 
later stages, over and above this we have shown that negative illness appraisals of 
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loss, shame and entrapment were significantly linked to depression in acute FEP, 
and unrelated to symptom severity. In the final regression model, the appraisal of 
entrapment (in combination with malevolent voices and engagement in safety 
behaviours) was a significant factor in the prediction of acute depression even after 
controlling for prodromal depression. Positive symptom severity and DUP did not 
contribute a significant effect in the model prediction.  Birchwoods’ previous study of 
post psychotic depression in a chronic sample(133) found that 70% of the group 
experienced depression during the acute phase and 39% post psychotic depression. 
Here depression recovered in line with symptom resolution. We can interpret these 
findings to mean that there is no direct relationship between symptom severity and 
depression, in keeping with proposals for an orthogonal depressive dimension in 
psychosis, rather it is the personal significance of illness that is more salient. 
Dunkley (128) proposed that individuals with high levels of self criticism are more 
reactive to stressors that imply failure or loss of control, and are less able to utilize 
effective problem solving. In depression, more recently, it has been argued that 
individuals may fall short of their preferred or aspired-to self, resulting  in a sense of 
entrapment and loss (133). The study presented in this chapter indicates that these 
factors are at work in the acute phase of FEP, and may be important in the 
development of depression here. These themes will be further addressed in Chapter 
7. 
6.63 Hypothesis 3:  
The final hypothesis proposed that personal threat from voices and persecutory 
delusions, combined with the use of safety behaviours, would be predictive of 
depression, independent of severity of psychosis. This was upheld, with the 
experience of personal threat from voices and persecutors, not severity of positive 
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symptoms, higher in the depressed compared with non depressed groups. In the 
regression model voice malevolence, delusional distress and engagement in safety 
behaviours were significant in the prediction of depression.  
Since the time of Geisingers’ first descriptions of a unitary psychosis, and Kraepelin’s 
distinction between affective and non-affective psychosis, the difficulties of 
depression in those with acute schizophrenia have been a challenge for traditional 
taxonomy(54). Findings presented in this study, in combination with other recent 
advances and challenges (175, 215), highlight the importance a depressive 
dimension as a potentially rich ground for future research. Chapter 5 described the 
course of depression throughout the first episode, and showed that whilst prodromal 
depression is predictive in some individuals of future depression in the acute and 
post psychotic phases, depression can also arrive “de novo” in significant numbers 
at any stage (149). In exploring in more detail here the drivers for depression in 
acute FEP, we have raised the possibility that in some depression is a reaction to the 
threat posed by supposed persecutors. Participants who are engaged with 
malevolent voices, feel that they are less powerful than their persecutors (are 
subordinate to them) and demonstrate higher delusional conviction, experience 
higher levels of depression. Freeman and others (140, 141) have also demonstrated 
the significance of persecutory beliefs and safety behaviours in the development and 
maintenance of delusional belief and distress.  Those participants in our study highly 
engaged in safety behaviours also experience more depression. The regression 
model demonstrated that over and above the influence of prodromal depression, the 
role of the psychological response to psychosis in the generation of acute 
depression is marked. The final model of voice malevolence, delusional distress, 
engagement in safety behaviours (and entrapment) explained a forty eight percent 
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increase in the prediction of depression from when prodromal depression was 
considered alone. This suggests the personal significance and reaction to perceived 
threat by voices and persecutors, and arrested flight, is overriding the severity of 
symptoms and is most significant in the generation of depression.  
Trower and Chadwick (216) propose two types of paranoia; “good me” and “bad me” 
whereby “bad me” paranoia is felt to be deserved and associated with less 
favourable self image. Recently, models of the development of persecutory beliefs 
also suggest a dynamic relationship between persecutor and subject, mediated by 
self esteem; Udachina (217) suggests that low levels of positive self esteem have a 
direct association with experiential avoidance (intolerance of negative mental 
experiences) and the development of persecutory beliefs by preventing 
disconfirmatory evidence. Positive symptoms of psychosis they suggest are not 
caused directly by negative emotions but rather the efforts to avoid unpleasant 
private experiences. In combination with the results of the study in this chapter an 
alternative model is possible; the personal appraisal of anomalous experiences 
drives ongoing emotional dysfunction, and through this further increases in positive 
symptoms and illness.  
 The regression model goes some way to answering what is a clear question of the 
directionality of influence; whether depression or appraisal is primary.  The personal 
significance of threat from persecutors and the ability to mitigate this threat was 
significant over and above the presence of prodromal depression.  Perhaps more 
significantly the results presented show us that the fuel for depression in the acute 
phase is clearly weighted in the favour of the personal significance of illness and 
threat imposed by persecutors. 
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6.7 Implications: 
The findings presented are significant in two respects: firstly care must be given 
when working to increase awareness of illness in individuals. This cannot be done in 
an unplanned or scattershot way, clinicians must be alert to the risks, along with the 
benefits, increasing awareness may bring. Negative appraisals, depression and thus 
risk and poorer outcome may be increased (218). Psychoeducation will need to be 
received hand in hand with aspects of treatment that increase a sense of control and 
empowerment rather than risking conferring loss and shame. This is no mean feat 
when also balancing the management of risk in FEP and the need to reduce the 
duration of untreated psychosis. Aspects of service response, risk management and 
patients pathways in care can often involve coercion and imposed powerlessness, 
for example through the use of the Mental Health Act.  
In other words, when patients are already feeling powerless in response to 
persecutors and voices, what little self determination and control they have left may 
then be taken away through services response. In addition at such times more subtle 
forms of power and control may be exerted by services: an example of which may be 
seen in the following quote from a young patient treated at home who felt hassled by 
both mental health services as well as his own persecutors, asking home treatment 
staff to “stop bringing this mental health to my door! Leave me alone”. Yet to leave 
illness untreated, with lengthening DUP and risk in acute illness is likewise not a 
viable option.  
Findings presented of the relationship between depression and threat from the 
positive symptoms of psychosis in the acute first episode, are also clinically 
important. Positive symptoms never occur in a vacuum, and contrary to a 
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phenomenological approach it is the content rather than the form positive symptoms 
take that is relevant in this study. Beliefs about, and engagement with, voices was a 
key predictor of depression in this acute phase. Depression as shown in Chapter 5 
and by others in enduring psychosis is a clear risk for suicidal thinking (133, 149, 
219). This knowledge will be invaluable to clinicians assessing risk in the acute first 
episode phase, who should be alert to the emotional response voices and 
persecutors provoke, in addition to the form in with they are experienced. There is 
also here the potential to inform the development of future therapies.  
Secondly, these findings are significant in terms of the pejorative public health 
perceptions that young people still have. Initiatives to reduce stigma of mental illness 
have achieved some ground in recent years, yet the stigma associated with 
psychosis is still profound (220). It is sobering finding that even in the throes of an 
acute first episode of psychosis, what insight is present is fertile ground for the 
development of negative appraisals which perceive current experience as shameful 
with accompanied loss of, aspired for, future goals. For this to change much more 
emphasis is needed on counteracting the stigmatizing and negative image of 
psychosis still portrayed within the media and professional circles. Perhaps only 
when this is achieved will the prevalence of shame in psychosis be reduced. Lack of 
help-seeking early in the course of illness is also a well recognised consequence of 
this shame(221) and it remains all too common that many patients first experience of 
mental health services are through a tortuous pathway into care (222). 
 
 It has been repeatedly demonstrated that the acute and early phases of illness have 
significant risk of self harm and suicide (194). Early psychosis programs also 
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highlight the effectiveness of cognitive treatment packages for the at risk mental 
state as well as early psychosis (142, 223). Increased theoretical knowledge of the 
relationship between malevolent voices, the power of persecutors, ability to cope 
with threat and the role of safety behaviours can add to the effectiveness of such 
interventions. Further work is necessary, stemming from this increased knowledge. 
Many opportunities can be translated into clinical intervention trials. These will be 
further discussed in Chapter 10.  
6.8 A Proposed Model of the generation of Depression in Acute First Episode 
Psychosis 
See Figure 6.4. 
Prodromal depression renders an individual vulnerable to depression in later stages 
of FEP. Individuals will also have hold of all of societal prejudices, stigma and fear 
regarding mental illness. As acute psychosis develops, insight remains, all be it for 
some at low levels, and this awareness of illness is used in appraising ones situation 
as shaming and humiliating. When florid positive symptoms develop, coping 
mechanisms will be employed, including appeasement and engagement with voices, 
subordination to persecutors and (ineffective) use of safety behaviours. The sum 
total is a common position of entrapment by illness, by society, by persecutors or 
voices, demoralization and a lack of control. Mental health services response may 
add to this position. The end result is depression, hopelessness and suicidal intent.  
6.9 Methodological Issues 
This study has three potential limitations.  A retrospective assessment of prodromal 
depression may be subject to recall bias, however is unavoidable without using large 
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numbers of “at risk” subjects, which would lead to small numbers of patients in the 
follow up after transition to FEP (224). Secondly, participant numbers, although large 
enough given power calculations for our broad aims, did not allow for subset analysis 
which would have revealed additional information, for example whether “de novo” 
depression has stronger association with voice or illness appraisals. Thirdly some 
might criticize the inclusion of all FEP participants, rather than including only those 
with schizophrenia spectrum disorders. Low numbers in the affective psychosis 
group should however be noted.   It is clear that diagnostic certainty is slim in FEP, 
with the largest change in diagnostic group being from FEP to schizophrenia (38). 
Results in this chapter reflect the full FEP range and are thus generalizable to this 
group. Finally, care must be taken when interpreting findings presented.  The 
direction of causality cannot be assumed; for example individuals may hear 
malevolent voices or interpret their experiences as shameful because they are 
depressed. This will be further addressed in chapter eight, however the final answer 
may only be found after intervention studies are conducted, for example 
demonstrating that change in negative appraisals prevents depression. 
Multicolinearity, hypothesised as one model of depression in schizophrenia with 
strong overlap between negative symptoms, extrapyramidal symptoms and 
depression, as discussed in chapter 1, is also possible. In some balance to this, 
specifically in the regression model used in this study, PANNS negative symptoms 
were excluded from the model. In addition in the univarite analysis there was no 
association between depression and positive or negative symptoms.  
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Figure 6.4 Proposed Model of the Generation of Depression in Acute Psychosis 
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Chapter 7  
The Development of Post Psychotic Depression following First Episode 
Psychosis 
 
7.1 Introduction 
Post psychotic depression (PPD) is the only form of affective disturbance formally 
recognised within historical and current schizophrenia classification systems. ICD-10 
F20.4 defines post psychotic depression as “A depressive episode, which may be 
prolonged, arising in the aftermath of a schizophrenic illness. Some schizophrenic 
symptoms, either "positive" or "negative", must still be present but they no longer 
dominate the clinical picture” (61). In addition, ICD-10 (F20.0) states that “The 
diagnosis of schizophrenia should not be made in the presence of extensive 
depressive or manic symptoms”.  
This clearly demonstrates the conceptual difficulties that have continued throughout 
the last century (35), with the positive symptoms of schizophrenia exclusively 
prominent over all “lesser” symptoms. Yet we know, and have demonstrated here in 
Chapter 5, that in the first episode clinically significant depression is present in over 
80% of patients (149). This demonstrates perhaps why the area of affective 
disturbance in psychosis has been neglected: the nosological difficulties alone are 
substantial. In Chapter 5 we demonstrated the predictive value of prodromal 
depression for further episodes, and in chapter 6 the potential role of negative illness 
appraisals and psychological response to threat in the acute phase. It was shown 
that in FEP those participants experiencing depression for the first time in the post 
psychotic phase are the exception with only four participants (5%) experiencing 
depression in follow up “unheralded” by prodromal or acute depression (149). In 
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other words, depression is more likely to re-emerge in those individuals who are 
already vulnerable by virtue of depression in the prodromal or acute phases. What 
other factors are involved in the prediction of PPD after FEP are unknown.  
Few studies have focused on depression occurring after the first episode, however 
those that do show a higher rate here than following acute relapse in established 
psychosis (65). Much of the literature that does exist around depression in 
schizophrenia focuses on the post psychotic and/or chronic phase of illness (117), 
but with little distinction between the two. Many different models have been proposed 
to explain PPD. Depression has been described as an intrinsic part of the syndrome 
itself, as a preformed reaction pattern associated with clear neurotransmitter 
dysfunction, progressing as the underlying brain dysfunction progresses. Heiden 
proposes a Jacksonian hierarchical model whereby in the pathway to 
brain dysfunction severe enough to produce psychotic symptoms, the lesser neural 
networks will inevitably be disordered (115). Depression in the post psychotic phase 
is proposed by others to be constantly present, yet only “revealed” as positive 
symptoms abate (54). Side effects of anti psychotic medication have also long been 
identified as a possible cause or confounder (54).  Alternatively, the Psychological 
Response model has recently begun to gather evidence. In their study of patients 
with established schizophrenia (mean age of 32), Birchwood and Iqbal (133) showed 
that depression in the acute phase recovered in line with positive symptoms, only to 
re-emerge later on in the post psychotic phase without the presence of psychotic 
symptoms. Birchwood et al (56, 131) also demonstrated that, in established 
schizophrenia, when developing insight, participants developed depression, lower 
self-esteem and a worsening of their appraisals of psychosis. They concluded that in 
PPD depression arises from the individuals’ appraisal of psychosis and its 
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implications for his/her perceived social identity and social position and feelings of 
being forced to accept a subordinate social identity without opportunity for escape. 
Threat and entrapment, in terms of thwarted escape, have long been recognised in 
animal models of depression and shown to be of significance in explaining many 
features of depression in humans; Gilbert describes these features of particular 
prediction of demobilization in depression; apathy, loss of energy and lack of interest 
exhibited in the face of arrested flight and submissive postures(127). The subjective 
experience of schizophrenia is also argued to be a significant, but neglected, factor in 
the recovery of individuals with severe mental illness (225). Strauss and Davidson 
(129) suggest that “reconstruction of the self” can only occur following acceptance of 
the disorder, allowing individuals to focus on their sense of self and ‘move forward’ in 
life. How the personal response to psychosis as a traumatic life event interacts with 
underlying vulnerability conveyed by previous depression to predict PPD in the first 
episode has not been looked at to date. 
Thus, although depression following FEP is more frequent than following subsequent 
acute episodes in established illness (63), the factors involved in the development of 
post psychotic depression here have not been adequately explored. Post psychotic 
depression remains a high risk factor for completed suicide and affects functional 
recovery (134, 201). Government policy and huge investment is shaped by this 
knowledge, for example the target of a seven day follow up post discharge from 
hospital (226), yet our knowledge of what causes PPD is not well developed. Our 
understanding of the predictors for PPD need to be more advanced, if we are to 
develop more effective treatment interventions and strategies. The psychological 
response model has been shown to be relevant in PPD in established schizophrenia 
(131). In this study therefore, the role of awareness of illness and negative 
103 
 
appraisals of psychosis as predictors of post psychotic depression following recovery 
from a first episode of psychosis will be examined. 
 
7.2 Hypotheses 
1. Post psychotic depression following recovery from the first episode of psychosis 
will be predicted by greater awareness of illness and negative appraisals of 
psychosis, independent of the severity of the psychosis  
2. Negative Illness appraisals will remain significant  in the prediction of PPD, after 
controlling for previous depression 
 
7.3 Method: 
Sampling 
See Chapter 4 for detailed description of study methods. However for this study all 
participants completing baseline and 12 month follow up measures were included.  
7.31 Baseline Measures 
1. Schedule for Clinical Assessment in Neuropsychiatry 2.1(SCAN)(150): 
2. Positive and Negative Symptom Scale (PANSS)(151): 
3. Duration of Untreated Psychosis: 
4. Depression Measures 
a. Prodromal Depression: SCAN(150)  
b. Baseline; Calgary Depression Scale for Schizophrenia: (116) 
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5. Appraisal of psychosis :  
a) Personal Beliefs about Illness Questionnaire (PBIQ-R) (133) 
 
7.32 Follow Up Measures: 
The CDSS was repeated at 6 and 12 months. PANSS and PBIQ-R were repeated at 
12 months. From the PANSS measure, item 12 on the general psychopathology 
scale (G12) rates global insight and judgement. Higher scores on the G12 item 
indicate poorer insight.  Previous studies comparing insight rating scales have 
included the PANSS G12 Item as a valid measure, with good correlation with other 
measures of insight(165) .  
 
7.4 Definition of Post Psychotic Depression 
Many previous studies of depression in schizophrenia, whist making conclusions 
regarding PPD have not often defined the phase of illness for their sample, and often 
include psychosis at any stage of illness (184).  We have investigated depression in 
acute psychosis in detail in chapter 6, and have specific aims to explore post 
psychotic depression in the present study. In order to exclude participants still 
experiencing high levels of acute symptoms, follow up PANSS scores were 
scrutinized. Any participant with positive symptoms rating  greater than 14 or any 
individual score of greater than 3 on the P1-7 positive scale, and thus experiencing 
significant positive symptoms (as the result of either treatment resistance or relapse) 
will be excluded from further analysis.  
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Depression assessed at 6 and 12 months points will be referred to as “post psychotic 
depression” only when CDSS score at either follow up point reached 7 or more. 
Whilst the use of the term Post Psychotic Depression may not have concurred 
exactly with ICD-10 definitions, i.e. that there should be some positive or negative 
symptoms still present, the difficulties with this definition are clear. Here we use Post 
Psychotic Depression to mean depression occurring in recovery following an acute 
psychotic episode. 
 
7.5 Statistical Analysis: 
Subjects were grouped in to those experiencing PPD and those without PPD based 
on a maximum CDSS score over 7 at either point in follow up, in the absence of 
acute symptoms, as described above (7.4). Sample size was calculated in line with 
detailed overall methodology as discussed in chapter 4, however for this study a 
power calculation was conducted using the PANSS and CDSS revealed that a 
sample size of 32 in each group (those with and those without PPD) would have a 
90% power to detect a significant difference in PANSS score. 
Quantitative non-categorical data were tested for normal distribution using the Blom 
method of p-p plots, and parametric tests of significance were used as appropriate 
on measures demonstrating normal distribution. Independent samples ANOVA was 
used to compare mean score for continuous variables (age, G12 Insight, PBIQ-R, 
DUP, PANSS Positive and Negative score) in participants with and without PPD. 
Chi-square tests of association were used to compare categorical data: diagnostic 
status, ethnicity, and the presence or absence of prodromal and acute depression in 
those individuals with PPD compared to those without PPD.  
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Variables with significance were then entered in to a linear regression model to 
determine the most significant predictors for post psychotic depression. 
 
7.6 Results 
Please see Chapter 5 for full details of the sample. However for this study data on 
eighty two participants who completed follow up were available (89% of the baseline 
sample). Full follow up data were available for all participants. Demographic details 
are given in Table 5.1. Of those not completing follow up, four had disengaged from 
services and six declined to take part in follow up measures; this group likewise did 
not differ in terms of age, gender or ethnicity from those participating in follow up 
(X2=0.26-0.27, p=ns). 
 
7.61 Prevalence of PPD: 
 At point of follow up, four out of the 82 participants scored 14 or more on PANSS 
positive scale or greater than 3 on any individual P1-7 measure, and thus were 
excluded from further analysis. Of the remaining78, 29 (37%) had moderate or 
severe depression as defined by a CDSS score of greater than 7 at one or more 
points in the follow up. This was defined as the PPD group.  Forty-nine (59%) had no 
significant depression, as defined by a score of < 7 on the CDSS at both follow up 
points. This was the non PPD group. 
Categorical data analysis using chi- square test of association revealed no significant 
difference between PPD and non- PPD groups on gender, ethnicity or diagnostic 
status (affective vs non affective psychosis).Those patients reporting depression in 
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the prodromal period were significantly more likely to have experienced a post 
psychotic depression (score >7 on the CDSS; X2 4.6, p=0.01).Those reporting 
depression in the acute phase were also significantly more likely to report post 
psychotic depression (X2 =3.9. p=0.03) see table 7.1 
 
7.62 Hypothesis1: Post psychotic depression will be predicted by greater insight and 
negative illness appraisals of psychosis, independent of the severity of the 
psychosis. 
Participants with PPD did not have significantly higher score on global insight 
measure, however they did score significantly greater on PBIQ-R subscales of 
Control, Loss and Shame (F8.54-11.96, p<0.001) see Table 7.2. Participants with 
PPD also reported a longer DUP (F4.31, p<0.05) and higher PANSS positive score 
(F3.9, p <0.05). See Table 7.2 
In summary, patients with PPD had a longer DUP, higher current PANSS positive 
score, and higher current scores on PBIQ-R subscales of Control, Loss and Shame 
but not overall insight.   
7.63 Hypothesis 2: Negative Illness appraisals will remain significant in the prediction 
of PPD, after controlling for previous depression 
A linear regression model was performed to assess the impact of the significant 
predictor variables, over and above the impact of depression in acute psychosis, on 
the likelihood that the participants would experience PPD. Acute depression was 
force entered at step one followed by, PANSS positive, DUP and PBIQ-R Loss, 
Shame and Control. Acute depression entered at Step1 explained 5.6% of the 
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variance in PPD (R-Square = 5.6). After the entry of PANSS positive, DUP, baseline 
measures of Loss, Shame and Control at Step 2 the total variance explained by the 
model as a whole, was 20% (R square = 0.20) F (4,74) =4.52, p< 0.01. The 
additional measures in the model explained a further 15% increase (p<0.01) of the 
variance in PPD. In the final model, however, only one measure was uniquely 
statistically significant; PBIQ-R Loss (Beta weight = 0.297, p<0.01) 
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Table 7.1 Comparison of Patients with and Without Post Psychotic Depression 
 
Variable PPD  
n=29 
No PPD 
n=49 
 
p* 
Ethnicity White 
               Asian                 
               Black 
14 
5 
10  
12 
20 
17 
 
n.s. 
Gender:   
               Male 
               Female 
 
37 
12 
 
21 
8 
 
n.s. 
Diagnostic Group: 
                Affective Psychosis  
               Non-affective Psychosis 
 
6 
23 
 
8 
41 
 
n.s. 
Prodromal Depression:  
                  Present 
                  Absent 
 
22 
7 
 
23 
26 
 
0.01 
Acute Depression 
                Present 
                 Absent 
 
22 
7 
 
26 
23 
 
0.03 
*Chi Square test of association 
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Table 7.2 Predictors of Post Psychotic depression 
 
 
Variable 
PPD n=29 
(mean s.d) 
NO PPD  n=49 
(mean and s.d) 
 
  F* 
 
     p 
Age 22.9 (5.30) 22.6 (4.76) 0.57 n.s. 
DUP 311 (595) 124 (165) 4.31 0.04 
PANSS 
POSITIVE 
10.82 (3.34) 9.48(2.56) 3.9 0.05 
PANSS 
NEGATIVE 
12.13(5.11) 11.12(3.79) 1.0 n.s  
INSIGHT 2.13 (1.50) 2.35 (1.60) 2.70 0.54 
PBIQ-Control 12.59 (4.09) 10.48 (3.26) 8.54 0.02 
PBIQ SHAME 15.32(3.78) 12.97(3.67) 11.96 0.005 
PBIQ Loss 18.07(3.94) 15.36(3.96) 9.78 0.005 
PBIQ Group 
Fit 
10.75(2.70) 10.36(4.09) 0.79 n.s. 
PBIQ 
Entrapment 
13.42(3.67) 12.61(3.94) 2.6 n.s. 
*one way anova 
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Figure 7.3  PBIQ Appraisal and  post-psychotic depression 
 
*ANOVA significant at p<0.05   **ANOVA significant at p=<0.01 
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7.7 Discussion 
 
Post psychotic depression following  FEP will be predicted by greater awareness of 
illness and negative appraisals of psychosis, independent of the severity of the 
psychosis:  
This hypothesis was only partially upheld. Those individuals who experienced PPD 
were not more insightful, but did appraise their psychosis as more shaming, felt a 
greater sense of loss and less control.  Also, in addition to a propensity to PPD 
conferred with prodromal and acute depression, a longer DUP was linked to PPD. 
DUP has been repeatedly shown to be a poor prognostic indicator in terms of 
symptom recovery and functional outcome (41). The study results presented here 
indicate that DUP may also confer a risk for PPD. This novel finding itself would 
warrant further investigation.  
There was also found to be an association with PPD and ongoing lower level positive 
symptoms, again against the hypothesis put forward. All participants experiencing 
clinically significant positive symptoms (an individual item PANSS positive score of 3 
or more or a total positive score of 14 or more) were excluded from the analysis, 
There remained a significant correlation between lower level positive symptoms and 
PPD. Participants with ongoing positive symptoms (rating minimal to mild on the 
PANSS) were more likely to be depressed. 
Negative Illness appraisals will remain significant  in the prediction of PPD, after 
controlling for previous depression 
The second hypothesis tested in this study was proven. In the regression analysis, 
once depression in the acute phase is controlled for, the addition of Loss, Shame 
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and Control significantly increased the predication of PPD. However, only Loss made 
a uniquely significant contribution to the model. 
 
We can interpret these both these hypothesis findings to mean that whilst negative 
personal appraisals of psychosis, particularly loss, confer the most risk for PPD, 
ongoing low level positive symptoms are also active and constitute an ongoing link to 
depression. The sense is of a grinding down of hope of recovery, with a longer 
period of illness in which future goals, forward plans and self esteem are allowed to 
whither.  Previous papers that have looked at a well defined PPD group have also 
shown a link with positive symptoms (65) with recovery occurring in line with a 
reduction in positive symptom (133). Koreen (65) concluded that “antidepressant 
therapy should be limited to patients in whom the depression persists”. However, the 
relationship between positive symptom and depression is not linear or straight 
forward: many other studies, including those presented in Chapters 5 and 6 here 
show little relationship between the frequency, intensity or severity of positive 
symptoms and depression (56, 63, 66, 227).  
The novel findings in this chapter could signify a risk for PPD brought about by the 
length (DUP) and ongoing nature of low level symptoms mediated through 
appraisals of loss, shame and control. In the presence of a less than full 
symptomatic recovery, hope, resolution and a regaining of self esteem is less likely 
to occur. This will be fuel for ongoing appraisals of loss and shame. The model 
suggested by this study’s results would consist of an ongoing link between distinct 
symptom dimensions in psychosis; of positive symptoms and depression that is 
more readily apparent in the recovery phase. The appraisal process overlays and is 
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driving both depression and this interaction with the lower level positive symptom 
dimension.  A clinical example may serve as illustration of this model: 
BW, a 23 year old young man, entered the study reporting both a long DUP 
(24 moths), prodromal depression and a florid acute episode characterised by 
hearing the male voices threatening to harm him by attacking him in the street 
or poisoning his food. In addition his acute episode also contained 
experiences of thought broadcast and passivity phenomena. He engaged in 
safety behaviours; he stopped going out and ate only pre- packaged food. 
Although response was good to antipsychotic medication, low level residual 
symptoms persisted in combination with post psychotic depression and poor 
functional recovery. Full recovery only occurred when a chance meeting with 
an old school friend enabled BW to begin to socialize more (the friend was a 
champion weight lifter, a local “bouncer” and BW felt safe in his company). He 
gained employment alongside his friend and formed new relationships, 
gaining self esteem. When asked directly BW admitted to still hearing quiet or 
muffled voices when he listened out for them, but reported to be “too busy” to 
do that very often and that he was no longer troubled by his experiences. 
 It is often reported that full recovery after FEP is possible for the majority of patients, 
and indeed optimism here is important (228). Initial recovery after FEP is the most 
common outcome in the broadest sense, and residual “treatment resistance” occurs 
in only a minority of people (229). Yet conventional definitions of recovery and 
treatment resistance are perhaps too broad. The international consensus statement 
of remission in schizophrenia whilst clearly capturing a reduction in acute symptoms 
and overt disability (230) allow the potential for subtle low level “sub-syndromal” 
symptoms to be missed. In addition, we know that patients with schizophrenia, as 
115 
 
indeed have those at high risk of first episode, have more intense and negative 
reactions to daily life hassles (186) and that these convey a risk for the transition to 
psychosis in relapse (48). There has been only one study looking at these low level 
symptoms after recovery form FEP (231) which revealed these experiences to be 
common, occurring in 73%, and stable; reflecting perhaps a trait rather than state 
effect. The results from the study presented in this chapter build on this to show an 
important area for future work. There is evidence form high risk groups that the 
frequency and intensity of anomalous experiences is mediated through to illness via 
affective disturbance (48, 217). In PPD, appraisals of Loss and Shame may be 
driving forward ongoing anomalous experiences and depression, preventing a full 
recovery. The concepts of “kindling “ whereby low level symptoms ‘catch fire’ leading 
to full relapse if left unchecked, is gaining momentum within research into affective 
disorders. Fava demonstrated this in 1999 and described a “roll back” phenomena in 
affective disorders where residual symptoms strongly resemble prodromal 
symptoms, and herald subsequent relapse(232). Such concepts could form useful 
areas of further research in psychotic disorder. Cognitive Behavioural Therapy has 
indeed been tested in relapse prevention in a randomised controlled trial after first 
episode psychosis(233), however was not significantly more effective than treatment 
as usual. Garety et al concluded that CBT in this group requires further development. 
Relapse prevention strategies could be usefully informed by the importance of 
targeting depression.    
7.8 Implications 
Appraisals of loss and shame appear to be at work in PPD. This is clinically 
important for a number of reasons. Those individuals with a long period of untreated 
psychosis, previous depression and less than full recovery are at highest risk of 
116 
 
PPD, particularly if they appraisal recent experiences and shaming or with a sense of 
loss. The post psychotic phase is often a period suggested for more intense 
psychological therapies; and indeed NICE and early intervention guidelines highlight 
the need for relapse prevention strategies and psychological treatments here (234). 
Yet, in terms of depression and suicidal thinking, more emphasis may need to be put 
on tackling loss and shame following FEP. Suicide prevention strategies may well 
need to focus reducing stigma and shame of psychosis on a population basis before 
real effect is seen. The propensity to feel shamed by psychosis will be baggage 
brought with an individual as in part as a result of health belief models, sigma of 
mental illness within a society context and cultural context. Thus only when psychotic 
illness is perceived as less stigmatizing within the general population, can an 
individual developing psychosis be free of shame.   
Whilst feelings of loss and shame are more common in those experiencing PPD, a 
direction of causality cannot be assumed. These negative appraisals could however 
be clear targets for ongoing therapy in the early phase. There is evidence 
psychological therapies are effective in early psychosis (144), and further knowledge 
of the subjective experience of PPD can help inform future detailed therapies.  
The subjective dimension of schizophrenia is said to have been lost in recent years; 
Strauss(225) comments that the biological context surrounding schizophrenia since 
the 1970’s has resulted in a major failure to consider adequately the patients 
subjective experiences in research theory and practice. In emphasising the biological 
basis of schizophrenia in recent years we have become too objective when 
investigating what are at their core subjective experiences. A person’s own role in 
reducing symptoms, or gaining mastery over them, enhances not only a sense of 
power but self esteem. These are key drivers not only to a fuller recovery from 
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positive symptoms, but also a recovery from affective disturbance.  The subjective 
experience of psychotic illness should not be excluded from our clinical focus. In 
looking at PPD in detail though the lens of self esteem and personal appraisal we 
can begin to redress the imbalance(225). 
7.9 Methodological Issues  
There are potential limitations to this study. Nosological difficulties with the definition 
of PPD are clear in ICD-10 as rehearsed in 7.1, and are frequently questioned. A 
pragmatic yet well defined definition of PPD was used in this study. International 
criteria also define remission criteria for schizophrenia (230)  and were not included 
in methodology when defining those with and without PPD. These criteria state that 
there needs to be 6 months or more of remission, as defined as less than 2 on 
PANSS items P1,2,3;N1,4,6 and G 5 and 9. Times scale and follow up of patients 
over 12 months precluded use of this strict definition. 
The use of the PANSS G12 measure for insight is less than robust, given the multi-
dimensional nature of insight as rehearsed in chapter 2, and it is possible that the 
role of insight in raising the risk of PPD was not replicated because of this.  
Numbers in the PPD group were low, and although were nearing those needed on 
power calculations (29 c.f.32) some aspects of the study may have been under 
powered, however most comparisons means reported showed no trend to 
significance (e.g. age, insight etc). In addition, as in previous chapters the frequency 
of follow up will mean some participants who did experience depression in the follow 
up might not have been placed in the PPD group if recovery from depression had 
already occurred at the time of follow up assessment.   
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Chapter 8  
The Stability of Illness Appraisals 
8.1 Introduction 
In Chapter 5, evidence was presented indicating that depression is pervasive at each 
stage of first episode psychosis, yet also that it can ebb and flow in individuals, 
unrelated to diagnosis or psychosis symptom severity. Depression can arrive at any 
stage, but the risk increases in those individuals vulnerable to depression, 
particularly those who experience depression in the prodromal phase. Those who 
have experienced prodromal depression are more likely to go on to experience 
depression in the acute and post psychotic phases (149). As shown in Chapters 6 
and 7, depression in both acute and post psychotic phase was linked to negative 
personal appraisals of psychotic illness in terms of loss, shame, entrapment and 
control. In the acute phase this is unrelated to the severity of positive symptoms, 
however in the post psychotic phase, low level, ongoing psychosis symptoms, 
appear linked to these appraisals and are predictive of depression. The question 
then arises: are these appraisals stable, trait like beliefs or do they change and 
improve in line with those of the acute symptoms and behave more as state 
variables?  
Depression has previously been shown to recover in line with positive symptoms in 
the acute episode of psychosis, only to break through again in the post psychotic 
period in those individual vulnerable to affective disturbance(133). Theories of  
depression in the absence of psychosis suggest that cognitive distortions, for 
example the presence of dysfunctional assumptions, and cognitive thinking errors 
such as overgeneralization are risk factors  for the generation and maintenance of 
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unipolar depression (107). These are proposed to be stable cognitive features  that 
cognitive therapy is designed to challenge(235). This knowledge has informed 
decades of research and interventions for affective disturbance. The importance of 
significant life events in relation to the generation of depression has likewise been 
known for many years (110), particularly where the event is viewed as humiliating or 
entrapping (112). A model of depression in psychosis can also be framed in terms of 
a psychologically traumatic event, be that a realization of loss, shame of having 
psychosis or as a trauma in face of persecutors and malevolent voices(132).  
Psychological therapies are increasingly recommended for psychotic illness, and do 
have an evidence base in terms of treatment for treatment resistant voices, 
command hallucinations and delusional beliefs (136, 139, 236). In addition, the 
evidence for CBT in general terms in psychosis is growing (142). It has been argued, 
however that psychological therapies in psychosis are treated as a “quasi 
neuroleptic”, and that they could find equally effective application with the affective 
dimension and ‘co-morbidities’ in psychosis as the core symptoms themselves (145). 
In Chapters 6 and 7, recommendations were proposed suggesting that the negative 
appraisals could be an additional target in therapy and that this could provide a 
means to reduce the affective symptoms. In particular it was suggested that the 
psychological therapies could target negative appraisals to reduce depression and 
suicidal thinking and improve recovery. However we do not yet know the course of 
these negative appraisals, whether they are stable or follow a natural path of 
recovery, in line with the psychosis itself. If indeed loss, shame and entrapment  
appraisals recover in line with a global recovery following FEP, with medication and 
other support, then the amelioration of depression that was observed in Chapters 6 
and 7, will require other forms of intervention; for example anti-depressants or 
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traditional cognitive therapy which does not need to embrace these illness 
appraisals. Thus we are as a first step required is to determine the extent to which 
these appraisals are state and/or trait characteristics. The central question 
addressed in this chapter is whether the appraisals of psychotic illness change in line 
with the recovery from acute psychosis.   
8.2 Hypothesis 
 
• Negative Illness appraisals of psychosis, loss, humiliation and entrapment, will 
recover in line with the acute psychosis symptoms. 
 
8.3 Method 
8.31 Sampling 
See Chapter 4 for a detailed report of methodology. Participants were followed up 
over a period of 12 months from the first psychotic episode and completed measures 
of psychosis, depression and illness appraisals.  
8.32 Baseline Measures 
1.Schedule for Clinical Assessment in Neuropsychiatry 2.1(SCAN)(150): 
2. Positive and Negative Symptom Scale (PANSS)(151): 
 3. Depression Measures: 
a) Prodromal Depression: SCAN(150) 
b) Depression in Acute Phase: Calgary Depression Scale for Schizophrenia: 
(116) 
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4. Illness Appraisals and Insight: 
a) Personal Beliefs about Illness Questionnaire (PBIQ-R) (133) 
b) Insight Scale (162) 
c) PANSS G12 Insight item (151) 
8.33 Follow Up Measures: 
PANSS and PBIQ-R were repeated at 12 months. CDSS was repeated at 6 and 12 
months. The full insight questionnaire was not completed as part of the follow up 
measures, however the PANSS specific question, item 12 on the general 
psychopathology scale (G12), specifically rates global insight and judgement. 
Previous studies comparing insight rating scales have included the PANSS G12 Item 
as a valid measure(165). 
8.4 Interventions received under treatment as usual 
Although this was not a study designed to test any specific intervention, it should be 
noted that all participants were under the care of Early Intervention Teams and as 
standard would receive intensive case management, consisting of an allocated care 
coordinator, regular medical and care plan reviews, access to psychological therapy 
as clinically indicated and pharmacological treatment.  
 
8.5 Statistical Analysis 
The aim of this study, to chart the recovery of symptoms and negative illness 
appraisals does not call for any specific power calculation. Mean scores at baseline 
and 12 month follow up will be presented. In addition, all continuous data were 
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assessed for normality using p-p plots and Blom’s proportion estimation. Paired 
samples t-test was used to detect any significant change in mean scores (in either 
direction) between baseline and follow up points. Pearson’s correlation co-efficient 
was used to detect and significant correlations of baseline and follow up illness 
appraisals.  
 
8.6 Results 
 
8.61 Sample Population: 
Please see Chapter 5 58- 60 for detailed description of the study sample. For this 
study 82 of the total sample of 92 (89% of the total sample) completed follow up 
measures and were included in the analysis. All 82 participants completed full 
measures included in this study.  
 
8.62 Hypothesis:  Negative Illness appraisals of psychosis, loss, humiliation and 
entrapment, will recover in line with the acute psychosis symptoms.  
All variables demonstrated normal distribution. Results for the cohort demonstrated 
that mean PANSS positive, negative and general scores showed a statistically 
significant decrease over the study period, in line with the process of recovery(see 
table 8.1; all p’s <0.001)  Similarly Scan G12 insight score reduced (participants 
gained insight) and CDSS scores fell. 
 PBIQ-R Loss, Shame, Entrapment, Control and Group Fit remained unchanged 
over the 12-month follow up period. Pearson r showed a moderate, significant 
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correlation between baseline and follow up score on all measures (Loss, Shame, 
Entrapment, Control and Group Fit; See Table 8.1-2 and Fgure 8.1. 
 
Table 8.1 Baseline and 12 Month follow up mean scores 
 baseline 
Mean (s.d.) 
12 month 
Mean (s.d) 
Mean 
difference 
(95%C.I.) 
Sig* 
PANSS 
Positive 
18.84 (5.12) 10.54 
(4.50) 
8.20 (6.88-
9.53) 
<0.001 
PANSS 
Negative 
14.48 (5,86) 11.56 (4.25) 2.91(1.15-
4.23) 
<0.001 
PANSS 
General 
38.43(9.4) 14.41 (4.80) 24.02 (21.73-
21.00) 
<0.001 
CDSS 7.36 (5.69) 4.18 (4.64) 3.09(1.80-
4.55) 
<0.001 
SCAN G12 
INSIGHT 
3.10 (1.32) 2.33 (1.62) 0.76 (0.37-
1.15) 
<0.001 
PBIQ LOSS 17.25 (4.54) 16.35 (4.11) 0.41(-0.21-
2.10) 
ns 
PBIQ SHAME 14.14 (3.29) 13.83 (3.58) 0.16 (-0.60-
1.22) 
ns 
PBIQ 
ENTRAPMENT 
14.44 (3.40) 12.90 (3.84) 1.53 (0.60-
2.46) 
ns 
PBIQ 
CONTROL 
12.01 (3.47 11.22 (3.69) 0.79 (-1.14-
1.73) 
ns 
PBIQ GROUP 
FIT 
11.43(3.01) 10.51 (3.63) 0.92(0.01-
1.84) 
 
ns 
              *Paired Samples t test  
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Table 8.2 Pearson Correlation: PBIQ-R Baseline and 12 Month Follow Up 
 R Sig 
Loss 0.24 <0.05 
Shame 0.32  <0.01 
Entrapment 0.37   <0.01 
Group Fit 0.26 <0.05 
Control 0.34  <0.01 
 
 
 
Figure 8.1 Stability and change in illness appraisals and psychosis symptoms 
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8.7 Discussion  
The hypothesis tested here, that negative illness appraisals will recover in line with 
symptom recovery, has not been supported. In fact, there is clear evidence that 
negative appraisals are relatively stable from the acute first episode through 
recovery and 12 month follow up, while significant reductions in positive, negative, 
general psychopathology, depression and an increase in insight were observed.  
Appraisals of Loss, Shame, Entrapment, Control and Group fit at follow up were also 
moderately correlated with baseline measures. We can interpret these findings to 
mean that if one experiences the traumatic life event of FEP in terms of loss, 
entrapment, and shame in the acute phase, these appraisals are likely to continue.  
Illness appraisals were linked to depression in the acute and follow up points, as 
shown in Chapters 6 and 7, yet it appears that the decline in depression for the 
cohort occurs independently from any change in negative appraisals and is linked to 
other psychosis recovery processes. Thus illness appraisals and psychosis recovery 
processes are both involved in the generation of depression, during the early course 
of depression, but acting independently. This knowledge may go some way to 
answering the question regarding direction of causality when looking at results 
presented; whether it is the depression that is driving the negative appraisals or 
negative appraisal driving the depression. Negative appraisals remain high and 
relatively stable throughout, and could not therefore simply be an epiphenomenon of 
depression. We may conclude that depression can decline over time and run the 
same course as psychosis, but that depression is also influenced by illness 
appraisals at any one point in time (including the acute phase).  
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There are two possible explanations for the failure of negative appraisals to reduce 
in line with symptom reduction: firstly that these are long lasting and relatively 
enduring factors (state); however secondly, it is possible  that they do change over 
time, but at a much slower rate and one not captured by the present study. If loss, 
shame and entrapment are enduring, state-like beliefs from their conception the 
implication is that they will not change without a specific intervention.  
 One previous paper has charted loss and shame following acute psychosis, and 
found that contrary to the findings in this chapter, there was a reduction in these 
appraisals in line with recovery and a reduction in depression (131). The Iqbal et al’s 
sample was patients with established schizophrenia, with an average age of 32, who 
would have experienced many acute episodes. The loss and shame following 
psychosis will be felt most acutely, and in terms of a life event will be most 
significant, at the first occurrence. This may explain a difference when compared to 
our findings. In established, relapsing and remitting illness, a reawakening of 
longstanding negative appraisals may indeed be drivers for depression. Additionally, 
functional decline is well known to occur significantly for most patients after each 
relapse, as are the chances for ongoing positive symptoms. Put simply, after a third 
or fourth relapse there may be little of one’s previous idealised self left to lose. This 
bleak outlook needs further scrutiny and investigation.  Full recovery after FEP is of 
course possible(228). Our understanding of recovery in FEP is coloured by 
schizophrenia research: a tautology can exist if by definition schizophrenia has a 
chronic course, research conducted on those with chronic illness will demonstrate 
that course. This may not in fact tell us what happens to the full spectrum of disorder. 
It is recognised that the original inevitable decline in functioning described in 
Kraepelinian schizophrenia is not the only or indeed most likely outcome (237); 
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Harrow describes greater than 50% of patients do not have a chronic and continuous 
course in 15 years of follow up. Thus in studies sampling patients with chronic 
illness, one can expect differing results to a first episode sample. Indeed this is the 
whole logic of the prevailing view that course and outcome issues require first 
episode inception samples to understand the true picture. 
The second explanation; appraisals of loss and shame can change in a clear 
direction as a group, but at a slower pace than acute or general symptoms, is also 
possible. Dinos et al., (238) conducted qualitative research in participants with a 
range of diagnoses; those patients with psychotic disorder experience the most 
stigma, although this was a pervasive concern to almost all participants. They also 
concluded that stigma may influence whether treatment will be adhered to and 
overall functioning.  If indeed feelings of loss and shame do recover at a slower rate, 
relapse prevention becomes even more a focus: patients may feel stigmatized by 
treatment offered, disengage and thus relapse, fuelling further disability and ongoing 
stigma. The case example given below may serve as illustration: 
M.J. experienced her first psychotic episode at the age of 25. She recalled feeling 
low and anxious for 8 months before becoming convinced that her personal safety 
was in jeopardy. She would watch passers-by in the street intently, monitoring 
their movements for signs of threat. She became increasingly isolated, protecting 
herself by staying at home. Over a period of 8 weeks these feelings intensified to 
formed persecutory delusions regarding work colleagues, accompanied by poor 
sleep, agitation and external auditory hallucinations. She heard voices that made 
derogatory comments about her and her family but also commented on her 
actions. M.J. was admitted under Section 2 of the Mental Health Act 1983 to a 
busy acute adult ward. Here, her behaviour was bizarre, her affect incongruous, 
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her self-care extremely poor and she was noted to be responding to unseen 
stimuli. M.J. was given intramuscular medication under restraint before accepting 
oral medication. She rapidly recovered and was discharged after 4 weeks.  M.J. 
struggled to return to work and reported feeling increasingly low, with fully formed 
ideas of self-harm. She reported intrusive flashbacks to her initial stay in hospital 
and being restrained. She was shamed by having ‘lost her mind’ and felt she had 
no control over becoming ill again. M.J. disclosed her experiences to no one, 
explaining to work colleagues that she had simply “been away” and declined to 
claim any sickness benefit. She was reluctant to discuss her experiences in 
hospital or previous positive symptoms with her care co-ordinator, and identified 
her main problems as a low sense of self-esteem and difficulty in trusting others. 
M.J. however made a full recovery from both her first episode psychosis and post 
psychotic depression, and returned to full-time work some 9 months later. Yet 
feelings of shame and stigma remained. Anecdotally, she relapsed shortly after. 
   
There has been evidence presented in some studies of depression, and affective 
symptoms in general, being in some way protective, or conveying a better prognosis 
in psychotic illness (105, 239). Conversely depression and hopelessness also 
convey increased risk of self harm and suicide, and may herald imminent relapse 
(88). Indeed as shown in high risk studies the transition to psychosis is often 
mediated through affective dysfunction(48). Ongoing appraisals of loss and shame, 
by driving on low level affective disturbance, could be antecedents to relapse. This 
area would warrant further investigation and if proved this information could engineer 
the more successful prevention of relapse. The question then arises as to why some 
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individuals might appraise their experience as shaming, with a loss of an idealized 
self more so than others. This question will form the basis of Chapter 9.  
 
8.7 Methodological Issues 
This study has potential limitations. Differences may exist that would only be 
captured by a longer follow up period, as discussed above, or with a larger sample. 
Although not reaching statistical significance, there was a fall in appraisal measures 
particularly in sub groups of “control” and “group fit. In addition, the frequency of 
follow up measures may mean that there are fluctuations in appraisals that are not 
captured with the current methodology. 
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Chapter 9 
Socio-cultural determinants of Negative Illness Appraisals 
 
9.1 Introduction 
First episode psychosis presents in young people from all walks of life, is present in 
all cultural groups and social backgrounds(10) . It is also clear that in addition to a 
genetic vulnerability, socio cultural factors affect the incidence, prevalence and 
outcome of schizophrenia and FEP. Urban upbringing is associated with a higher 
risk of developing psychosis (240), incidence rates are higher in minority ethnic 
groups(241) and childhood trauma is increasingly recognised as a risk factor for FEP 
and schizophrenia (30). Socio-cultural factors have recently been identified as also 
playing a role in the progression of high risk status to FEP, and ongoing prognosis 
(242).  
The incidence of psychosis is higher in UK Black and minority ethnic groups (BME), 
highest in African-Caribbeans (241), who have an incidence risk rate (IRR) of 
between 6.7 (all psychoses) and 9.1 (narrow schizophrenia) when compared to the 
overall population. There are many hypotheses but no clear cut answer for this 
finding, however the AESoP study concluded that “either additional risk factors are 
operating in African-Caribbeans and Black Africans or that these factors are 
particularly prevalent in these groups”. Also of relevance to studies presented in this 
theses, they noted an increase in affective (mainly mania) presentations in BME 
groups(241). Studies presented to date in this thesis do not however identify higher 
rates of affective disturbance (as defined by depression or broad diagnosis of 
affective or non-affective psychoses) in BME groups.  
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There is evidence that the estimation of risk of psychosis in BME groups may be 
confounded by socioeconomic status leading to an overestimation of incidence in 
these groups. However, it is also clear that the risk of psychosis in immigrant and 
minority groups extends to many different settings, and has been observed over 
many years; Odegaards original study in 1932 demonstrated an increase in 
schizophrenia in Norwegian immigrants to New York(243).  
 In the UK, African-Caribbeans also have the highest relapse rate after FEP and 
poorer overall prognosis (244). High rates on detention under the Mental Health Act 
(1983) and use of compulsion in BME groups have been a cause for concern for a 
number of years(245, 246). Many competing explanations exist, such as the 
perception of increased risk and institutional racism (247), poorer insight(248) and 
higher rates of stigma within the minority communities leading to delayed help 
seeking(249). Delayed help seeking mediated through a longer DUP has been 
offered as explanations for poorer outcome, with some good evidence(250). 
Detention under the MHA (1983) itself will intuitively be an extremely traumatic 
event, yet as such has rarely been studied. Jackson(251) identified significant 
evidence of trauma in a small sample of FEP patients, however did not find any 
direct association with the subjective experience of trauma and detention under the 
MHA, rather coping and recovery style were implicated. 
 Alternatively, it has been suggested that stable family networks are protective 
against relapse and evidence suggests an improved outcome, both in some 
developing countries and in Asian populations in the UK (252).  
Whilst there has been no investigation into the influences culture brings on negative 
appraisals of psychosis, patients of different ethnic and religious backgrounds are 
known to attribute different meanings and have different responses to psychosis. For 
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example Afro-Caribbean patients often consider mental illness in a more spiritual 
way than White patients and some Asian cultures are more likely to attribute 
symptoms to non-biological causes such as “God’s will”(253). It is plausible that 
people who have an external locus of control may attribute events to something 
outside of themselves (such as God or society), rather than to themselves or their 
illness. They therefore may not appraise the events as resulting from or contributing 
to personal loss or as shaming. Strong family and religious values may be 
associated with less overall psychological distress in schizophrenia (254). Thus, 
people from BME backgrounds are more likely to explain their illness by social or 
supernatural causes, yet how this might impact on the experience of psychosis as a 
traumatic life event has not been explored to date. 
 Literature from affective disorders may also be enlightening as to the socio cultural 
determinants of negative appraisals in psychosis. We know from robust studies in 
major depressive disorders that certain socio-cultural factors also convey a 
vulnerability to later depression, for example being female, unemployed, exposed to 
deprivation, and other early traumas (52). Risk factors for depression and negative 
appraisal of life events also include, from the original study by Brown and Harris, 
past losses and in particular the loss is of a mother. They found also that past loss by 
death was associated with psychotic-like depressive symptoms and argued that 
these associations probably reflect direct causal links (110). We also know that 
traumatic experiences in general increase the risk of psychosis (255), and it is 
possible the traumatic events predisposing to psychosis will also predispose 
individuals to appraise their psychosis in negative terms, through a generalised 
negative cognitive bias. Different socio-economic and cultural groups may also be 
subject to differing levels of pre-morbid traumatic events and loss.  
133 
 
   In summary, current research is increasing understanding of how socio-cultural 
factors influence incidence, pathways to care, and prognosis in patients with 
schizophrenia and FEP. As demonstrated in Chapters 5-7, the importance of 
depression and the psychological response to FEP was also clear. Negative 
appraisals of loss, shame and entrapment are clearly significant and associated with 
depression, which in turn conveys an increased risk of ongoing depression and 
suicide. Negative appraisals have been shown to be relatively stable from the first 
episode. Further knowledge of the influences and development of negative 
appraisals can contribute to even greater understanding of prognosis and recovery 
after FEP. In light of this, this study aims to determine whether negative illness 
appraisals in FEP are associated with socio-cultural variables, ethnicity and initial 
experience of mental health care. 
 
9.2 Hypotheses 
Negative appraisals of the personal experience of psychosis will differ according to 
gender, age, occupation, deprivation, use of the MHA and ethnicity. 
 
9.3 Methodology 
Please see Chapter 4 for a detailed description of methodology and sampling, 
however for the purposes of this study, all participants completing baseline 
measures were included.  
Demographic Details: 
As gathered by the SCAN interview and proforma, details on age, gender, 
occupational status, ethnicity, post code and MHA status was available.  
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Participants presenting with FEP are acutely ill, and thus unlikely to be fit for work at 
the point of interview, however it was felt important to capture recent occupational 
status. Occupational status was coded for the six month period leading up to the 
baseline interview. The SCAN interview codes occupational status as full time 
employed, part time employed, household duties, sheltered work, primarily a student 
and unemployed. These categories were reported and then collapsed to three: 
employed (comprising of full and part time employment), student (student and 
household duties) and unemployed to ensure adequate numbers in each group. 
Please see statistical analysis for further details 
Ethnicity was recorded as per the participants own identification, in line with 2001 
census groups. Categories available are diverse and include Indian, Pakistani, 
Bangladeshi, Other Asian, Caribbean, African, Other Black, White and Black 
Caribbean, White and Black African, White and Asian, other mixed, Chinese, White 
British, White Irish and Other White. Full details of the participant groups were 
recorded, however to ensure adequate numbers groups were then collapsed, into 
White, Asian and Black along similar methodology used in recent research e.g. the 
AESoP study group (241). 
Postcode of participant’s home address was matched to Indices of Deprivation using 
2001 census details and DOH statistical information (147). Indices of deprivation 
range from 0-32,000, and include data on income, employment, education, health, 
crime, living environment, and barriers to services.  
As reported in Chapter 4, sampling moved purposely from the HoB area to South 
area of Birmingham to afford a greater range of deprivation and ethnic background. 
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Mental health act status was recorded as a binary yes/ no whereby “yes” was any 
history of detention, in the current first episode. As all participants were seen at 
baseline within four weeks of their first contact with services, this also constituted 
history of any detention under the MHA (1983). 
 
Illness Appraisals: 
    Personal Beliefs about Illness Questionnaire (PBIQ-R) (133): baseline measure 
 
9.4 Statistical Analysis 
Frequency and percentages will be reported. As detailed above detailed ethnicity 
grouping will then be collapsed to produce a count of more than 5 in 80% of cells.  
Continuous variables will tested for distribution using a p-p plot. Means and standard 
deviation were recorded for age and deprivation indices. Pearson’s tests of 
association were used to detect any significant correlation between continuous 
variables of age and deprivation with negative appraisals of Loss, Shame and 
Entrapment. One-way ANOVA were used to compare Gender, MHA status and 
occupation for mean PBIQ scores on loss, shame, entrapment, control and group fit. 
A post hoc Tukey’s test was used to make multiple comparisons of mean difference 
between ethnic groups.  
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9.5 Results 
As detailed in Chapter 5 and Table 5.1, the total sample consisted of 92 participants. 
69 were (75%) male and 23 (25%) female with a mean age of 22 (s.d. 4.89). 
Collapsed groups contained 31 (35%) White, 28 (29%) Asian and 33 (36%) Black 
participants, see Table 9.2 for detailed breakdown. In addition, 22 (24%) were 
employed, 18 (19%) students and 52 (57%) unemployed in the six months leading 
up to baseline interview. 28 (30%) had a history of detention under the Mental health 
Act (1983) and 64 (70%) no history of detention. 
 
9.51 Hypothesis:   Negative appraisals of the personal experience of psychosis will 
differ according to gender, age, occupation, MHA status, deprivation and ethnicity. 
a) Gender, Age, Occupation and MHA status: 
There were no significant differences in mean PBIQ-R appraisal scores by gender, 
or MHA status. Participants who had been employed or a student in the 6 months 
prior to baseline assessment felt significantly more in control of their illness 
(p=0.001); see table 9.1. There was no significant correlation (pearsons r) between 
age and PBIQ appraisal score; Loss r-0.11, p0.28, Shame r=0.03, p=o.73, 
Entrapment r= -0.12, p0.23, Control r=0.27, p=0,24 and Group Fit r=-0.03, p=0.79.  
b) Deprivation Indices: 
Results on deprivation reflected the inner-city setting, and scores on deprivation 
indices were markedly low. A score of 3249 or less indicates deprivation in the 
lowest 10% of the UK (range 70-24,000). In this sample, mean indices of deprivation, 
was 5166, median 4660. Scores of deprivation were not however normally 
137 
 
distributed (Kolmorgorov-Smirnov 0.22, sig<0.01) with a significant positive skew to 
the lower end of the scale. 51 (55%) of participants lived within the 10% most 
deprived areas in the UK. Raw scores of deprivation were thus transformed with a 
log scale (log10/deprivation) to adequate normal distribution prior to any further 
analysis. 
There was no significant correlation (Pearsons r) between deprivation score and 
PBIQ-R negative appraisal: Loss r=0.03, p=0.64, Shame r=0.12, p=0.19; Entrapment 
r=0.00.p=0.99; Control r=-0.05, p0.06; Group Fit r=0.06, p=0.52. 
 
c) Ethnicity 
Please see table 9.2 for detailed report. Collapsed groups contained 31 (35%) White, 
28(29%) Asian and 33 (36%) Black participants. There were significant differences in 
mean scores on all measures (Loss, Shame, Entrapment, Control and group Fit) 
between groups. White participants were significantly more likely to report high levels 
of negative appraisal compared to BME groups. Asian participants reported the 
lowest score on all measures. Differences between Black and Asian groups were not 
statistically significant, with the exception of Group Fit, which was significantly higher 
in black participants (i.e. they felt less part of their peer group). See Tables 9.3 and 
9.4. 
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Table 9.1 Appraisal Scores and Gender, MHA status and Employment  
 
MHA  
Detention 
 
Gender 
 
Employment 
 
Yes 
n=28 
No 
n=64 
 
ANOVA 
F (sig)  
Male 
n=69 
Female 
n=23 
 
ANOVA 
  F (sig) 
Employed 
/student 
n=52 
Unempl
oyed 
n=40 
 
ANOVA 
F (sig) 
Loss 
 Mean (s.d.) 
17.18 
(4.62) 
17.16 
(4.18) 
0.001  
(0.98) 
17.55  
(4.14) 
16.00 
(4.64) 
2.27 
(0.35) 
17.45 
(4.08) 
16.94 
(4.47) 
0.31 
(0.57) 
Shame 
Mean (s.d.) 
14.86 
(3.17) 
14.09 
(3.62) 
0.93  
(0.33) 
14.33  
(3.49) 
14.30 
(4.73) 
0.02  
(0.97) 
15.10 
(6.76) 
13.73 
(3.18) 
3.57 
(0.06) 
Entrapment  
Mean (s.d.) 
14.96 
(3.36) 
14.50 
(3.55) 
0.35 
 (0.55) 
14.86 
(3.17) 
14.09 
(3.62) 
0.37 
(0.85) 
15.03 
(3.44) 
14.35 
(3.35) 
0.89 
(0.34) 
Control  
Mean (s.d.) 
12.11 
(3.39) 
12.31 
(3.55) 
0.88 
(0.34) 
12.29 
(3.28) 
12.13 
(4.12) 
0.36  
(0.85) 
13.30 
(3.70) 
11.44 
(3.11) 
6.82 
(0.01) 
Group Fit 
Mean (s.d.) 
11.96 
(2.82) 
11.34 
(2.94) 
0.06 
(0.79) 
11.70 
(2.71) 
11.04 
(3.43) 
0.86 
(0.35) 
11.83 
(3.00) 
11.31 
(2.83) 
0.71 
(0.40) 
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Table 9.2 Detailed Ethnicity Breakdown (2001 census groups) 
Group Frequency % 
Indian 9  9.8 
Pakistani 18 19.5 
Bangladeshi 1 1.1 
Carribean  27 29.4 
African 3 3.3 
White and Black Carribean 2 2.2 
White and Black African 1 1.1 
White British 28 30.4 
White Other 3 3.2 
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Figure 9.1 Mean Appraisal Score and Ethnicity 
 
 
 
  
 
Table 9.3 Post Hoc Tukey: Multiple Comparisons Ethnicity and PBIQ Negative 
Appraisals 
 
 
   Mean 
Difference 
95% c.i. Sig 
White Asian 3.27 0.72-5.82 <0.001 
White Black 2.70 0.26-5.15 <0.01 
Loss 
Black Asian 1.56 -3.08-1.94 0.86 
White Asian 1.89 0.254-4.03 0.05 
White Black 1.96 -0.79-3.32 0.05 
Shame 
Black Asian -0.66 -3.73-2.48 0.75 
White Asian 2.90 0.89-4.91 <0.01 
White Black 1.05 -0.87-2.98 0.29 
Entrapment 
Black Asian 1.85 0.13-3.83 0.07 
White Asian 2.51 1.16-4.52 <0.01 
White Black 1.49 0.29-3.94 0.28 
Control 
Black Asian 1.02 0.15-3.17 0.46 
White Asian 2.84 0.42-4.61 <0.001 
White Black 1.33 0.52-3.50 0.12 
Group Fit 
Black Asian 1.51 1.12-3.09 0.05 
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9.6 Discussion 
 
The hypothesis tested in this study, that appraisals would differ in line with socio- 
cultural variables was only partially upheld. No differences were found with age, 
gender, level of deprivation or use of the MHA. A small significant difference was 
seen in patients who had been in recent employment; they felt more in control of 
their illness. Participants who had been in recent employment are likely to have had 
a shorter DUP and have a higher level of premorbid functioning which both convey a 
better prognosis (201), in addition an increased sense of control and mastery may 
also improve prognosis.  
 Markedly significant differences were seen with regards to ethnicity, with white 
participants experiencing greater levels of negative illness appraisals compared to 
those from BME backgrounds. Asian patients scored significantly lower in all areas 
of negative appraisal compared with white participants, and in relation to group fit 
scored lower than both white and black participants (i.e. they still felt part of their 
social groups).  
We can interpret these findings to mean that whilst depression occurs in all groups 
after FEP, there may be some more at risk in light of stronger negative appraisals, or 
indeed that some groups may be protected from these negative appraisals by way of 
their cultural background. There were no differences in incidence of depression itself 
in ethnic groups, as show in Chapter 7. However, explanatory models of psychosis in 
differing cultural groups have been investigated to some extent, for example in terms 
of DUP(241), help seeking and insight (256). Saravanan (256) found that in South 
Asian populations, patients will hold a variety of explanations from spiritual or black 
magic being the most common, in comparison to biomedical models and that those 
patients with biomedical model showed the greatest insight. As discussed in chapter 
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two however, a tautology can exist when measuring insight in a structure that 
includes for example adherence to medication: patients with more “insight” as so 
defined will by definition have a greater acceptance of a medical model. The medical 
model of insight is challenged (257), and some argue clearly contributes to stigma of 
mental illness(258). Appraisal of psychosis as we have shown in Chapters 2 and 6 is 
intricately linked with one aspect of insight: the awareness of illness. Ones 
awareness of illness comes with it a value judgement as to the personal significance. 
Interestingly our findings reflect those of Saravanan; patients of Asian origin show 
the least negative appraisals. It is impossible to say from our results whether this is 
the result of spiritual explanation of psychosis, but clearly this area warrants further 
investigation.  Outcome of psychosis in patients from Asian background has been 
shown to be favourable when compared to those in white participants whether in 
developing or developed countries(259). The ability to understand psychosis in a 
spiritual or non stigmatizing way by nature of an act of God or possession by spirits, 
may be part of the pathway to this improved outcome. Indeed this may mitigate a 
DUP lengthened by delayed help seeking that has also demonstrated to be linked to 
mental health beliefs in this cultural group(260). 
 Alternatively, the significant results in this chapter may have arisen from different 
rates of reporting of negative appraisals. In other words, participants may have 
experienced the same levels of loss and shame, for example, but did not report this 
in the questionnaire. Under-reporting of affective symptoms has been previously 
demonstrated in BME groups, where somatisation may be more a prevalent 
expression of emotional dysfunction (261), and there may be a similar under-
reporting of negative feelings here. Thus results presented need to be treated with 
caution. Socio-cultural factors and in particular low self esteem precipitated by early 
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childhood loss, lack of family unit and isolation have been cited as causal factors for 
the increase incidence of schizophrenia in African-Caribbean men in the UK (262). 
These findings are at odds with those presented in this chapter, whereby BME 
groups displayed less negative appraisals than white participants. Additionally, whilst 
outcome is poorer in African-Caribbean men in psychosis, they report lower levels of 
negative appraisals than white participants in this study. Gumley et al., (263) 
reported that patients who went on to relapse (and thus had a poorer outcome) were 
more likely to have higher score on negative appraisals in a sample of chronic 
schizophrenia. Alternatively, Birchwood (264) has previously suggested that an 
underreporting of social anxiety in young black men may actually be due to 
increased sensitivity to stigma and subsequent denial in this population. Recovery 
style has been investigated in the past, and patients demonstrate a range of styles of 
recovery from “integration” and curiosity of their illness, to “sealing over” with 
cognitive avoidance of diagnosis(172). ‘Sealing over’ is associated with poorer 
outcome (265). It may be that cultural differences are related to recovery style, yet 
this has not been studied to date. This could go some way to explaining results in 
this chapter, i.e., those participants who recover using a ‘sealing over’ style are less 
likely to report negative appraisals such as shame and loss, yet will also have a 
poorer prognosis. 
Differing socio-cultural groups will be subject to differing levels of pre morbid trauma, 
however the results presented here did not detect differences with regard to 
appraisals and levels of deprivation or gender. It would be interesting to know 
whether those participants reporting high levels of loss and shame in the studies 
presented in this thesis had other previous vulnerability factors such as those 
suggested by Brown and Harris (110) such as loss of a parent, and this subject  
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warrants further investigation.  Some authors argue there is evidence of the affective 
versus cognitive/ neurodevelopmental pathway to psychosis. Myin-Germeys (266) 
found that increased emotional reactivity was independent from cognitive 
impairments, and proposed this as evidence of an affective pathway to psychosis 
that may underlie a more episodic, reactive, “good-outcome” type of psychosis. 
Evidence for this hypothesis was found in data suggesting that the experience of 
stressful life events and early trauma were associated with increased stress-
sensitivity(267). The results from this chapter may be used to reinforce these 
hypotheses; socio-cultural determinants, by leading to increased vulnerability to 
psychosis and heightened negative appraisals, may offer one explanation for the 
affective pathway into psychosis. Future studies looking at the distinction between an 
affective or neurodevelopmental pathway could include negative appraisals, culture 
and health beliefs. The ability to generate an affective response, driven by negative 
appraisals, occurring in those with less neurocognitive impairment, could indicate a 
group with better prognosis, notwithstanding the risks of suicidality. Recent challenge 
to the heterogeneity of outcomes in schizophrenia worldwide has also begun; with on 
the one hand a rejection of the idea that in schizophrenia low and middle income 
countries have a more benign outcome(268), whilst some evidence also suggesting 
that in African countries a relapsing clinical course, with more overall affective 
symptoms, is not associated with the presumed functional decline(269). 
Evidence from the study presented here shows that ethnicity has an influence on 
negative illness appraisals, which in turn may influence the likelihood of depression, 
although in this study rates of depression were similar across ethnic groups. Other 
factors however may well be involved in the generation of negative appraisals, yet 
those tested here such as gender, age, deprivation were not significant. Previous 
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postulations also include the acceptance and internalization of negative cultural 
stereotypes, which would occur across all groups(270). It may also be that some 
areas are influenced by premorbid functioning, for example, some people may be 
more predisposed to view psychosis as a loss- if for example--they were graduates 
or had higher expectations than others. In our study the employed felt more in 
control of their illness, reflecting perhaps a stronger sense of pre-morbid control and 
mastery that comes with paid employment. This area itself that has not been studied 
to date clearly warrants further investigation.  
9.7 Methodological Issues: 
This study has potential limitations. Primarily, ethnicity as presented here is a blunt 
and insensitive proxy measure of cultural beliefs. No distinction was made between 
first and second generation immigrant populations, despite knowledge that 
assimilation of western values and culture in subsequent generations is not only 
likely to occur but could have a direct result on findings of this study. It should also 
be noted that certainly second generation African-Caribbean participants will be 
culturally “Westerners” with a subculture within African-Caribbean tradition. In 
addition, broad ethnic group descriptors such as Asian or indeed African-Caribbean 
contain many different subcultures. The Asian descriptor includes Indian and 
Pakistani populations and ignores the differences in cultural beliefs and practices. 
Care must be made when interpreting results presented here in any broad sense. A 
larger sample size, allowing for better informed ethnic groupings that allows for 
analysis of sub cultural variations and generational differences is likely to produce 
more valid results.  Results presented here however add weight to the notion that 
this would be an important avenue to investigate. 
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Chapter 10 Discussion 
 
10.1 Significant Findings: 
This series of studies has revealed a number of significant results. Firstly, 
depression is pervasive during the early course of psychosis, with eighty percent 
experiencing at least one moderate or severe depressive episode in the months 
studied. Sixty-three percent experienced depression and suicidal thinking at some 
point in the early course. Although longitudinal depression pathways vary between 
individuals, the findings have suggested that prodromal depression, not the severity 
of positive or negative symptoms, predicts depression in the early course, and that 
post psychotic depression rarely occurs de novo in the absence of depression in the 
prodrome or acute phases. Findings corroborate previous observations (97) of the 
risk associated with untreated psychosis; at baseline many had already made 
suicide attempts, most frequent methods used including overdose and attempted 
hanging, with the majority of attempts occurring within the DUP phase. 
Secondly we saw that during the acute first episode, depression was predicted by 
the appraisal of personal threat from voices and persecutors. Results demonstrated 
that feelings of entrapment by illness or persecutors, in combination with malevolent 
voices and higher engagement in safety behaviours, were most significant in the 
prediction of acute depression. Personal reaction to threat, we hypothesised 
triggering cues from evolutionary psychology and social power together with feelings 
of entrapment and thwarted escape were found to be significant in the generation of 
depression.  The greater use of safety behaviours, independent of severity of 
positive symptoms, was also more frequently used in those who had depression 
accompanying persecutory delusions. This was interpreted to mean that in spite of 
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using safety behaviours, the threat was not mitigated, leading to helplessness and a 
depressive reaction. Also, awareness of illness and its personal significance was 
related to the development of depression. Insight, especially the awareness of 
illness, was present during the acute episode, driving and precipitating negative 
appraisals of the illness and its implications for the future.   
Thirdly, those individuals who experienced Post Psychotic Depression (PPD) 
appraised their psychosis as more shaming and felt a greater sense of loss of future 
goals, roles and status. An inability to control psychosis and hence to escape from its 
grip was also linked to depression. Over and above a risk of PPD conferred by the 
presence of prodromal depression, a longer DUP was also predictive of experiencing 
PPD. Also, in contrast to depression in the acute phase of FEP, in PPD an 
association was found between depression and ongoing lower level positive 
symptoms. Whilst negative personal appraisals of psychosis may confer the most 
risk for PPD, ongoing low level positive symptoms may constitute an active link to 
depression in this phase , for example by conferring ‘hard evidence’  to the individual 
of an ongoing illness and entrapment therein. The individual is faced with another 
thwarted escape, this time from the psychosis itself. The sense is of a grinding down 
of hope of recovery, following on from a longer period of illness by way of DUP and 
ongoing lower level symptoms. Despite treatment, engagement with mental health 
services and individual coping strategies, symptoms persist, albeit at much lower 
levels and future goals, forward plans and self esteem will continue to be challenged. 
Fourthly, there was clear evidence that negative illness appraisals are relatively 
stable from the acute first episode through recovery and 12 month follow up, while at 
the same time significant reductions in positive, negative, general psychopathology, 
depression and an increase in insight occur. In addition, baseline and follow up 
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measures of negative appraisals were correlated. Thus we can interpret these 
findings to suggest that where patients view the onset of their psychosis with 
appraisal of loss, entrapment, and shame (in the acute phase), these appraisals are 
likely to continue for some time to come, irrespective of the early course of the 
illness. 
Finally, socio-cultural factors appeared to influence the development of negative 
illness appraisals. Significant differences were seen with regards to ethnicity, with 
BME patients reporting significantly less loss, shame and entrapment compared with 
White participants. In relation to the appraisal of community identity and belonging (‘ 
group fit’) Asian patients reported that they still felt part of their social groups, in 
contrast to white and Black participants. People who attribute their psychosis in 
terms of an event outside their control, by way of God’s will or society, rather than for 
example a personal weakness, may be protected from the tendency to attribute 
illness as a shameful personal experience. We did not however demonstrate a 
significant difference in rates of depression between cultural groups suggesting that 
culture, ethnicity and depression are complex multi factorial issues. We have shown 
however that ethnicity does appear to play a role in negative appraisals after FEP. 
Strong family and religious values may be associated with less overall psychological 
distress. In addition, participants who had been in recent employment felt more in 
control of their illness; this group were likely to have had a shorter DUP and  a higher 
level of premorbid functioning which both convey a better prognosis. The mechanism 
for an improved outcome associated with a shorter DUP following FEP may be, as 
some evidence presented in this thesis demonstrates, through an increased sense of 
control over the illness and lower levels of negative appraisals.  
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 10.2 Depression in First Episode Psychosis 
Previous research looking at point prevalence and without a longitudinal design (133, 
179) found high rates of depression in FEP, in keeping with results from this thesis. 
There is also good evidence that adolescent depression per se is common and will 
predict future mental illness (181). Depression in adolescence could therefore 
provide some of the “fuel” needed to translate psychotic-like experiences seen in 
UHR groups to frank psychotic symptoms. Potential for treatments could target this 
age group (183) and have impact on outcome in first episode psychosis. Recently 
there has been an increased focus on youth mental health(271), and by directly 
tackling adolescent depression the potential to improve outcome in severe mental 
illness, including psychosis, is possible. 
Is the high level of co-occurrence of depression and psychosis the result of a 
common vulnerability, e.g. expression of underlying brain dysfunction  or gene 
expression(24); the result of shared environmental risk factors for depression and 
psychosis (185); or does depression occur as a result of a psychological reaction to 
psychosis as a major life event (131)?  Results from this thesis suggest that more 
than one pathway to depression is at work at different stages. An overriding 
vulnerability to future episodes of depression is conveyed by depression in the 
prodromal phase, often occurring during adolescence. When considering what may 
cause depression in the prodrome of FEP, many areas of future work can be readily 
identified; Dunkley (128) proposed that individuals with high levels of self criticism 
are more reactive to stressors, and are less able to utilize effective problem solving, 
both of which are evidenced as commonly occurring in prodromal samples (39, 272). 
In depression, more recently, it has been argued that individuals may fall short of 
their preferred or aspired-to self, resulting in a sense of entrapment and loss (114). 
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Whilst biological drivers may be at play in the prodrome, levels of self criticism, self 
esteem and feelings of entrapment and loss may also be at work in the affective 
symptoms accompanying the build up to FEP. This area would warrant further 
investigation and interventions.    
 In the acute episode insight is not lost completely and the consequent awareness of 
illness is accompanied by potentially depressogenic negative appraisals. Personal 
reaction to, and coping with the perceived threat from persecutors also appears to be 
involved in the development of depression in this phase. In post psychotic 
depression, ongoing low level symptoms, reflecting an incomplete recovery interact 
with residual negative appraisals in certain individuals. Our results suggest that 
certain ethno semantic models may be protective for some cultural groups. In 
addition, plausible biological mechanisms may also be at work; for example in terms 
of under activity of forebrain dopamine preventing the initiation of new activity and 
enjoyment(273) , or depression being an “expression of an inborn mild reaction 
pattern followed by progression to increasing brain dysfunction and more severe 
patterns like psychosis”(274). There is also new evidence from imaging studies that 
in patients with high levels of affective symptoms, different   mood states are 
associated with different neurobiological responses to emotion across the patient 
groups(275). Each of these areas could form the focus of future work in FEP groups, 
with the novel aim being to further understand what drives depression in the early 
and prodromal phase of first episode psychosis.  Birchwoods’ previous study of post 
psychotic depression in a chronic sample(133) found that 70% of the group 
experienced depression during the acute phase and 39% post psychotic depression. 
Here depression in the acute phase recovered in line with symptom resolution. 
Whilst our results did not provide clear evidence for a direct causal relationship 
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between severity of symptoms and depression in a cross sectional evaluation, what 
has been shown clearly is the role of personal significance of symptoms and illness 
appraisal. This could be interpreted as argument for a dimensional conceptualization 
of psychosis with a clear depressive dimension, interacting with positive symptoms 
and other dimensions in the model, as shown by the finding of clear links between 
lower level positive symptoms and post psychotic depression. Koreen (65) 
concluded that “antidepressant therapy should be limited to patients in whom the 
depression persists”. However, the relationship between positive symptom and 
depression is not linear or straight forward: many other studies, as replicated by the 
results in this theses, show little relationship between the frequency, intensity or 
severity of positive symptoms and depression (56, 63, 66, 227). One model 
suggested by this thesis results would propose an ongoing link between distinct 
symptom dimensions in psychosis; between positive symptom dimension and 
depression that is more readily apparent in the recovery phase. The appraisal 
process overlays this link and is potentially driving both depression and this 
interaction with the lower level positive symptom dimension. For illustration, when an 
individual hears a slight whispered voice, or has a vague suspicious thought, they 
will be reminded of their incomplete recovery, thwarted goals and shame, leading to 
the further development of depression. 
Patients with schizophrenia have been demonstrated to show more intense and 
variable negative emotional response to daily life hassles and family 
environments(186) . Stress reactivity is high in first episode psychosis with and 
without cerebral tissue alteration (188) or cognitive dysfunction (189). Stress 
reactivity is also high in those at high risk of psychosis (48); ie intense reactions to 
low level daily life stressors often predate the onset of psychosis. The affective and 
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neurocognitive pathways to psychosis theory, argued by Myin-Germeys and van Os 
(186) is attractive, and supported by results in this thesis. We have shown 
depression in the prodrome is common, and predicts depression at later stages. 
Following on from work on stress reactivity and cognitive function, it would be 
important to investigate whether those with an affective pathway to psychosis were a 
group with greater of lesser neurocognitive deficit. Recent research by Murray et al 
(104) demonstrates that significant depression in FEP is associated with marked 
neurocognitive deficits, whereby deficits in patients with mania symptoms were less 
evident. The suggestion may well be that within affective symptoms in psychotic 
illness, it is mania rather than depression that is either protective or indicates a better 
overall prognosis. In addition, clear evidence exists that neuropsychological deficit, 
for example in performance IQ is more evident in core schizophrenia than bipolar 
disorder, but is present across the diagnostic groups(275). There may exist a clear 
neurobiological pathway to core or “deficit” schizophrenia more readily identifiable in 
the smaller number of patients (20% in the studies presented in this thesis) who do 
not experience significant affective symptoms. This area warrants further 
investigation.  
The potential affective pathway proposed by Myin-Germeys (276) and van Os (277) 
is that affective disturbance may be a primary mechanism involved in the majority of 
FEP. Anomalous psychotic-like experiences also occur with more frequency than 
were previously understood in the general and high risk populations (278). They 
propose that clinical “caseness”, indicating the need for care, is mediated by 
environmental factors and affective disturbance via a neurobiological mechanism 
interacting on genetic predisposition. There is further evidence from high risk groups 
that the frequency and intensity of anomalous experiences is mediated through to 
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illness via affective disturbance (48, 217). Thus, the presence or absence of 
depression in the early phase of psychosis may not be pathognomonic for a subtype 
of schizophrenia (for example a schizoaffective disorder) but best understood as a 
dimension or pathway to psychotic experience in its own right (27, 191).  
 
10.3 An integrated model for depression in First Episode Psychosis: See figure 10.1 
In bringing together the findings of studies in this thesis, and integrated model of 
depression in the course of first episode psychosis can be proposed. Initially, 
prodromal depression, a common occurrence as we have demonstrated, may be the 
result of shared environmental or genetic risk factors, or be the expression of illness 
progression for the majority of individuals. Having experienced depression in the 
prodromal stage, an increased risk of further depression in the acute phase is 
propagated by appraisals of positive symptoms; malevolent content of voices and 
perceived subordination to persecutors. Persecutors dominate, triggering innate 
dominant –subordinate relationship signals best understood from evolutionary 
psychology. Thwarted escape and failure to exert or win control of symptoms 
through use of safety behaviours are at play. Learned helplessness in response to 
unrelenting positive symptoms continues until treatment arrives. Following recovery, 
negative appraisals of the impact of illness, with loss shame and entrapment, also 
beginning to work in the acute phase, now dominate and drive post psychotic 
depression. Ongoing low level positive symptoms and long DUP add to these by way 
of reminders of illness, having a continued impact through perpetuation of feelings of 
loss and shame.   
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Figure 10.1 Integrated Model of Depression in the Course of FEP 
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10.4 Suicidality and DUP 
Thirty-three percent of participants had already made suicide attempts by the time of 
their inclusion in these studies, and although rates of self harm decreased 
dramatically after treatment in EIS services, the long term risk of completed suicide 
remains high in this group. Our findings also concur with others showing a link 
between the frequency of DSH in first episode psychosis and depression throughout 
the early course (99), a relationship also seen later in the course of the illness (192).  
The best predictor of future self harm and completed suicide is a history of  previous 
attempts (76), and thus the most effective way of reducing suicide in psychosis will 
be to decrease the frequency of self harm occurring at this early phase, prior to 
contact with treatment services.  Violent methods were used by our study group, 
again increasing risk. This risk has recently been highlighted whereby a combination 
of psychotic illness and violent initial attempt predicted a dramatic increase in 
completed suicide both at one-year and five--year follow up; in Runeson’s study 
group over 80% who had attempted hanging and had a psychotic disorder had 
completed suicide at five-year follow up (279). The InterSePT studies (95) and Haw 
et al (192) identified previous deliberate self harm as one of the key risk factors for 
completed suicide in schizophrenia. The TIPS study (193), similarly highlighted risk 
within the period of untreated psychosis, and showed how DUP could be reduced in 
this area with a public health drive and training of primary care. Many delays in 
access to care in the UK however appear to lie within mental health services 
themselves (280). In other words patients, are help seeking, but have difficulty 
having their needs met in the early phases of psychosis. Thus we still face the 
challenge in the UK to find effective means of reducing DUP to influence this end 
result. 
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One interesting finding in this series of studies was the lower rates of negative 
appraisals in BME groups, with lowest levels in Black participants. No overt 
difference was seen in rates of depression or acts of self harm by ethnic group, it is 
interesting to speculate that illness appraisals that do differ between ethnic groups 
may influence DSH in psychosis.  Previous work  has also shown no difference in 
ethnicity and incidence of self harm in FEP (281), yet it would be important to take 
into account here the broader epidemiology of ethnicity and suicide, of which there is 
an established body of work(76). There is evidence that suicide is lower in black 
men, compared to white men in the UK(80), however this may be less so in younger 
and second or third immigrant generations. There is also a higher proportion of 
schizophrenia in Africa-Caribbean patients who do commit suicide when compared 
to other populations(282). Suicide, and violent methods used, is likewise higher in 
young Asian women compared to their white and black counterparts (282). Ethno 
semantic and religious belief beliefs, may also be protective in suicide (283), yet at 
the same time isolation, entrapment in cultural roles and other social stressors (for 
example social exclusion) may be more significant in some minority groups, 
mitigating any protective factors from religion or health beliefs. Larger scale studies 
will be needed to further investigate the role of negative illness appraisals on suicidal 
behaviour. 
 
10.5 Symptom Appraisals and Safety Behaviours 
During the acute first episode, depression significantly correlated with the perceived 
personal threat from voices and persecutors, combined with the use of safety 
behaviours, independently of the severity of psychosis. While no direction of 
causality can be assumed, it is interesting to think why threat in this manner would 
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produce a depressive response, as opposed to anger, fear or anxiety? The idea of 
personal relationships has been explored previously in those who experience voices 
and persecutors (131). Our results concur that people who experience auditory 
hallucinations and have delusions frequently have an interpersonal relationship with 
their voices and persecutors(170). Evolutionary psychology concepts argue that in 
order to avoid physical conflict to establish dominance, particularly with regard to 
choosing a mate and species survival, displays of power and dominance were 
necessary and developed over time. Where no new territory, or escape pathway was 
available, it became important for animals to be able to signal subordination to the 
dominant member of a group thus avoiding direct physical contact. Within human 
relationships social power and recognition of social status and rank is believed to 
have developed from these primitive origins, to indicate subordination to the 
dominant in any group or pair. Dominant-subordinate socially ranked relationships 
are an important dimension of human relationships (126) and established through 
complex mechanisms of perceived attack signals and submission responses. Similar 
to observations in animal ethnology, where escape to a new territory is impossible, 
appeasement and deferring to an individual in the position of power will occur. In 
psychosis, individuals will form similar relationships with their perceived persecutors 
or “owners” of their voices, and when in positions of weakness, either physical or 
social, adopt those behaviours necessary for survival; placating or attempting to 
appease the dominant partner (126). Essentially a relationship can exist internally 
with attack signals, subordinate defences and negative self labels (an acceptance of 
inferior rank), leading to the development of depression. Depression in this sense 
can be considered a signal indicating withdrawal from interpersonal competition.  
   
158 
 
Hopelessness, helplessness and power, again reflecting a dominant subordinate 
relationship, have also been recognised as significant factors in the development of 
persecutory delusions themselves (140, 141). Moreover, a hostile or critical voice, or 
threat of social or physical harm from persecutors may initially produce a flight/fight 
response, yet in the face of ongoing threat or hostility and unsuccessful efforts to 
escape this by appeasement or avoidance, a depressive response would follow. As 
in theories of learned helplessness(108), a subject will come to know that despite all 
efforts to escape the threat, the adverse punishment will continue. This will be 
particularly relevant in the acute first episode, when positive symptoms are novel and 
until treated likely to continue unabated, despite an individuals’ best efforts at self 
help thought avoidance and appeasement.   
These theories, of subordination in evolutionary models and learned helplessness, 
are now well established in the development of unipolar depression. Results from 
studies presented here will open further debate and research questions in to the 
area of depression in psychosis. 
 
10.6 Insight and Illness Appraisals 
Insight, and feelings of loss, shame and entrapment were present at significant 
levels in the acute FEP. The experience of FEP in terms of a negative appraisal was 
also significantly higher in those with depression.  Raised Insight has long been 
recognised as a precursor to post psychotic depression and indeed suicidal 
thinking(134). Results here show that with increasing awareness of illness, opens 
the way for the individual to consider the implications of the pejorative diagnosis, 
which comes with negative personal appraisals of shame, loss, entrapment that 
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appear to mediate the development of depression. These processes are at play in 
both the acute and post psychotic phases. 
Previous research has demonstrated a relationship between high levels of 
awareness and negative appraisals: Cooke et al., (213) found high insight related to 
low self-esteem, but not depression, in a sample of individuals with established 
psychosis. They conclude this relationship was driven by the awareness of illness 
dimension of insight. Karatzias (214) explored negative appraisals in a sample with 
chronic illness and likewise found a strong association between personal beliefs 
about illness and affective co-morbid conditions, while Crumlish (203) demonstrated 
the significance of greater acknowledgment of illness in the prediction of depression.  
 It is perhaps straightforward to recognise that negative appraisals will be linked to 
depression, yet there may be no direct causal relationship. The personal significance 
of illness does however appear to be implicated in the maintenance and ongoing 
negative cognitions in participants whose’ depression is significant in the acute and 
post psychotic phases. Dunkley (128) proposed that individuals with high levels of 
self criticism are more reactive to stressors that imply failure or loss of control, and 
are less able to utilize effective problem solving. We can see how this ongoing 
depression will lead to further negative assumptions, and appraisals in FEP.  Brown 
(111) argues that in unipolar depression individuals may fall short of their preferred or 
aspired-to self, and that these internal failures result  in a sense of entrapment. 
These are clearly echoed in patients recovering from FEP whereby real loss of 
status, employment and entrapment in mental health systems may have occurred.  
10.7 Future Work: 
A number of recommendations for future areas of research have been made during 
these studies and in the discussion to date. It is helpful to cluster these in to three 
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groups; focusing on depression, suicide prevention and negative appraisals of 
psychosis. 
 
10.71 Depression: 
We have seen how depression, particularly in the prodromal phase predicts future 
depression and suicidal thinking. The accurate identification of groups at high risk for 
psychosis in recent years has opened up many opportunities(272). One would 
question that does arise is whether detection and early treatment of depression in 
prodromal psychosis could prevent further affective episodes, in the acute and post 
psychotic phases, and improve outcome. Whilst it is possible to identify patients in 
the prodrome to FEP, transition rates in high risk groups have been shown to be 
between 15-50%(224), and thus a large scale study with both a randomized control 
design and longitudinal follow up would be needed. Interventions to target 
depression in the prodromal phase would need to include specific psychological 
interventions (over and above that offered as standard) and pharmacological 
treatment. One study has focused on whether treatment with antidepressant 
medication during the prodrome to schizophrenia can limit or prevent the onset of 
psychosis; Cornblatt et al., (284) demonstrated that a number of adolescents 
meeting criteria for prodromal schizophrenia were successfully treated with 
antidepressants, on a needs led basis, and advocate this as a first step in patients 
with prodromal symptoms presenting with high levels of depression. Their focus was 
on the prevention of transition to psychosis, a task itself having proved more difficult 
than first conceived (285), yet an alternative question would be whether 
pharmacological treatment of depression in the prodrome could prevent further 
episodes of depression, suicidal thinking and improve recovery.   
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Furthermore, assumptions have been made regarding the subjective experience of 
depression in psychosis, and although specific measures were used in these studies 
to detect depression in individuals with psychotic symptoms, it would be important to 
understand whether phenomenologically this was the same as depression in major 
affective disorder. This would give further focus to potential causal pathways and 
treatments. A qualitative study to look at the subjective experience, comparing 
depression in a FEP sample to that in unipolar depression for example, would be a 
first step towards this and has not been done to date. If indeed core features of 
depression in FEP are different in psychosis, for example more weighted to 
hopelessness rather than anergia, more specific interventions could follow.  
 
10.72 Suicidal Prevention: 
There does appear to be a rising incidence of DSH in young people (84). It would be 
important, in light of findings presented in this thesis, to understand whether this 
increase is having an effect on increasing the number of young people with a history 
of self harm already established by the time their psychosis develops. In addition, 
DSH could be used as a measure to detect a sub group of young people at risk of 
FEP.  Many young people present to emergency departments with self harm, and 
novel methodology would be a prospective study of all young A&E attendees who 
present with DSH, with intensive follow up and measures to detect early psychosis. 
Participants would then have quick access to treatment services. Planned within a 
defined catchment area, pre--intervention DUP could be compared to post-
intervention DUP as a proxy outcome measure. One key study would be to 
investigate effective methods to reduce DUP in the UK, with a clear focus on the 
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reduction of early suicidal behaviour. Whilst some major trials are underway to either 
replicate the TIPS (42) study of reduction of DUP, or exploring other methods 
sensitive to the UK, for example with a focus on ethnic minority groups (ref enrich 
personal communication), suicidal behaviour is not a prime focus. Thus a large 
epidemiological exploration of that aspect, DSH in the DUP phase, across a wider 
community, would be important.  
In addition, we know that psychotic symptoms do appear to be present at a much 
higher level than previously understood within general populations (277). A 
population based community study, investigating the frequency of co occurring DSH 
and lower level psychosis symptoms would be useful. This would enable the context 
from which our present sample had been drawn, with DSH and frank psychotic 
symptoms, to be better understood. A novel methodology could include the use of 
internet surveys, increasingly common in research engaging with young people, 
allowing very large numbers to be recruited. It is important to recognise that previous 
research, for example by Yung (286) and Morrision (287) has clearly demonstrated 
that it is depression that best predicts transition to psychosis in UHR samples. 
  
10.73 Modification of Negative Appraisals 
There has been no robust study of targeted interventions to address negative 
appraisals in psychosis. Results in this thesis, demonstrating the importance of such 
appraisals and their stable nature raises the question as to whether such targeted 
interventions to change these beliefs could improve outcome, both in terms of 
prevention of depression and functional outcome. Negative appraisals of the 
experience of psychosis by way of loss of social roles, evidenced by unemployment, 
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exclusion from friendship groups (“group fit”) and shame of psychosis need to also 
be understood in a wider sociological context. Negative stereotype reporting of 
mental illness, violence associated with schizophrenia, madness and loss of control 
remain the norm for social views on mental illness, reinforced repeatedly in western 
cultures and media. Indeed, people with FEP will be likely to lose their jobs, feel a 
lack of control and feel different to their peers by very nature of their experiences. 
Thus negative appraisals as such may indeed be viewed as a reasonable reaction to 
FEP.  However, as we have shown, these appraisals vary between individuals and 
are influenced by a number of variables. 
Studies which have focussed of CBT in first episode psychosis have concentrated on 
the amelioration of psychotic symptoms and/ or social and occupational functioning 
(142, 288). Wykes’ systematic review demonstrated that only a minority of trials of 
CBT for psychosis included depression as an outcome measure(236). None of these 
specifically have the use of CBT to treat or prevent depression in early psychosis as 
a primary aim. These are now much needed studies. Interventions that work to 
improve awareness of illness may also need to be accompanied by specific 
measures to reduce feelings of loss, increase control and reduce shame in 
psychosis. Gumley et al (263) previously used a CBT protocol aimed at the early 
signs of relapse, found greater increases in self esteem for those receiving CBT 
intervention. An accurate knowledge of which component of therapy achieves this 
goal would be essential for clinical practice. First episode studies in which 
psychological therapies have addressed issues of trauma, suicidality and self 
esteem have tended to produce mixed results (251, 289). McGorry and Power, 
developed cognitive-oriented psychotherapy for early psychosis (COPE), a phase 
specific cognitive therapy intervention aimed at reducing the impact of early 
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psychosis on an individual’s identity and sense of self, but reported few significant 
findings (290). In fact one study in the series report and increase in suicidal 
behaviours in the treatment group(289). Jackson’s (291) study in 2009 concluded 
that with regard to CBT for depression in established schizophrenia, overall there 
was no evidence that depression can be significantly reduced with specific 
intervention. In that study, the best predictor of “post-intervention depression” was 
the level of pre intervention depression, reflecting results presented in this thesis; 
that previous and early depression will predict subsequent episodes. Thus the timing 
of interventions and the specific targeting of negative appraisals early in the course 
of FEP may be a way forward. 
  
Furthermore, as evidenced by results presented in this thesis, negative appraisals 
must be seen within a cultural and social context from which they develop. Health 
belief models, stigmatization, culture and ethnicity may all play a role in the 
propensity to develop negative appraisals in the face of psychosis. The next step is 
to ascertain whether these factors can be modified. Further information and larger 
scale studies are needed to further understand the complex development of loss, 
shame and entrapment. If indeed some ethno-semantic beliefs are protective of 
negative appraisals, and depression, then how this may influence recovery and 
outcome needs to be understood. Both qualitative and wider quantitative studies 
focusing on negative appraisals, health beliefs, recovery style, ethnicity and culture 
linking in to functional outcome and suicide are strongly indicated. 
The studies presented in this thesis move forward the evidence base and knowledge 
of the frequency and importance of depression in FEP, together with new models to 
further explore in terms of the development of this depression both within an 
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individual’s threat to self and wider sociocultural group influences. Care must be 
given however, as to the over assumption moving association to causality. Caution in 
the direction of influence, for example in the development of feelings of shame and 
entrapment occurring because an overarching depression has developed cannot be 
ignored. Further work is needed to fully establish this direction, as indeed what 
interventions may influence the development of depression at this important stage.  
The papers presented in this thesis do bring together and advance recent knowledge 
as to the commonality, theoretical and clinical relevance of depression in early 
psychosis.  The importance of depression, in predicting outcome, by way of further 
episodes of depression, and knowledge of affective dimension in psychosis is clear 
in the results presented.  The psychological response model of depression in 
psychosis can apply to differing stages of psychosis and our increased 
understanding of this has much potential for forming future intervention strategies. 
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